TermID	Term	Enrichment	logP	Genes in Term	Target Genes in Term	Fraction of Targets in Term	Total Target Genes	Total Genes	Entrez Gene IDs	Gene Symbols
R-HSA-1799339	SRP-dependent cotranslational protein targeting to membrane	3.69096420310053e-16	-35.5354737623324	107	40	0.0550964187327824	726	8202	6202,6209,23480,6235,6193,6138,6748,23521,6164,6745,6137,23478,6141,6134,6170,6155,6227,6222,6228,6207,6159,7311,10952,6133,6160,6144,6129,6142,6232,4736,6157,6189,6130,6158,6210,1650,6201,6208,60559,6146	RPS8,RPS15,SEC61G,RPS29,RPS5,RPL15,SSR4,RPL13A,RPL34,SSR1,RPL13,SEC11A,RPL18,RPL10,RPL39,RPL27,RPS21,RPS18,RPS23,RPS13,RPL29,UBA52,SEC61B,RPL9,RPL31,RPL21,RPL7,RPL18A,RPS27,RPL10A,RPL27A,RPS3A,RPL7A,RPL28,RPS15A,DDOST,RPS7,RPS14,SPCS3,RPL22
R-HSA-156842	Eukaryotic Translation Elongation	2.88693208512614e-15	-33.4785820188827	88	35	0.0482093663911846	726	8202	6202,6209,6235,6193,6138,23521,6164,1933,6137,6141,6134,6170,6155,6227,6222,1936,6228,6207,6159,7311,6133,6160,6144,6129,6142,6232,4736,6157,6189,6130,6158,6210,6201,6208,6146	RPS8,RPS15,RPS29,RPS5,RPL15,RPL13A,RPL34,EEF1B2,RPL13,RPL18,RPL10,RPL39,RPL27,RPS21,RPS18,EEF1D,RPS23,RPS13,RPL29,UBA52,RPL9,RPL31,RPL21,RPL7,RPL18A,RPS27,RPL10A,RPL27A,RPS3A,RPL7A,RPL28,RPS15A,RPS7,RPS14,RPL22
R-HSA-192823	Viral mRNA Translation	3.87042083821133e-15	-33.1854131500573	84	34	0.046831955922865	726	8202	6202,6209,5611,6235,6193,6138,23521,6164,6137,6141,6134,6170,6155,6227,6222,6228,6207,6159,7311,6133,6160,6144,6129,6232,6142,4736,6157,6189,6130,6158,6210,6201,6208,6146	RPS8,RPS15,DNAJC3,RPS29,RPS5,RPL15,RPL13A,RPL34,RPL13,RPL18,RPL10,RPL39,RPL27,RPS21,RPS18,RPS23,RPS13,RPL29,UBA52,RPL9,RPL31,RPL21,RPL7,RPS27,RPL18A,RPL10A,RPL27A,RPS3A,RPL7A,RPL28,RPS15A,RPS7,RPS14,RPL22
R-HSA-72764	Eukaryotic Translation Termination	5.9188729916224e-15	-32.7606303371748	85	34	0.046831955922865	726	8202	6202,6209,6235,6193,6138,327,23521,6164,6137,6141,6134,6170,6155,6227,6222,6228,6207,6159,7311,6133,6160,6144,6129,6232,6142,4736,6157,6189,6130,6210,6158,6201,6208,6146	RPS8,RPS15,RPS29,RPS5,RPL15,APEH,RPL13A,RPL34,RPL13,RPL18,RPL10,RPL39,RPL27,RPS21,RPS18,RPS23,RPS13,RPL29,UBA52,RPL9,RPL31,RPL21,RPL7,RPS27,RPL18A,RPL10A,RPL27A,RPS3A,RPL7A,RPS15A,RPL28,RPS7,RPS14,RPL22
R-HSA-156902	Peptide chain elongation	2.78665746360749e-14	-31.2113484660268	84	33	0.0454545454545455	726	8202	6202,6209,6235,6193,6138,23521,6164,6137,6141,6134,6170,6155,6227,6222,6228,6207,6159,7311,6133,6160,6144,6129,6232,6142,4736,6157,6189,6130,6210,6158,6201,6208,6146	RPS8,RPS15,RPS29,RPS5,RPL15,RPL13A,RPL34,RPL13,RPL18,RPL10,RPL39,RPL27,RPS21,RPS18,RPS23,RPS13,RPL29,UBA52,RPL9,RPL31,RPL21,RPL7,RPS27,RPL18A,RPL10A,RPL27A,RPS3A,RPL7A,RPS15A,RPL28,RPS7,RPS14,RPL22
R-HSA-72766	Translation	1.02934959020109e-13	-29.9046790719638	146	44	0.0606060606060606	726	8202	6202,6209,23480,6235,6193,6138,327,6748,23521,6164,1933,6745,6137,23478,6141,6134,6170,6155,6227,8665,6222,1936,6228,6207,6159,7311,10952,6133,6160,6144,6129,6142,6232,4736,6157,6189,6130,6158,6210,1650,6201,6208,60559,6146	RPS8,RPS15,SEC61G,RPS29,RPS5,RPL15,APEH,SSR4,RPL13A,RPL34,EEF1B2,SSR1,RPL13,SEC11A,RPL18,RPL10,RPL39,RPL27,RPS21,EIF3F,RPS18,EEF1D,RPS23,RPS13,RPL29,UBA52,SEC61B,RPL9,RPL31,RPL21,RPL7,RPL18A,RPS27,RPL10A,RPL27A,RPS3A,RPL7A,RPL28,RPS15A,DDOST,RPS7,RPS14,SPCS3,RPL22
R-HSA-72689	Formation of a pool of free 40S subunits	1.96305796527412e-13	-29.2591027651421	94	34	0.046831955922865	726	8202	6202,6209,6235,6193,6138,23521,6164,6137,6141,6134,6170,6155,6227,8665,6222,6228,6207,6159,7311,6133,6160,6144,6129,6232,6142,4736,6157,6189,6130,6158,6210,6201,6208,6146	RPS8,RPS15,RPS29,RPS5,RPL15,RPL13A,RPL34,RPL13,RPL18,RPL10,RPL39,RPL27,RPS21,EIF3F,RPS18,RPS23,RPS13,RPL29,UBA52,RPL9,RPL31,RPL21,RPL7,RPS27,RPL18A,RPL10A,RPL27A,RPS3A,RPL7A,RPL28,RPS15A,RPS7,RPS14,RPL22
R-HSA-975956	Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC)	1.96917879005909e-13	-29.2559896109201	89	33	0.0454545454545455	726	8202	6202,6209,6235,6193,6138,23521,6164,6137,6141,6134,6170,6155,6227,6222,6228,6207,6159,6133,7311,6160,6144,6129,6232,6142,4736,6157,6189,6130,6210,6158,6201,6208,6146	RPS8,RPS15,RPS29,RPS5,RPL15,RPL13A,RPL34,RPL13,RPL18,RPL10,RPL39,RPL27,RPS21,RPS18,RPS23,RPS13,RPL29,RPL9,UBA52,RPL31,RPL21,RPL7,RPS27,RPL18A,RPL10A,RPL27A,RPS3A,RPL7A,RPS15A,RPL28,RPS7,RPS14,RPL22
R-HSA-156827	L13a-mediated translational silencing of Ceruloplasmin expression	5.46180547853191e-12	-25.9332417071084	104	34	0.046831955922865	726	8202	6202,6209,6235,6193,6138,23521,6164,6137,6141,6134,6170,6155,6227,8665,6222,6228,6207,6159,7311,6133,6160,6144,6129,6232,6142,4736,6157,6189,6130,6158,6210,6201,6208,6146	RPS8,RPS15,RPS29,RPS5,RPL15,RPL13A,RPL34,RPL13,RPL18,RPL10,RPL39,RPL27,RPS21,EIF3F,RPS18,RPS23,RPS13,RPL29,UBA52,RPL9,RPL31,RPL21,RPL7,RPS27,RPL18A,RPL10A,RPL27A,RPS3A,RPL7A,RPL28,RPS15A,RPS7,RPS14,RPL22
R-HSA-72706	GTP hydrolysis and joining of the 60S ribosomal subunit	7.41114949519753e-12	-25.6280355610946	105	34	0.046831955922865	726	8202	6202,6209,6235,6193,6138,23521,6164,6137,6141,6134,6170,6155,6227,8665,6222,6228,6207,6159,7311,6133,6160,6144,6129,6232,6142,4736,6157,6189,6130,6158,6210,6201,6208,6146	RPS8,RPS15,RPS29,RPS5,RPL15,RPL13A,RPL34,RPL13,RPL18,RPL10,RPL39,RPL27,RPS21,EIF3F,RPS18,RPS23,RPS13,RPL29,UBA52,RPL9,RPL31,RPL21,RPL7,RPS27,RPL18A,RPL10A,RPL27A,RPS3A,RPL7A,RPL28,RPS15A,RPS7,RPS14,RPL22
R-HSA-168254	Influenza Infection	1.19238799508353e-11	-25.1524780080236	147	41	0.0564738292011019	726	8202	6202,6209,5611,6235,6193,6138,3303,23521,6164,6137,6141,6134,55746,6170,6155,6227,6222,6228,6207,6159,7311,6133,5441,3841,6160,6144,6129,6142,6232,4736,6157,9636,3304,6189,6130,6158,6210,6201,6208,3838,6146	RPS8,RPS15,DNAJC3,RPS29,RPS5,RPL15,HSPA1A,RPL13A,RPL34,RPL13,RPL18,RPL10,NUP133,RPL39,RPL27,RPS21,RPS18,RPS23,RPS13,RPL29,UBA52,RPL9,POLR2L,KPNA5,RPL31,RPL21,RPL7,RPL18A,RPS27,RPL10A,RPL27A,ISG15,HSPA1B,RPS3A,RPL7A,RPL28,RPS15A,RPS7,RPS14,KPNA2,RPL22
R-HSA-927802	Nonsense-Mediated Decay (NMD)	5.03441607161692e-11	-23.7121384773491	106	33	0.0454545454545455	726	8202	6202,6209,6235,6193,6138,23521,6164,6137,6141,6134,6170,6155,6227,6222,6228,6207,6159,6133,7311,6160,6144,6129,6232,6142,4736,6157,6189,6130,6210,6158,6201,6208,6146	RPS8,RPS15,RPS29,RPS5,RPL15,RPL13A,RPL34,RPL13,RPL18,RPL10,RPL39,RPL27,RPS21,RPS18,RPS23,RPS13,RPL29,RPL9,UBA52,RPL31,RPL21,RPL7,RPS27,RPL18A,RPL10A,RPL27A,RPS3A,RPL7A,RPS15A,RPL28,RPS7,RPS14,RPL22
R-HSA-975957	Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC)	5.03441607161692e-11	-23.7121384773491	106	33	0.0454545454545455	726	8202	6202,6209,6235,6193,6138,23521,6164,6137,6141,6134,6170,6155,6227,6222,6228,6207,6159,6133,7311,6160,6144,6129,6232,6142,4736,6157,6189,6130,6210,6158,6201,6208,6146	RPS8,RPS15,RPS29,RPS5,RPL15,RPL13A,RPL34,RPL13,RPL18,RPL10,RPL39,RPL27,RPS21,RPS18,RPS23,RPS13,RPL29,RPL9,UBA52,RPL31,RPL21,RPL7,RPS27,RPL18A,RPL10A,RPL27A,RPS3A,RPL7A,RPS15A,RPL28,RPS7,RPS14,RPL22
R-HSA-72737	Cap-dependent Translation Initiation	5.56326614371184e-11	-23.6122506512256	112	34	0.046831955922865	726	8202	6202,6209,6235,6193,6138,23521,6164,6137,6141,6134,6170,6155,6227,8665,6222,6228,6207,6159,7311,6133,6160,6144,6129,6232,6142,4736,6157,6189,6130,6158,6210,6201,6208,6146	RPS8,RPS15,RPS29,RPS5,RPL15,RPL13A,RPL34,RPL13,RPL18,RPL10,RPL39,RPL27,RPS21,EIF3F,RPS18,RPS23,RPS13,RPL29,UBA52,RPL9,RPL31,RPL21,RPL7,RPS27,RPL18A,RPL10A,RPL27A,RPS3A,RPL7A,RPL28,RPS15A,RPS7,RPS14,RPL22
R-HSA-72613	Eukaryotic Translation Initiation	5.56326614371184e-11	-23.6122506512256	112	34	0.046831955922865	726	8202	6202,6209,6235,6193,6138,23521,6164,6137,6141,6134,6170,6155,6227,8665,6222,6228,6207,6159,7311,6133,6160,6144,6129,6232,6142,4736,6157,6189,6130,6158,6210,6201,6208,6146	RPS8,RPS15,RPS29,RPS5,RPL15,RPL13A,RPL34,RPL13,RPL18,RPL10,RPL39,RPL27,RPS21,EIF3F,RPS18,RPS23,RPS13,RPL29,UBA52,RPL9,RPL31,RPL21,RPL7,RPS27,RPL18A,RPL10A,RPL27A,RPS3A,RPL7A,RPL28,RPS15A,RPS7,RPS14,RPL22
R-HSA-168255	Influenza Life Cycle	6.46513505481691e-11	-23.4620121207793	136	38	0.0523415977961433	726	8202	6202,6209,5611,6235,6193,6138,3303,23521,6164,6137,6141,6134,55746,6170,6155,6227,6222,6228,6207,6159,7311,6133,5441,6160,6144,6129,6142,6232,4736,6157,3304,6189,6130,6158,6210,6201,6208,6146	RPS8,RPS15,DNAJC3,RPS29,RPS5,RPL15,HSPA1A,RPL13A,RPL34,RPL13,RPL18,RPL10,NUP133,RPL39,RPL27,RPS21,RPS18,RPS23,RPS13,RPL29,UBA52,RPL9,POLR2L,RPL31,RPL21,RPL7,RPL18A,RPS27,RPL10A,RPL27A,HSPA1B,RPS3A,RPL7A,RPL28,RPS15A,RPS7,RPS14,RPL22
R-HSA-168273	Influenza Viral RNA Transcription and Replication	1.32749198446664e-10	-22.7425594938913	127	36	0.0495867768595041	726	8202	6202,6209,5611,6235,6193,6138,23521,6164,6137,6141,6134,55746,6170,6155,6227,6222,6228,6207,6159,7311,6133,5441,6160,6144,6129,6142,6232,4736,6157,6189,6130,6158,6210,6201,6208,6146	RPS8,RPS15,DNAJC3,RPS29,RPS5,RPL15,RPL13A,RPL34,RPL13,RPL18,RPL10,NUP133,RPL39,RPL27,RPS21,RPS18,RPS23,RPS13,RPL29,UBA52,RPL9,POLR2L,RPL31,RPL21,RPL7,RPL18A,RPS27,RPL10A,RPL27A,RPS3A,RPL7A,RPL28,RPS15A,RPS7,RPS14,RPL22
R-HSA-392499	Metabolism of proteins	1.03622017801971e-06	-13.7799309096616	943	125	0.172176308539945	726	8202	9945,4351,9820,64924,10383,5611,9091,6235,6193,1798,84617,79642,1933,6745,410,1912,23478,3670,6141,6464,6134,25813,55746,8733,6227,8665,5627,6222,3998,10130,1363,10159,84261,6207,1639,152,10484,6159,8615,6133,7311,10952,7941,4597,6160,7039,6612,6142,25870,6232,26503,672,55741,4736,10610,8869,29926,2934,1650,6903,79694,3703,55062,6201,6208,6400,6483,55568,8237,6146,6202,6209,3489,23480,7508,6138,327,136,23265,6748,23521,4000,4189,6164,4121,6137,4245,9632,6170,1471,6904,6155,149371,5238,653604,3485,54512,55033,9114,1936,6228,516,9868,10678,9761,51604,6144,11253,80267,6129,84790,6157,6189,6130,10897,2517,11196,6158,6210,4905,5371,85365,60559,140838,37	GFPT2,MPI,CUL7,SLC30A5,TUBB4B,DNAJC3,PIGQ,RPS29,RPS5,DPAGT1,TUBB6,ARSJ,EEF1B2,SSR1,ARSA,PHC2,SEC11A,ISL1,RPL18,SHC1,RPL10,SAMM50,NUP133,GPAA1,RPS21,EIF3F,PROS1,RPS18,LMAN1,PDIA6,CPE,ATP6AP2,FBXW9,RPS13,DCTN1,ADRA2C,SEC23A,RPL29,USO1,RPL9,UBA52,SEC61B,PLA2G7,MVD,RPL31,TGFA,SUMO3,RPL18A,SUMF2,RPS27,SLC17A5,BRCA1,EDEM2,RPL10A,ST6GALNAC2,ST3GAL5,GMPPA,GSN,DDOST,TBCC,MANEA,STT3A,WIPI1,RPS7,RPS14,SEL1L,ST3GAL2,GALNT10,USP11,RPL22,RPS8,RPS15,IGFBP6,SEC61G,XPC,RPL15,APEH,ADORA2B,EXOC7,SSR4,RPL13A,LMNA,DNAJB9,RPL34,MAN1A1,RPL13,MGAT1,SEC24C,RPL39,CST3,TBCD,RPL27,EXOC8,PGM3,HIST2H3D,IGFBP2,EXOSC4,FKBP14,ATP6V0D1,EEF1D,RPS23,ATP5G1,TOMM70A,B3GNT2,MLEC,PIGT,RPL21,MAN1B1,EDEM3,RPL7,TUBA1C,RPL27A,RPS3A,RPL7A,YIF1A,FUCA1,SEC23IP,RPL28,RPS15A,NSF,PML,ALG2,SPCS3,NANP,ACADVL
R-HSA-1643685	Disease	1.98333831560689e-06	-13.1307291150073	657	93	0.128099173553719	726	8202	375790,5721,5611,79885,6235,6193,2064,5720,54894,1026,162,3303,6141,182,4193,6464,6134,55746,5290,1027,6227,6222,60489,55534,6207,6159,6133,7311,3841,5441,8322,51107,6160,6142,6232,4736,292,2260,51616,572,6827,6201,6208,399687,6400,6772,1174,3065,3838,6146,1175,6202,6209,2308,6138,3978,3105,57534,23521,6164,6137,2261,6170,2232,6155,6774,6228,4851,2254,4303,6144,5295,8841,6129,5905,54492,6829,6157,1956,9636,3304,6189,6130,3667,155382,6158,6210,2263,160,1462,4792,7855,164	AGRN,PSME2,DNAJC3,HDAC11,RPS29,RPS5,ERBB2,PSME1,RNF43,CDKN1A,AP1B1,HSPA1A,RPL18,JAG1,MDM2,SHC1,RPL10,NUP133,PIK3CA,CDKN1B,RPS21,RPS18,APOBEC3G,MAML3,RPS13,RPL29,RPL9,UBA52,KPNA5,POLR2L,FZD4,APH1A,RPL31,RPL18A,RPS27,RPL10A,SLC25A5,FGFR1,TAF9B,BAD,SUPT4H1,RPS7,RPS14,MYO18A,SEL1L,STAT1,AP1S1,HDAC1,KPNA2,RPL22,AP2S1,RPS8,RPS15,FOXO1,RPL15,LIG1,HLA-A,MIB1,RPL13A,RPL34,RPL13,FGFR3,RPL39,FDXR,RPL27,STAT3,RPS23,NOTCH1,FGF9,FOXO4,RPL21,PIK3R1,HDAC3,RPL7,RANGAP1,NEURL1B,SUPT5H,RPL27A,EGFR,ISG15,HSPA1B,RPS3A,RPL7A,IRS1,VPS37D,RPL28,RPS15A,FGFR2,AP2A1,VCAN,NFKBIA,FZD5,AP1G1
R-HSA-5663205	Infectious disease	2.66408733677693e-06	-12.8356490217481	347	57	0.0785123966942149	726	8202	6202,6209,5721,5611,6235,6193,6138,3978,5720,162,3303,3105,23521,6164,6137,6141,6134,55746,6170,6155,6227,6222,60489,6228,6207,6159,7311,6133,3841,5441,6160,6144,6129,6142,6232,5905,4736,6829,6157,292,9636,3304,51616,6189,6130,155382,6827,6158,6210,6201,6208,160,1174,3838,6146,164,1175	RPS8,RPS15,PSME2,DNAJC3,RPS29,RPS5,RPL15,LIG1,PSME1,AP1B1,HSPA1A,HLA-A,RPL13A,RPL34,RPL13,RPL18,RPL10,NUP133,RPL39,RPL27,RPS21,RPS18,APOBEC3G,RPS23,RPS13,RPL29,UBA52,RPL9,KPNA5,POLR2L,RPL31,RPL21,RPL7,RPL18A,RPS27,RANGAP1,RPL10A,SUPT5H,RPL27A,SLC25A5,ISG15,HSPA1B,TAF9B,RPS3A,RPL7A,VPS37D,SUPT4H1,RPL28,RPS15A,RPS7,RPS14,AP2A1,AP1S1,KPNA2,RPL22,AP1G1,AP2S1
R-HSA-381038	XBP1(S) activates chaperone genes	3.54423871079676e-05	-10.2476020781761	53	15	0.0206611570247934	726	8202	10897,9820,10952,6464,55062,23480,5611,10130,37,55033,9114,4189,4000,1639,6745	YIF1A,CUL7,SEC61B,SHC1,WIPI1,SEC61G,DNAJC3,PDIA6,ACADVL,FKBP14,ATP6V0D1,DNAJB9,LMNA,DCTN1,SSR1
R-HSA-72695	Formation of the ternary complex, and subsequently, the 43S complex	4.45490598252219e-05	-10.0189195080811	48	14	0.0192837465564738	726	8202	6202,6209,6210,6201,6208,6235,6193,8665,6227,6232,6222,6228,6189,6207	RPS8,RPS15,RPS15A,RPS7,RPS14,RPS29,RPS5,EIF3F,RPS21,RPS27,RPS18,RPS23,RPS3A,RPS13
R-HSA-381070	IRE1alpha activates chaperones	5.70561694818496e-05	-9.77147434584051	55	15	0.0206611570247934	726	8202	10897,9820,10952,6464,55062,23480,5611,10130,37,55033,9114,4189,4000,1639,6745	YIF1A,CUL7,SEC61B,SHC1,WIPI1,SEC61G,DNAJC3,PDIA6,ACADVL,FKBP14,ATP6V0D1,DNAJB9,LMNA,DCTN1,SSR1
R-HSA-191273	Cholesterol biosynthesis	8.31133272240706e-05	-9.39530549322076	23	9	0.012396694214876	726	8202	4047,3422,4598,6307,4597,7108,6713,3156,2222	LSS,IDI1,MVK,MSMO1,MVD,TM7SF2,SQLE,HMGCR,FDFT1
R-HSA-983170	Antigen Presentation: Folding, assembly and peptide loading of class I MHC	0.000122629388517814	-9.0063438526024	24	9	0.012396694214876	726	8202	3106,10484,6892,9632,6890,51752,3107,3105,64167	HLA-B,SEC23A,TAPBP,SEC24C,TAP1,ERAP1,HLA-C,HLA-A,ERAP2
R-HSA-2122948	Activated NOTCH1 Transmits Signal to the Nucleus	0.000161774544275647	-8.72930689405074	30	10	0.0137741046831956	726	8202	4851,182,7311,51107,23220,113878,54492,92737,57534,1272	NOTCH1,JAG1,UBA52,APH1A,DTX4,DTX2,NEURL1B,DNER,MIB1,CNTN1
R-HSA-909733	Interferon alpha/beta signaling	0.000220386325374543	-8.42012852719047	68	16	0.0220385674931129	726	8202	10410,11274,3664,8638,3437,9636,6773,3105,9021,3433,3106,6772,103,3107,4940,3659	IFITM3,USP18,IRF6,OASL,IFIT3,ISG15,STAT2,HLA-A,SOCS3,IFIT2,HLA-B,STAT1,ADAR,HLA-C,OAS3,IRF1
R-HSA-72702	Ribosomal scanning and start codon recognition	0.000224210176857979	-8.40292665648316	55	14	0.0192837465564738	726	8202	6202,6209,6210,6201,6208,6235,6193,8665,6227,6232,6222,6228,6189,6207	RPS8,RPS15,RPS15A,RPS7,RPS14,RPS29,RPS5,EIF3F,RPS21,RPS27,RPS18,RPS23,RPS3A,RPS13
R-HSA-72649	Translation initiation complex formation	0.000224210176857979	-8.40292665648316	55	14	0.0192837465564738	726	8202	6202,6209,6210,6201,6208,6235,6193,8665,6227,6232,6222,6228,6189,6207	RPS8,RPS15,RPS15A,RPS7,RPS14,RPS29,RPS5,EIF3F,RPS21,RPS27,RPS18,RPS23,RPS3A,RPS13
R-HSA-77286	mitochondrial fatty acid beta-oxidation of saturated fatty acids	0.000239248725724997	-8.33800685376871	8	5	0.0068870523415978	726	8202	35,3033,37,1892,3032	ACADS,HADH,ACADVL,ECHS1,HADHB
R-HSA-72662	Activation of the mRNA upon binding of the cap-binding complex and eIFs, and subsequent binding to 43S	0.000275058752812827	-8.19852583652479	56	14	0.0192837465564738	726	8202	6202,6209,6210,6201,6208,6235,6193,8665,6227,6232,6222,6228,6189,6207	RPS8,RPS15,RPS15A,RPS7,RPS14,RPS29,RPS5,EIF3F,RPS21,RPS27,RPS18,RPS23,RPS3A,RPS13
R-HSA-77350	Beta oxidation of hexanoyl-CoA to butanoyl-CoA	0.000283158780870117	-8.16950275451283	5	4	0.00550964187327824	726	8202	35,3033,1892,3032	ACADS,HADH,ECHS1,HADHB
R-HSA-1980143	Signaling by NOTCH1	0.000441516622235777	-7.72529488917082	72	16	0.0220385674931129	726	8202	4851,7311,51107,79885,8841,54492,92737,57534,182,3091,23220,3065,7088,113878,1272,55534	NOTCH1,UBA52,APH1A,HDAC11,HDAC3,NEURL1B,DNER,MIB1,JAG1,HIF1A,DTX4,HDAC1,TLE1,DTX2,CNTN1,MAML3
R-HSA-446203	Asparagine N-linked glycosylation	0.000544037154165544	-7.51649301534211	181	30	0.0413223140495868	726	8202	9945,10484,4351,8615,9761,4597,7039,11253,80267,1798,26503,55741,10610,8869,29926,4121,2517,11196,1650,79694,4245,3703,4905,9632,6400,5238,6483,85365,140838,3998	GFPT2,SEC23A,MPI,USO1,MLEC,MVD,TGFA,MAN1B1,EDEM3,DPAGT1,SLC17A5,EDEM2,ST6GALNAC2,ST3GAL5,GMPPA,MAN1A1,FUCA1,SEC23IP,DDOST,MANEA,MGAT1,STT3A,NSF,SEC24C,SEL1L,PGM3,ST3GAL2,ALG2,NANP,LMAN1
R-HSA-157118	Signaling by NOTCH	0.000558701046371287	-7.48989602863304	110	21	0.0289256198347107	726	8202	4851,7311,51107,79885,8841,54492,92737,57534,3725,595,182,5986,3091,23220,6400,7088,3065,113878,4343,55534,1272	NOTCH1,UBA52,APH1A,HDAC11,HDAC3,NEURL1B,DNER,MIB1,JUN,CCND1,JAG1,RFNG,HIF1A,DTX4,SEL1L,TLE1,HDAC1,DTX2,MOV10,MAML3,CNTN1
R-HSA-3299685	Detoxification of Reactive Oxygen Species	0.00062711792715764	-7.37437595342535	29	9	0.012396694214876	726	8202	847,2936,7295,25824,475,6648,2950,9973,2876	CAT,GSR,TXN,PRDX5,ATOX1,SOD2,GSTP1,CCS,GPX1
R-HSA-77352	Beta oxidation of butanoyl-CoA to acetyl-CoA	0.000690896136690219	-7.27752105419131	3	3	0.00413223140495868	726	8202	35,3033,1892	ACADS,HADH,ECHS1
R-HSA-351200	Interconversion of polyamines	0.000690896136690219	-7.27752105419131	3	3	0.00413223140495868	726	8202	196743,54498,6303	PAOX,SMOX,SAT1
R-HSA-2262752	Cellular responses to stress	0.000854808563898033	-7.06463301597093	379	52	0.0716253443526171	726	8202	9134,1030,23043,10808,5564,7295,3397,6767,5565,8655,6648,3337,1026,2950,9973,8726,3303,1912,3725,6118,1031,4193,2936,55746,28956,1027,653604,51434,112399,6774,3306,7014,7311,475,3312,23466,5571,2353,3304,847,817,2114,55062,3091,25824,8453,10670,5594,4343,11065,2876,405	CCNE2,CDKN2B,TNIK,HSPH1,PRKAB1,TXN,ID1,ST13,PRKAB2,DYNLL1,SOD2,DNAJB1,CDKN1A,GSTP1,CCS,EED,HSPA1A,PHC2,JUN,RPA2,CDKN2C,MDM2,GSR,NUP133,LAMTOR2,CDKN1B,HIST2H3D,ANAPC7,EGLN3,STAT3,HSPA2,TERF2,UBA52,ATOX1,HSPA8,CBX6,PRKAG1,FOS,HSPA1B,CAT,CAMK2D,ETS2,WIPI1,HIF1A,PRDX5,CUL2,RRAGA,MAPK1,MOV10,UBE2C,GPX1,ARNT
R-HSA-74160	Gene Expression	0.00152325672594532	-6.48690465332248	1330	147	0.202479338842975	726	8202	7559,7295,5565,134353,196513,64426,5720,79898,79042,83443,6745,85441,6427,143686,6141,6134,22869,8665,6227,6222,30834,7311,6133,7561,5468,10557,6628,6160,3312,5571,4736,27244,10421,51616,6827,10520,57570,115509,6208,25824,7768,55699,27297,3065,7596,3315,5442,6209,57343,860,23480,55621,1660,327,6138,677,6748,23521,6137,1656,126070,6170,94039,10642,64425,6228,1936,171392,10780,9219,388561,6829,4781,81856,221830,7025,6130,10940,155054,6158,50484,5859,9167,90338,10670,25973,29959,2810,5564,55599,5721,6235,55659,8270,10978,6193,7576,79074,85456,3303,79818,1933,23478,54700,2936,55746,28956,103,7769,6207,55534,6159,10952,5441,6232,79084,6142,1650,6201,55157,80818,6146,6202,1030,9422,51058,8726,6164,158399,6155,253639,653604,54512,4851,7050,79862,6144,6129,204851,6157,57547,3304,6189,148254,58492,6210,60559	ZNF12,TXN,PRKAB2,LSM11,DCP1B,SUDS3,PSME1,ZNF613,TSEN34,SF3B5,SSR1,HELZ2,SRSF2,SESN3,RPL18,RPL10,ZNF510,EIF3F,RPS21,RPS18,ZNRD1,UBA52,RPL9,ZNF14,PPARG,RPP38,SNRPB,RPL31,HSPA8,PRKAG1,RPL10A,SESN1,CD2BP2,TAF9B,SUPT4H1,ZNF211,TRMT5,ZNF689,RPS14,PRDX5,ZNF225,IARS2,CRCP,HDAC1,ZNF45,HSPB1,POLRMT,RPS15,ZNF304,RUNX2,SEC61G,TRMT1,DHX9,APEH,RPL15,ZFP36L1,SSR4,RPL13A,RPL13,DDX6,ZNF440,RPL39,ZNF101,IGF2BP1,POLR1E,RPS23,EEF1D,ZNF675,ZNF234,MTA2,ZNF761,SUPT5H,NFIB,ZNF611,TWISTNB,NR2F1,RPL7A,POP1,ZNF425,RPL28,RRM2B,QARS,COX7A2L,ZNF160,RRAGA,PARS2,NRBP1,SFN,PRKAB1,RNPC3,PSME2,RPS29,ZNF416,LAGE3,CLP1,RPS5,ZNF28,C2orf49,TNKS1BP1,HSPA1A,ZNF552,EEF1B2,SEC11A,RRN3,GSR,NUP133,LAMTOR2,ADAR,ZNF226,RPS13,MAML3,RPL29,SEC61B,POLR2L,RPS27,WDR77,RPL18A,DDOST,RPS7,DARS2,ZNF436,RPL22,RPS8,CDKN2B,ZNF264,ZNF691,EED,RPL34,ZNF483,RPL27,ZNF620,HIST2H3D,EXOSC4,NOTCH1,TGIF1,ZNF669,RPL21,RPL7,HIPK1,RPL27A,ZNF624,HSPA1B,RPS3A,ZNF555,ZNF77,RPS15A,SPCS3
R-HSA-1059683	Interleukin-6 signaling	0.0015741093999055	-6.45406562701501	11	5	0.0068870523415978	726	8202	3570,6774,3572,6772,9021	IL6R,STAT3,IL6ST,STAT1,SOCS3
R-HSA-5625900	RHO GTPases activate CIT	0.00173814528447061	-6.35493666272664	16	6	0.00826446280991736	726	8202	4637,1027,4628,389,9928,388	MYL6,CDKN1B,MYH10,RHOC,KIF14,RHOB
R-HSA-1655829	Regulation of cholesterol biosynthesis by SREBP (SREBF)	0.00223507965964383	-6.10347840965296	54	12	0.0165289256198347	726	8202	10484,4047,85441,3422,4598,9632,4597,6713,7108,57678,2222,3156	SEC23A,LSS,HELZ2,IDI1,MVK,SEC24C,MVD,SQLE,TM7SF2,GPAM,FDFT1,HMGCR
R-HSA-2426168	Activation of gene expression by SREBF (SREBP)	0.00247057999805163	-6.0033023388825	41	10	0.0137741046831956	726	8202	4047,85441,3422,4598,4597,6713,7108,57678,2222,3156	LSS,HELZ2,IDI1,MVK,MVD,SQLE,TM7SF2,GPAM,FDFT1,HMGCR
R-HSA-264870	Caspase-mediated cleavage of cytoskeletal proteins	0.00250334649559223	-5.99012684399499	12	5	0.0068870523415978	726	8202	836,2934,7431,840,6709	CASP3,GSN,VIM,CASP7,SPTAN1
R-HSA-75035	Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex	0.00250334649559223	-5.99012684399499	12	5	0.0068870523415978	726	8202	7465,891,995,983,2810	WEE1,CCNB1,CDC25C,CDK1,SFN
R-HSA-3000157	Laminin interactions	0.00286879659169175	-5.85386264317471	23	7	0.00964187327823691	726	8202	3910,3913,3685,3909,3675,3691,3912	LAMA4,LAMB2,ITGAV,LAMA3,ITGA3,ITGB4,LAMB1
R-HSA-3000171	Non-integrin membrane-ECM interactions	0.00299108284768162	-5.81211980072709	42	10	0.0137741046831956	726	8202	3910,3909,375790,3912,3913,59277,87,3685,3691,780	LAMA4,LAMA3,AGRN,LAMB1,LAMB2,NTN4,ACTN1,ITGAV,ITGB4,DDR1
R-HSA-381119	Unfolded Protein Response (UPR)	0.00322399076372534	-5.73713531919132	86	16	0.0220385674931129	726	8202	9820,10952,23480,5611,4189,4000,6745,10897,6464,55062,54512,37,10130,9114,55033,1639	CUL7,SEC61B,SEC61G,DNAJC3,DNAJB9,LMNA,SSR1,YIF1A,SHC1,WIPI1,EXOSC4,ACADVL,PDIA6,ATP6V0D1,FKBP14,DCTN1
R-HSA-1430728	Metabolism	0.00323976656435676	-5.73225399981152	1691	179	0.246556473829201	726	8202	1591,4598,7295,4712,375790,1376,5565,27242,113278,7358,3074,5720,4942,2752,79586,1890,85441,6821,548596,9061,5290,3032,7385,5499,1738,204962,1545,35,7311,5468,8612,25870,292,93100,5162,126969,7263,4047,7298,8714,6483,6794,4702,3636,84803,51477,2053,1119,2799,760,8824,6307,5211,54498,10476,112,51582,191,8694,5631,223,2052,2222,4907,4522,3156,56603,516,91289,3992,54704,8841,2274,5836,7108,3615,9517,51129,847,51292,50484,1462,9167,6713,4190,55748,66002,37,2582,9060,1728,5721,57214,3635,6513,7389,9123,10162,9615,79642,54539,6389,8895,2783,410,5331,5164,2936,3422,55746,65263,64428,2941,51074,51703,152,10484,7390,4597,8800,1371,6303,55788,9446,8050,123,54331,196743,53905,221,210,51363,8821,51495,113612,8566,4048,2730,10295,55191,4719,8760,6819,55276,84245,7086,682,54797,2950,788,2937,373156,3038,9632,1384,2232,26027,501,4728,960,6576,2184,5236,60481,10678,83401,5295,1892,7384,5264,5834,3033,51,5243,38,57678,5223,2876,3712	CYP24A1,MVK,TXN,NDUFB6,AGRN,CPT2,PRKAB2,TNFRSF21,SLC52A3,UGDH,HEXB,PSME1,OAT,GLUL,CHPF,TYMP,HELZ2,SUOX,CKMT1A,PAPSS1,PIK3CA,HADHB,UQCRC2,PPP1CA,DLD,SLC44A5,CYP1B1,ACADS,UBA52,PPARG,PLPP2,SUMF2,SLC25A5,NAPRT,PDHB,SLC44A3,TST,LSS,TYMS,ABCC3,ST3GAL2,STK11,NDUFA8,INPPL1,GPAT3,ISYNA1,EPHX2,CHKA,GNS,CA2,CES2,MSMO1,PFKL,SMOX,ATP5H,ADCY6,AZIN1,AHCY,DGAT1,PRPS1,ALDH9A1,EPHX1,FDFT1,NT5E,MTHFD1,HMGCR,CYP26B1,ATP5G1,LMF2,FADS1,PDP1,HDAC3,FHL2,PYGL,TM7SF2,IMPDH2,SPTLC2,ANGPTL4,CAT,GMPR2,RRM2B,VCAN,COX7A2L,SQLE,MDH1,CNDP2,CYP4F12,ACADVL,GALE,PAPSS2,NQO1,PSME2,CEMIP,INPP5D,SLC2A1,UROD,SLC16A3,LPCAT3,GDA,ARSJ,NDUFB11,SDHA,CPNE3,GNB2,ARSA,PLCB3,PDK2,GSR,IDI1,NUP133,PYCRL,NARFL,GSTA4,APIP,ACSL5,ADRA2C,SEC23A,UROS,MVD,PEX11A,CPOX,SAT1,LMBRD1,GSTO1,PDHX,PLIN2,GNG2,PAOX,DUOX1,ALDH3B1,ALAD,CHST15,INPP4B,HACD3,CYP2U1,PDXK,LTA4H,GCLM,BCKDK,NADSYN1,NDUFS1,CDS2,SULT1C2,PGM2,MRI1,TKT,BSG,MED18,GSTP1,SLC25A20,GSS,GSTK1,HAS3,SEC24C,CRAT,FDXR,ACOT11,ALDH7A1,NDUFS8,CD44,SLC25A1,FAH,PGM1,ELOVL5,B3GNT2,ELOVL3,PIK3R1,ECHS1,UQCRC1,PHYH,PYGB,HADH,ACOX1,ABCB1,ACAT1,GPAM,PGAM1,GPX1,IVD
R-HSA-535734	Fatty acid, triacylglycerol, and ketone body metabolism	0.0035356416175995	-5.64486049183208	212	31	0.0426997245179063	726	8202	51703,3992,35,60481,5468,1376,5565,27242,84803,8800,8841,83401,1892,2274,54797,51129,788,123,85441,3033,51,26027,3032,38,51495,57678,8694,37,6576,2222,3156	ACSL5,FADS1,ACADS,ELOVL5,PPARG,CPT2,PRKAB2,TNFRSF21,GPAT3,PEX11A,HDAC3,ELOVL3,ECHS1,FHL2,MED18,ANGPTL4,SLC25A20,PLIN2,HELZ2,HADH,ACOX1,ACOT11,HADHB,ACAT1,HACD3,GPAM,DGAT1,ACADVL,SLC25A1,FDFT1,HMGCR
R-HSA-2559585	Oncogene Induced Senescence	0.00365025068197266	-5.61295943375359	30	8	0.0110192837465565	726	8202	1031,1030,4193,7311,3397,2114,4343,5594	CDKN2C,CDKN2B,MDM2,UBA52,ID1,ETS2,MOV10,MAPK1
R-HSA-416572	Sema4D induced cell migration and growth-cone collapse	0.00374594949711838	-5.58708015686682	24	7	0.00964187327823691	726	8202	4637,2064,998,4628,389,9475,388	MYL6,ERBB2,CDC42,MYH10,RHOC,ROCK2,RHOB
R-HSA-1614635	Sulfur amino acid metabolism	0.00374594949711838	-5.58708015686682	24	7	0.00964187327823691	726	8202	2730,191,51074,55748,6821,84245,7263	GCLM,AHCY,APIP,CNDP2,SUOX,MRI1,TST
R-HSA-70268	Pyruvate metabolism	0.00374594949711838	-5.58708015686682	24	7	0.00964187327823691	726	8202	682,5164,54704,1738,8050,5162,9123	BSG,PDK2,PDP1,DLD,PDHX,PDHB,SLC16A3
R-HSA-5362517	Signaling by Retinoic Acid	0.00429264232106646	-5.45085280999005	44	10	0.0137741046831956	726	8202	56603,5164,8854,220,157506,1382,1738,9249,5162,8050	CYP26B1,PDK2,ALDH1A2,ALDH1A3,RDH10,CRABP2,DLD,DHRS3,PDHB,PDHX
R-HSA-3371568	Attenuation phase	0.00544893922361109	-5.21233432712092	14	5	0.0068870523415978	726	8202	3337,3306,3303,3312,3304	DNAJB1,HSPA2,HSPA1A,HSPA8,HSPA1B
R-HSA-204174	Regulation of pyruvate dehydrogenase (PDH) complex	0.00544893922361109	-5.21233432712092	14	5	0.0068870523415978	726	8202	5164,54704,1738,8050,5162	PDK2,PDP1,DLD,PDHX,PDHB
R-HSA-77310	Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA	0.00602729133800937	-5.11145756683926	5	3	0.00413223140495868	726	8202	3033,1892,3032	HADH,ECHS1,HADHB
R-HSA-77346	Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA	0.00602729133800937	-5.11145756683926	5	3	0.00413223140495868	726	8202	3033,1892,3032	HADH,ECHS1,HADHB
R-HSA-77348	Beta oxidation of octanoyl-CoA to hexanoyl-CoA	0.00602729133800937	-5.11145756683926	5	3	0.00413223140495868	726	8202	3033,1892,3032	HADH,ECHS1,HADHB
R-HSA-70370	Galactose catabolism	0.00602729133800937	-5.11145756683926	5	3	0.00413223140495868	726	8202	5236,55276,2582	PGM1,PGM2,GALE
R-HSA-111461	Cytochrome c-mediated apoptotic response	0.00602729133800937	-5.11145756683926	5	3	0.00413223140495868	726	8202	836,840,317	CASP3,CASP7,APAF1
R-HSA-964739	N-glycan trimming and elongation in the cis-Golgi	0.00602729133800937	-5.11145756683926	5	3	0.00413223140495868	726	8202	79694,4245,4121	MANEA,MGAT1,MAN1A1
R-HSA-69478	G2/M DNA replication checkpoint	0.00602729133800937	-5.11145756683926	5	3	0.00413223140495868	726	8202	7465,891,983	WEE1,CCNB1,CDK1
R-HSA-111459	Activation of caspases through apoptosome-mediated cleavage	0.00602729133800937	-5.11145756683926	5	3	0.00413223140495868	726	8202	836,840,317	CASP3,CASP7,APAF1
R-HSA-877300	Interferon gamma signaling	0.00639051460346238	-5.05294048121205	92	16	0.0220385674931129	726	8202	23321,23087,3664,8638,3105,9021,817,3106,7706,5371,6772,3107,4940,3459,960,3659	TRIM2,TRIM35,IRF6,OASL,HLA-A,SOCS3,CAMK2D,HLA-B,TRIM25,PML,STAT1,HLA-C,OAS3,IFNGR1,CD44,IRF1
R-HSA-913531	Interferon Signaling	0.00648283709024768	-5.0385970418652	194	28	0.0385674931129477	726	8202	23586,23321,7311,3841,10410,11274,23087,3664,8638,3437,9636,6773,3105,9021,3106,817,3433,7706,55746,6772,5371,103,3838,4940,3107,960,3459,3659	DDX58,TRIM2,UBA52,KPNA5,IFITM3,USP18,TRIM35,IRF6,OASL,IFIT3,ISG15,STAT2,HLA-A,SOCS3,HLA-B,CAMK2D,IFIT2,TRIM25,NUP133,STAT1,PML,ADAR,KPNA2,OAS3,HLA-C,CD44,IFNGR1,IRF1
R-HSA-2219528	PI3K/AKT Signaling in Cancer	0.00710127373221677	-4.94748111212116	85	15	0.0206611570247934	726	8202	3667,572,2261,2254,4193,4303,2308,2263,5295,5290,1027,2064,1026,1956,2260	IRS1,BAD,FGFR3,FGF9,MDM2,FOXO4,FOXO1,FGFR2,PIK3R1,PIK3CA,CDKN1B,ERBB2,CDKN1A,EGFR,FGFR1
R-HSA-2691232	Constitutive Signaling by NOTCH1 HD Domain Mutants	0.00758673881398957	-4.88135344868475	15	5	0.0068870523415978	726	8202	4851,182,7311,54492,57534	NOTCH1,JAG1,UBA52,NEURL1B,MIB1
R-HSA-2691230	Signaling by NOTCH1 HD Domain Mutants in Cancer	0.00758673881398957	-4.88135344868475	15	5	0.0068870523415978	726	8202	4851,182,7311,54492,57534	NOTCH1,JAG1,UBA52,NEURL1B,MIB1
R-HSA-400685	Sema4D in semaphorin signaling	0.00761066704446513	-4.87820445727511	27	7	0.00964187327823691	726	8202	4637,2064,998,4628,389,9475,388	MYL6,ERBB2,CDC42,MYH10,RHOC,ROCK2,RHOB
R-HSA-180292	GAB1 signalosome	0.00776673615636354	-4.85790525994735	102	17	0.0234159779614325	726	8202	2254,4303,2308,5295,2064,1026,55824,2260,1956,3667,572,2261,4193,2263,5290,1027,4343	FGF9,FOXO4,FOXO1,PIK3R1,ERBB2,CDKN1A,PAG1,FGFR1,EGFR,IRS1,BAD,FGFR3,MDM2,FGFR2,PIK3CA,CDKN1B,MOV10
R-HSA-168330	Viral RNP Complexes in the Host Cell Nucleus	0.00782506674152826	-4.85042301332351	2	2	0.00275482093663912	726	8202	3303,3304	HSPA1A,HSPA1B
R-HSA-141334	PAOs oxidise polyamines to amines	0.00782506674152826	-4.85042301332351	2	2	0.00275482093663912	726	8202	196743,54498	PAOX,SMOX
R-HSA-164938	Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters	0.00803119440463768	-4.82442201929035	21	6	0.00826446280991736	726	8202	1174,162,164,1175,160,3105	AP1S1,AP1B1,AP1G1,AP2S1,AP2A1,HLA-A
R-HSA-2979096	NOTCH2 Activation and Transmission of Signal to the Nucleus	0.00803119440463768	-4.82442201929035	21	6	0.00826446280991736	726	8202	182,7311,54492,51107,57534,1272	JAG1,UBA52,NEURL1B,APH1A,MIB1,CNTN1
R-HSA-174048	APC/C:Cdc20 mediated degradation of Cyclin B	0.00803119440463768	-4.82442201929035	21	6	0.00826446280991736	726	8202	51434,7311,891,11065,983,991	ANAPC7,UBA52,CCNB1,UBE2C,CDK1,CDC20
R-HSA-74259	Purine catabolism	0.00828270513817498	-4.79358565643319	10	4	0.00550964187327824	726	8202	847,9615,2876,4907	CAT,GDA,GPX1,NT5E
R-HSA-901032	ER Quality Control Compartment (ERQC)	0.00828270513817498	-4.79358565643319	10	4	0.00550964187327824	726	8202	55741,11253,80267,6400	EDEM2,MAN1B1,EDEM3,SEL1L
R-HSA-164940	Nef mediated downregulation of MHC class I complex cell surface expression	0.00828270513817498	-4.79358565643319	10	4	0.00550964187327824	726	8202	1174,162,164,3105	AP1S1,AP1B1,AP1G1,HLA-A
R-HSA-109704	PI3K Cascade	0.00879970665000395	-4.73303689328043	79	14	0.0192837465564738	726	8202	3667,2261,2254,5564,2263,5565,28956,5295,5290,10670,51719,5571,6794,2260	IRS1,FGFR3,FGF9,PRKAB1,FGFR2,PRKAB2,LAMTOR2,PIK3R1,PIK3CA,RRAGA,CAB39,PRKAG1,STK11,FGFR1
R-HSA-380972	Energy dependent regulation of mTOR by LKB1-AMPK	0.00939055044521798	-4.66805136711607	28	7	0.00964187327823691	726	8202	51719,5571,6794,5564,5565,28956,10670	CAB39,PRKAG1,STK11,PRKAB1,PRKAB2,LAMTOR2,RRAGA
R-HSA-2730905	Role of LAT2/NTAL/LAB on calcium mobilization	0.00941893396997271	-4.66503336346726	104	17	0.0234159779614325	726	8202	2254,4303,2308,5295,2064,1026,1956,2260,3667,572,2261,4193,6464,2263,5290,1027,4343	FGF9,FOXO4,FOXO1,PIK3R1,ERBB2,CDKN1A,EGFR,FGFR1,IRS1,BAD,FGFR3,MDM2,SHC1,FGFR2,PIK3CA,CDKN1B,MOV10
R-HSA-3371571	HSF1-dependent transactivation	0.0102336499385018	-4.58207397491987	22	6	0.00826446280991736	726	8202	817,3337,3306,3303,3312,3304	CAMK2D,DNAJB1,HSPA2,HSPA1A,HSPA8,HSPA1B
R-HSA-5628897	TP53 Regulates Metabolic Genes	0.010914632113288	-4.51765099424013	73	13	0.0179063360881543	726	8202	5564,143686,2936,7295,50484,5565,25824,9167,28956,10670,5571,27244,2810	PRKAB1,SESN3,GSR,TXN,RRM2B,PRKAB2,PRDX5,COX7A2L,LAMTOR2,RRAGA,PRKAG1,SESN1,SFN
R-HSA-3700989	Transcriptional Regulation by TP53	0.010914632113288	-4.51765099424013	73	13	0.0179063360881543	726	8202	5564,143686,2936,7295,50484,5565,25824,9167,28956,10670,5571,27244,2810	PRKAB1,SESN3,GSR,TXN,RRM2B,PRKAB2,PRDX5,COX7A2L,LAMTOR2,RRAGA,PRKAG1,SESN1,SFN
R-HSA-176417	Phosphorylation of Emi1	0.0112647741648249	-4.48607475280666	6	3	0.00413223140495868	726	8202	891,983,991	CCNB1,CDK1,CDC20
R-HSA-1839124	FGFR1 mutant receptor activation	0.0114565961170323	-4.46918963476217	29	7	0.00964187327823691	726	8202	2254,6774,5295,2260,399687,6772,5290	FGF9,STAT3,PIK3R1,FGFR1,MYO18A,STAT1,PIK3CA
R-HSA-983169	Class I MHC mediated antigen processing & presentation	0.0115304580775602	-4.4627632163004	267	35	0.0482093663911846	726	8202	9820,7317,9903,23480,5721,9039,6890,79654,65264,9666,9520,5720,9354,9867,3105,9632,51434,64219,3107,64167,10484,10952,7311,991,127544,9021,3106,6892,1535,8453,51752,3685,22954,11065,10489	CUL7,UBA1,KLHL21,SEC61G,PSME2,UBA3,TAP1,HECTD3,UBE2Z,DZIP3,NPEPPS,PSME1,UBE4A,PJA2,HLA-A,SEC24C,ANAPC7,PJA1,HLA-C,ERAP2,SEC23A,SEC61B,UBA52,CDC20,RNF19B,SOCS3,HLA-B,TAPBP,CYBA,CUL2,ERAP1,ITGAV,TRIM32,UBE2C,LRRC41
R-HSA-1250342	PI3K events in ERBB4 signaling	0.011694731216586	-4.44861686197317	98	16	0.0220385674931129	726	8202	2254,4303,2308,5295,2064,1026,2260,1956,3667,572,2261,4193,2263,5290,1027,4343	FGF9,FOXO4,FOXO1,PIK3R1,ERBB2,CDKN1A,FGFR1,EGFR,IRS1,BAD,FGFR3,MDM2,FGFR2,PIK3CA,CDKN1B,MOV10
R-HSA-5654720	PI-3K cascade:FGFR4	0.011694731216586	-4.44861686197317	98	16	0.0220385674931129	726	8202	2254,4303,2308,5295,2064,1026,2260,1956,3667,572,2261,4193,2263,5290,1027,4343	FGF9,FOXO4,FOXO1,PIK3R1,ERBB2,CDKN1A,FGFR1,EGFR,IRS1,BAD,FGFR3,MDM2,FGFR2,PIK3CA,CDKN1B,MOV10
R-HSA-5654689	PI-3K cascade:FGFR1	0.011694731216586	-4.44861686197317	98	16	0.0220385674931129	726	8202	2254,4303,2308,5295,2064,1026,2260,1956,3667,572,2261,4193,2263,5290,1027,4343	FGF9,FOXO4,FOXO1,PIK3R1,ERBB2,CDKN1A,FGFR1,EGFR,IRS1,BAD,FGFR3,MDM2,FGFR2,PIK3CA,CDKN1B,MOV10
R-HSA-5654695	PI-3K cascade:FGFR2	0.011694731216586	-4.44861686197317	98	16	0.0220385674931129	726	8202	2254,4303,2308,5295,2064,1026,2260,1956,3667,572,2261,4193,2263,5290,1027,4343	FGF9,FOXO4,FOXO1,PIK3R1,ERBB2,CDKN1A,FGFR1,EGFR,IRS1,BAD,FGFR3,MDM2,FGFR2,PIK3CA,CDKN1B,MOV10
R-HSA-5654710	PI-3K cascade:FGFR3	0.011694731216586	-4.44861686197317	98	16	0.0220385674931129	726	8202	2254,4303,2308,5295,2064,1026,2260,1956,3667,572,2261,4193,2263,5290,1027,4343	FGF9,FOXO4,FOXO1,PIK3R1,ERBB2,CDKN1A,FGFR1,EGFR,IRS1,BAD,FGFR3,MDM2,FGFR2,PIK3CA,CDKN1B,MOV10
R-HSA-1257604	PIP3 activates AKT signaling	0.011694731216586	-4.44861686197317	98	16	0.0220385674931129	726	8202	2254,4303,2308,5295,2064,1026,1956,2260,3667,572,2261,4193,2263,5290,1027,4343	FGF9,FOXO4,FOXO1,PIK3R1,ERBB2,CDKN1A,EGFR,FGFR1,IRS1,BAD,FGFR3,MDM2,FGFR2,PIK3CA,CDKN1B,MOV10
R-HSA-1963642	PI3K events in ERBB2 signaling	0.011694731216586	-4.44861686197317	98	16	0.0220385674931129	726	8202	2254,4303,2308,5295,2064,1026,2260,1956,3667,572,2261,4193,2263,5290,1027,4343	FGF9,FOXO4,FOXO1,PIK3R1,ERBB2,CDKN1A,FGFR1,EGFR,IRS1,BAD,FGFR3,MDM2,FGFR2,PIK3CA,CDKN1B,MOV10
R-HSA-189451	Heme biosynthesis	0.0121161884171518	-4.41321283483607	11	4	0.00550964187327824	726	8202	7390,210,1371,7389	UROS,ALAD,CPOX,UROD
R-HSA-5663202	Diseases of signal transduction	0.0121794187059221	-4.40800774313303	268	35	0.0482093663911846	726	8202	2308,5721,79885,2064,5720,54894,1026,57534,2261,182,4193,6464,5290,1027,6774,55534,2254,4851,7311,4303,8322,51107,5295,8841,54492,2260,1956,3667,572,2263,399687,6772,6400,3065,7855	FOXO1,PSME2,HDAC11,ERBB2,PSME1,RNF43,CDKN1A,MIB1,FGFR3,JAG1,MDM2,SHC1,PIK3CA,CDKN1B,STAT3,MAML3,FGF9,NOTCH1,UBA52,FOXO4,FZD4,APH1A,PIK3R1,HDAC3,NEURL1B,FGFR1,EGFR,IRS1,BAD,FGFR2,MYO18A,STAT1,SEL1L,HDAC1,FZD5
R-HSA-532668	N-glycan trimming in the ER and Calnexin/Calreticulin cycle	0.0134775939085055	-4.30672668286414	17	5	0.0068870523415978	726	8202	9761,55741,11253,80267,6400	MLEC,EDEM2,MAN1B1,EDEM3,SEL1L
R-HSA-5627117	RHO GTPases Activate ROCKs	0.0134775939085055	-4.30672668286414	17	5	0.0068870523415978	726	8202	4637,4628,389,9475,388	MYL6,MYH10,RHOC,ROCK2,RHOB
R-HSA-77289	Mitochondrial Fatty Acid Beta-Oxidation	0.0134775939085055	-4.30672668286414	17	5	0.0068870523415978	726	8202	35,3033,37,1892,3032	ACADS,HADH,ACADVL,ECHS1,HADHB
R-HSA-446193	Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein	0.0135524747254573	-4.30118611176734	67	12	0.0165289256198347	726	8202	9945,4351,4597,5238,1798,6483,85365,26503,140838,10610,8869,29926	GFPT2,MPI,MVD,PGM3,DPAGT1,ST3GAL2,ALG2,SLC17A5,NANP,ST6GALNAC2,ST3GAL5,GMPPA
R-HSA-5656169	Termination of translesion DNA synthesis	0.0138324403795708	-4.28073869337149	30	7	0.00964187327823691	726	8202	6118,5111,7311,5982,7706,5429,9636	RPA2,PCNA,UBA52,RFC2,TRIM25,POLH,ISG15
R-HSA-446219	Synthesis of substrates in N-glycan biosythesis	0.0144093232637443	-4.23987983303365	52	10	0.0137741046831956	726	8202	9945,4351,4597,5238,6483,26503,140838,10610,29926,8869	GFPT2,MPI,MVD,PGM3,ST3GAL2,SLC17A5,NANP,ST6GALNAC2,GMPPA,ST3GAL5
R-HSA-198203	PI3K/AKT activation	0.0154062894319147	-4.17297944826726	101	16	0.0220385674931129	726	8202	2254,4303,2308,5295,2064,1026,2260,1956,3667,572,2261,4193,2263,5290,1027,4343	FGF9,FOXO4,FOXO1,PIK3R1,ERBB2,CDKN1A,FGFR1,EGFR,IRS1,BAD,FGFR3,MDM2,FGFR2,PIK3CA,CDKN1B,MOV10
R-HSA-1226099	Signaling by FGFR in disease	0.0154648396631706	-4.16918624062141	45	9	0.012396694214876	726	8202	2261,2254,2263,5295,399687,6772,5290,6774,2260	FGFR3,FGF9,FGFR2,PIK3R1,MYO18A,STAT1,PIK3CA,STAT3,FGFR1
R-HSA-5674400	Constitutive Signaling by AKT1 E17K in Cancer	0.0158620300920952	-4.14382707020421	24	6	0.00826446280991736	726	8202	1027,572,4193,1026,4303,2308	CDKN1B,BAD,MDM2,CDKN1A,FOXO4,FOXO1
R-HSA-933542	TRAF6 mediated NF-kB activation	0.0158620300920952	-4.14382707020421	24	6	0.00826446280991736	726	8202	23586,64135,7706,4792,4214,1660	DDX58,IFIH1,TRIM25,NFKBIA,MAP3K1,DHX9
R-HSA-109606	Intrinsic Pathway for Apoptosis	0.0162613757131777	-4.11896257123496	38	8	0.0110192837465565	726	8202	572,836,840,8655,581,27113,317,2810	BAD,CASP3,CASP7,DYNLL1,BAX,BBC3,APAF1,SFN
R-HSA-111465	Apoptotic cleavage of cellular proteins	0.0162613757131777	-4.11896257123496	38	8	0.0110192837465565	726	8202	836,2934,840,63967,5588,7431,4000,6709	CASP3,GSN,CASP7,CLSPN,PRKCQ,VIM,LMNA,SPTAN1
R-HSA-933543	NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10	0.0169226093783169	-4.07910471811788	12	4	0.00550964187327824	726	8202	23586,8737,64135,7706	DDX58,RIPK1,IFIH1,TRIM25
R-HSA-1839117	Signaling by FGFR1 fusion mutants	0.0173322362093074	-4.05518714668895	18	5	0.0068870523415978	726	8202	6774,5295,399687,6772,5290	STAT3,PIK3R1,MYO18A,STAT1,PIK3CA
R-HSA-447043	Neurofascin interactions	0.0184279713036842	-3.99388558912239	7	3	0.00413223140495868	726	8202	286,6386,1272	ANK1,SDCBP,CNTN1
R-HSA-111471	Apoptotic factor-mediated response	0.0184279713036842	-3.99388558912239	7	3	0.00413223140495868	726	8202	836,840,317	CASP3,CASP7,APAF1
R-HSA-420597	Nectin/Necl  trans heterodimerization	0.0184279713036842	-3.99388558912239	7	3	0.00413223140495868	726	8202	81607,25945,5818	PVRL4,PVRL3,PVRL1
R-HSA-1980145	Signaling by NOTCH2	0.0196039739118534	-3.93202298269203	32	7	0.00964187327823691	726	8202	182,7311,54492,51107,57534,1272,55534	JAG1,UBA52,NEURL1B,APH1A,MIB1,CNTN1,MAML3
R-HSA-5637815	Signaling by Ligand-Responsive EGFR Variants in Cancer	0.0218515903398344	-3.82348157565741	19	5	0.0068870523415978	726	8202	7311,6464,1956,5295,5290	UBA52,SHC1,EGFR,PIK3R1,PIK3CA
R-HSA-110320	Translesion Synthesis by POLH	0.0218515903398344	-3.82348157565741	19	5	0.0068870523415978	726	8202	6118,5111,7311,5982,5429	RPA2,PCNA,UBA52,RFC2,POLH
R-HSA-389977	Post-chaperonin tubulin folding pathway	0.0218515903398344	-3.82348157565741	19	5	0.0068870523415978	726	8202	84790,84617,6903,10383,6904	TUBA1C,TUBB6,TBCC,TUBB4B,TBCD
R-HSA-1236382	Constitutive Signaling by Ligand-Responsive EGFR Cancer Variants	0.0218515903398344	-3.82348157565741	19	5	0.0068870523415978	726	8202	7311,6464,1956,5295,5290	UBA52,SHC1,EGFR,PIK3R1,PIK3CA
R-HSA-1643713	Signaling by EGFR in Cancer	0.0218515903398344	-3.82348157565741	19	5	0.0068870523415978	726	8202	7311,6464,1956,5295,5290	UBA52,SHC1,EGFR,PIK3R1,PIK3CA
R-HSA-110330	Recognition and association of DNA glycosylase with site containing an affected purine	0.0220934079510507	-3.81247599771147	3	2	0.00275482093663912	726	8202	4350,4595	MPG,MUTYH
R-HSA-77305	Beta oxidation of palmitoyl-CoA to myristoyl-CoA	0.0220934079510507	-3.81247599771147	3	2	0.00275482093663912	726	8202	37,3032	ACADVL,HADHB
R-HSA-110331	Cleavage of the damaged purine	0.0220934079510507	-3.81247599771147	3	2	0.00275482093663912	726	8202	4350,4595	MPG,MUTYH
R-HSA-73927	Depurination	0.0220934079510507	-3.81247599771147	3	2	0.00275482093663912	726	8202	4350,4595	MPG,MUTYH
R-HSA-2046104	alpha-linolenic (omega3) and linoleic (omega6) acid metabolism	0.0227662156846292	-3.78247761014397	13	4	0.00550964187327824	726	8202	3992,60481,51,83401	FADS1,ELOVL5,ACOX1,ELOVL3
R-HSA-2046106	alpha-linolenic acid (ALA) metabolism	0.0227662156846292	-3.78247761014397	13	4	0.00550964187327824	726	8202	3992,60481,51,83401	FADS1,ELOVL5,ACOX1,ELOVL3
R-HSA-198323	AKT phosphorylates targets in the cytosol	0.0227662156846292	-3.78247761014397	13	4	0.00550964187327824	726	8202	1027,572,4193,1026	CDKN1B,BAD,MDM2,CDKN1A
R-HSA-556833	Metabolism of lipids and lipoproteins	0.0234819512292329	-3.75152318571891	628	70	0.0964187327823691	726	8202	1591,4598,1376,5565,3635,27242,3074,10162,79642,8895,410,85441,3422,5290,3032,5499,204962,1545,51703,35,10484,5468,4597,8800,8612,25870,126969,123,4047,221,8821,51495,8714,113612,4048,8760,3636,84803,54797,2053,788,1119,6307,9632,1384,2232,26027,8694,6576,3156,2222,3992,91289,60481,8841,83401,5295,1892,2274,7108,9517,51129,5264,3033,51,6713,38,57678,37,2876	CYP24A1,MVK,CPT2,PRKAB2,INPP5D,TNFRSF21,HEXB,LPCAT3,ARSJ,CPNE3,ARSA,HELZ2,IDI1,PIK3CA,HADHB,PPP1CA,SLC44A5,CYP1B1,ACSL5,ACADS,SEC23A,PPARG,MVD,PEX11A,PLPP2,SUMF2,SLC44A3,PLIN2,LSS,ALDH3B1,INPP4B,HACD3,ABCC3,CYP2U1,LTA4H,CDS2,INPPL1,GPAT3,MED18,EPHX2,SLC25A20,CHKA,MSMO1,SEC24C,CRAT,FDXR,ACOT11,DGAT1,SLC25A1,HMGCR,FDFT1,FADS1,LMF2,ELOVL5,HDAC3,ELOVL3,PIK3R1,ECHS1,FHL2,TM7SF2,SPTLC2,ANGPTL4,PHYH,HADH,ACOX1,SQLE,ACAT1,GPAM,ACADVL,GPX1
R-HSA-2894858	Signaling by NOTCH1 HD+PEST Domain Mutants in Cancer	0.0264199631593409	-3.63363537431206	57	10	0.0137741046831956	726	8202	4851,182,7311,51107,79885,8841,3065,54492,57534,55534	NOTCH1,JAG1,UBA52,APH1A,HDAC11,HDAC3,HDAC1,NEURL1B,MIB1,MAML3
R-HSA-2644602	Signaling by NOTCH1 PEST Domain Mutants in Cancer	0.0264199631593409	-3.63363537431206	57	10	0.0137741046831956	726	8202	4851,182,7311,51107,79885,8841,3065,54492,57534,55534	NOTCH1,JAG1,UBA52,APH1A,HDAC11,HDAC3,HDAC1,NEURL1B,MIB1,MAML3
R-HSA-2644606	Constitutive Signaling by NOTCH1 PEST Domain Mutants	0.0264199631593409	-3.63363537431206	57	10	0.0137741046831956	726	8202	4851,182,7311,51107,79885,8841,3065,54492,57534,55534	NOTCH1,JAG1,UBA52,APH1A,HDAC11,HDAC3,HDAC1,NEURL1B,MIB1,MAML3
R-HSA-2894862	Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants	0.0264199631593409	-3.63363537431206	57	10	0.0137741046831956	726	8202	4851,182,7311,51107,79885,8841,3065,54492,57534,55534	NOTCH1,JAG1,UBA52,APH1A,HDAC11,HDAC3,HDAC1,NEURL1B,MIB1,MAML3
R-HSA-2644603	Signaling by NOTCH1 in Cancer	0.0264199631593409	-3.63363537431206	57	10	0.0137741046831956	726	8202	4851,182,7311,51107,79885,8841,3065,54492,57534,55534	NOTCH1,JAG1,UBA52,APH1A,HDAC11,HDAC3,HDAC1,NEURL1B,MIB1,MAML3
R-HSA-202733	Cell surface interactions at the vascular wall	0.0269280432832636	-3.61458703416482	99	15	0.0206611570247934	726	8202	2335,6464,3675,3635,961,5295,9123,5290,682,10544,50848,5627,3685,960,965	FN1,SHC1,ITGA3,INPP5D,CD47,PIK3R1,SLC16A3,PIK3CA,BSG,PROCR,F11R,PROS1,ITGAV,CD44,CD58
R-HSA-5340588	RNF mutants show enhanced WNT signaling and proliferation	0.0275716897448948	-3.59096576656467	8	3	0.00413223140495868	726	8202	54894,7855,8322	RNF43,FZD5,FZD4
R-HSA-2046105	Linoleic acid (LA) metabolism	0.0275716897448948	-3.59096576656467	8	3	0.00413223140495868	726	8202	3992,60481,83401	FADS1,ELOVL5,ELOVL3
R-HSA-182971	EGFR downregulation	0.0278197598228752	-3.58200872577805	27	6	0.00826446280991736	726	8202	7311,998,1175,160,1956,10252	UBA52,CDC42,AP2S1,AP2A1,EGFR,SPRY1
R-HSA-453279	Mitotic G1-G1/S phases	0.0283470584522254	-3.56323201249057	135	19	0.0261707988980716	726	8202	9134,1030,7311,5721,81620,5720,1026,891,983,595,1031,6118,7153,7465,5111,1163,1027,3065,7298	CCNE2,CDKN2B,UBA52,PSME2,CDT1,PSME1,CDKN1A,CCNB1,CDK1,CCND1,CDKN2C,RPA2,TOP2A,WEE1,PCNA,CKS1B,CDKN1B,HDAC1,TYMS
R-HSA-162658	Golgi Cisternae Pericentriolar Stack Reorganization	0.0296931262682239	-3.51683969873991	14	4	0.00550964187327824	726	8202	8615,891,5594,983	USO1,CCNB1,MAPK1,CDK1
R-HSA-164952	The role of Nef in HIV-1 replication and disease pathogenesis	0.0328459078352899	-3.41592811303521	28	6	0.00826446280991736	726	8202	1174,162,164,1175,160,3105	AP1S1,AP1B1,AP1G1,AP2S1,AP2A1,HLA-A
R-HSA-4641263	Regulation of FZD by ubiquitination	0.0330218861177031	-3.41058472165802	21	5	0.0068870523415978	726	8202	54894,7311,7855,55366,8322	RNF43,UBA52,FZD5,LGR4,FZD4
R-HSA-5655302	Signaling by FGFR1 in disease	0.0357891735390024	-3.33010984642382	36	7	0.00964187327823691	726	8202	2254,6774,5295,2260,399687,6772,5290	FGF9,STAT3,PIK3R1,FGFR1,MYO18A,STAT1,PIK3CA
R-HSA-4419969	Depolymerisation of the Nuclear Lamina	0.0377318126153755	-3.27725170440596	15	4	0.00550964187327824	726	8202	891,983,4000,7112	CCNB1,CDK1,LMNA,TMPO
R-HSA-901042	Calnexin/calreticulin cycle	0.0377318126153755	-3.27725170440596	15	4	0.00550964187327824	726	8202	55741,11253,80267,6400	EDEM2,MAN1B1,EDEM3,SEL1L
R-HSA-5637812	Signaling by EGFRvIII in Cancer	0.0377318126153755	-3.27725170440596	15	4	0.00550964187327824	726	8202	6464,1956,5295,5290	SHC1,EGFR,PIK3R1,PIK3CA
R-HSA-5637810	Constitutive Signaling by EGFRvIII	0.0377318126153755	-3.27725170440596	15	4	0.00550964187327824	726	8202	6464,1956,5295,5290	SHC1,EGFR,PIK3R1,PIK3CA
R-HSA-112411	MAPK1 (ERK2) activation	0.0386875827525149	-3.25223658954084	9	3	0.00413223140495868	726	8202	3570,5594,3572	IL6R,MAPK1,IL6ST
R-HSA-446107	Type I hemidesmosome assembly	0.0386875827525149	-3.25223658954084	9	3	0.00413223140495868	726	8202	1308,3909,3691	COL17A1,LAMA3,ITGB4
R-HSA-110313	Translesion synthesis by Y family DNA polymerases bypasses lesions on DNA template	0.0409008136572922	-3.19660532230993	37	7	0.00964187327823691	726	8202	6118,5111,7311,5982,7706,5429,9636	RPA2,PCNA,UBA52,RFC2,TRIM25,POLH,ISG15
R-HSA-156590	Glutathione conjugation	0.0409008136572922	-3.19660532230993	37	7	0.00964187327823691	726	8202	373156,2941,9446,2730,55748,2950,2937	GSTK1,GSTA4,GSTO1,GCLM,CNDP2,GSTP1,GSS
R-HSA-140179	Amine Oxidase reactions	0.041606004099321	-3.17951079281879	4	2	0.00275482093663912	726	8202	196743,54498	PAOX,SMOX
R-HSA-71406	Pyruvate metabolism and Citric Acid (TCA) cycle	0.041609158275136	-3.17943498509994	45	8	0.0110192837465565	726	8202	5164,54704,9123,682,1738,5162,8050,6389	PDK2,PDP1,SLC16A3,BSG,DLD,PDHB,PDHX,SDHA
R-HSA-69236	G1 Phase	0.0464645577089231	-3.06906545681889	38	7	0.00964187327823691	726	8202	1031,1163,1027,595,1030,1026,7311	CDKN2C,CKS1B,CDKN1B,CCND1,CDKN2B,CDKN1A,UBA52
R-HSA-69231	Cyclin D associated events in G1	0.0464645577089231	-3.06906545681889	38	7	0.00964187327823691	726	8202	1031,1163,1027,595,1030,1026,7311	CDKN2C,CKS1B,CDKN1B,CCND1,CDKN2B,CDKN1A,UBA52
R-HSA-110312	Translesion synthesis by REV1	0.0468940200143434	-3.05986511668402	16	4	0.00550964187327824	726	8202	6118,5111,7311,5982	RPA2,PCNA,UBA52,RFC2
R-HSA-70895	Branched-chain amino acid catabolism	0.047194113683853	-3.05348610425544	23	5	0.0068870523415978	726	8202	38,10295,1738,3712,223	ACAT1,BCKDK,DLD,IVD,ALDH9A1
R-HSA-5696397	Gap-filling DNA repair synthesis and ligation in GG-NER	0.047194113683853	-3.05348610425544	23	5	0.0068870523415978	726	8202	3978,6118,5111,7311,5982	LIG1,RPA2,PCNA,UBA52,RFC2
R-HSA-179409	APC-Cdc20 mediated degradation of Nek2A	0.047194113683853	-3.05348610425544	23	5	0.0068870523415978	726	8202	51434,7311,9184,11065,991	ANAPC7,UBA52,BUB3,UBE2C,CDC20
R-HSA-112409	RAF-independent MAPK1/3 activation	0.047194113683853	-3.05348610425544	23	5	0.0068870523415978	726	8202	11221,3570,5594,983,3572	DUSP10,IL6R,MAPK1,CDK1,IL6ST
R-HSA-2151209	Activation of PPARGC1A (PGC-1alpha) by phosphorylation	0.0517182445869622	-2.96194466635513	10	3	0.00413223140495868	726	8202	5571,5564,5565	PRKAG1,PRKAB1,PRKAB2
R-HSA-74749	Signal attenuation	0.0517182445869622	-2.96194466635513	10	3	0.00413223140495868	726	8202	3667,6464,5594	IRS1,SHC1,MAPK1
R-HSA-110056	MAPK3 (ERK1) activation	0.0517182445869622	-2.96194466635513	10	3	0.00413223140495868	726	8202	3570,983,3572	IL6R,CDK1,IL6ST
R-HSA-450341	Activation of the AP-1 family of transcription factors	0.0517182445869622	-2.96194466635513	10	3	0.00413223140495868	726	8202	3725,5594,2353	JUN,MAPK1,FOS
R-HSA-1236975	Antigen processing-Cross presentation	0.0518367334014729	-2.9596562420124	81	12	0.0165289256198347	726	8202	3106,6892,7311,10952,1535,23480,5721,6890,5720,3685,3107,3105	HLA-B,TAPBP,UBA52,SEC61B,CYBA,SEC61G,PSME2,TAP1,PSME1,ITGAV,HLA-C,HLA-A
R-HSA-2122947	NOTCH1 Intracellular Domain Regulates Transcription	0.0520280748336852	-2.95597180544683	47	8	0.0110192837465565	726	8202	4851,7311,3091,79885,8841,7088,3065,55534	NOTCH1,UBA52,HIF1A,HDAC11,HDAC3,TLE1,HDAC1,MAML3
R-HSA-165159	mTOR signalling	0.0524896328479776	-2.94713959844657	39	7	0.00964187327823691	726	8202	51719,5571,6794,5564,5565,28956,10670	CAB39,PRKAG1,STK11,PRKAB1,PRKAB2,LAMTOR2,RRAGA
R-HSA-1236974	ER-Phagosome pathway	0.0533187414345381	-2.93146738795362	64	10	0.0137741046831956	726	8202	3106,6892,7311,10952,23480,5721,6890,5720,3107,3105	HLA-B,TAPBP,UBA52,SEC61B,SEC61G,PSME2,TAP1,PSME1,HLA-C,HLA-A
R-HSA-71291	Metabolism of amino acids and derivatives	0.0543210206666738	-2.912844006021	212	26	0.0358126721763085	726	8202	2730,10295,1728,5721,84245,6303,5720,4942,2752,7263,196743,53905,6821,54498,548596,65263,38,51582,501,191,51074,55748,1738,3712,223,2184	GCLM,BCKDK,NQO1,PSME2,MRI1,SAT1,PSME1,OAT,GLUL,TST,PAOX,DUOX1,SUOX,SMOX,CKMT1A,PYCRL,ACAT1,AZIN1,ALDH7A1,AHCY,APIP,CNDP2,DLD,IVD,ALDH9A1,FAH
R-HSA-5365859	RA biosynthesis pathway	0.0554393988391481	-2.89246476760899	24	5	0.0068870523415978	726	8202	56603,9249,8854,220,157506	CYP26B1,DHRS3,ALDH1A2,ALDH1A3,RDH10
R-HSA-1280218	Adaptive Immune System	0.0556286797175416	-2.88905638845823	668	71	0.0977961432506887	726	8202	9820,7317,5721,8655,3635,6890,79654,65264,2064,9666,5720,11004,1026,162,9867,10121,55824,4193,6464,998,5290,1027,51434,64219,64167,1639,10484,7311,10952,991,5588,127544,2260,9021,572,6892,1535,1174,22954,4343,1175,2308,23480,9903,9039,1326,9520,29127,9354,3105,2261,6494,9632,79659,3107,2254,10112,4303,5295,1956,3667,3106,2263,160,8453,4792,51752,3685,164,11065,10489	CUL7,UBA1,PSME2,DYNLL1,INPP5D,TAP1,HECTD3,UBE2Z,ERBB2,DZIP3,PSME1,KIF2C,CDKN1A,AP1B1,PJA2,ACTR1A,PAG1,MDM2,SHC1,CDC42,PIK3CA,CDKN1B,ANAPC7,PJA1,ERAP2,DCTN1,SEC23A,UBA52,SEC61B,CDC20,PRKCQ,RNF19B,FGFR1,SOCS3,BAD,TAPBP,CYBA,AP1S1,TRIM32,MOV10,AP2S1,FOXO1,SEC61G,KLHL21,UBA3,MAP3K8,NPEPPS,RACGAP1,UBE4A,HLA-A,FGFR3,SIPA1,SEC24C,DYNC2H1,HLA-C,FGF9,KIF20A,FOXO4,PIK3R1,EGFR,IRS1,HLA-B,FGFR2,AP2A1,CUL2,NFKBIA,ERAP1,ITGAV,AP1G1,UBE2C,LRRC41
R-HSA-5656121	Translesion synthesis by POLI	0.0571759972791993	-2.86162109665087	17	4	0.00550964187327824	726	8202	6118,5111,7311,5982	RPA2,PCNA,UBA52,RFC2
R-HSA-5655862	Translesion synthesis by POLK	0.0571759972791993	-2.86162109665087	17	4	0.00550964187327824	726	8202	6118,5111,7311,5982	RPA2,PCNA,UBA52,RFC2
R-HSA-176412	Phosphorylation of the APC/C	0.0571759972791993	-2.86162109665087	17	4	0.00550964187327824	726	8202	51434,891,11065,983	ANAPC7,CCNB1,UBE2C,CDK1
R-HSA-2142845	Hyaluronan metabolism	0.0571759972791993	-2.86162109665087	17	4	0.00550964187327824	726	8202	960,3038,57214,3074	CD44,HAS3,CEMIP,HEXB
R-HSA-69205	G1/S-Specific Transcription	0.0571759972791993	-2.86162109665087	17	4	0.00550964187327824	726	8202	7298,5111,983,81620	TYMS,PCNA,CDK1,CDT1
R-HSA-189445	Metabolism of porphyrins	0.0571759972791993	-2.86162109665087	17	4	0.00550964187327824	726	8202	7390,210,1371,7389	UROS,ALAD,CPOX,UROD
R-HSA-70221	Glycogen breakdown (glycogenolysis)	0.0571759972791993	-2.86162109665087	17	4	0.00550964187327824	726	8202	5836,5236,55276,5834	PYGL,PGM1,PGM2,PYGB
R-HSA-109703	PKB-mediated events	0.0589829961524274	-2.83050607742057	40	7	0.00964187327823691	726	8202	51719,5571,6794,5564,5565,28956,10670	CAB39,PRKAG1,STK11,PRKAB1,PRKAB2,LAMTOR2,RRAGA
R-HSA-1538133	G0 and Early G1	0.064461422524573	-2.74168833450802	25	5	0.0068870523415978	726	8202	7153,9134,3065,5111,983	TOP2A,CCNE2,HDAC1,PCNA,CDK1
R-HSA-425410	Metal ion SLC transporters	0.064461422524573	-2.74168833450802	25	5	0.0068870523415978	726	8202	1317,30061,64924,27173,7922	SLC31A1,SLC40A1,SLC30A5,SLC39A1,SLC39A7
R-HSA-982772	Growth hormone receptor signaling	0.064461422524573	-2.74168833450802	25	5	0.0068870523415978	726	8202	3667,6774,5594,6772,9021	IRS1,STAT3,MAPK1,STAT1,SOCS3
R-HSA-2262749	Cellular response to hypoxia	0.064461422524573	-2.74168833450802	25	5	0.0068870523415978	726	8202	7311,112399,3091,405,8453	UBA52,EGLN3,HIF1A,ARNT,CUL2
R-HSA-1234174	Regulation of Hypoxia-inducible Factor (HIF) by oxygen	0.064461422524573	-2.74168833450802	25	5	0.0068870523415978	726	8202	7311,112399,3091,405,8453	UBA52,EGLN3,HIF1A,ARNT,CUL2
R-HSA-2132295	MHC class II antigen presentation	0.0647854330742875	-2.73667449913112	102	14	0.0192837465564738	726	8202	10484,10112,8655,9632,160,1174,29127,11004,79659,162,164,10121,1175,1639	SEC23A,KIF20A,DYNLL1,SEC24C,AP2A1,AP1S1,RACGAP1,KIF2C,DYNC2H1,AP1B1,AP1G1,ACTR1A,AP2S1,DCTN1
R-HSA-446205	Synthesis of GDP-mannose	0.0653251459401164	-2.72837823351571	5	2	0.00275482093663912	726	8202	4351,29926	MPI,GMPPA
R-HSA-111464	SMAC-mediated dissociation of IAP:caspase complexes	0.0653251459401164	-2.72837823351571	5	2	0.00275482093663912	726	8202	836,840	CASP3,CASP7
R-HSA-1614517	Sulfide oxidation to sulfate	0.0653251459401164	-2.72837823351571	5	2	0.00275482093663912	726	8202	6821,7263	SUOX,TST
R-HSA-2142850	Hyaluronan biosynthesis and export	0.0653251459401164	-2.72837823351571	5	2	0.00275482093663912	726	8202	3038,57214	HAS3,CEMIP
R-HSA-157881	Cyclin B2 mediated events	0.0653251459401164	-2.72837823351571	5	2	0.00275482093663912	726	8202	995,983	CDC25C,CDK1
R-HSA-111463	SMAC binds to IAPs	0.0653251459401164	-2.72837823351571	5	2	0.00275482093663912	726	8202	836,840	CASP3,CASP7
R-HSA-163680	AMPK inhibits chREBP transcriptional activation activity	0.0653251459401164	-2.72837823351571	5	2	0.00275482093663912	726	8202	6794,5565	STK11,PRKAB2
R-HSA-5624138	Trafficking of myristoylated proteins to the cilium	0.0653251459401164	-2.72837823351571	5	2	0.00275482093663912	726	8202	6102,84747	RP2,UNC119B
R-HSA-111469	SMAC-mediated apoptotic response	0.0653251459401164	-2.72837823351571	5	2	0.00275482093663912	726	8202	836,840	CASP3,CASP7
R-HSA-446210	Synthesis of UDP-N-acetyl-glucosamine	0.0653251459401164	-2.72837823351571	5	2	0.00275482093663912	726	8202	9945,5238	GFPT2,PGM3
R-HSA-2559583	Cellular Senescence	0.0655425465546252	-2.72505578149796	187	23	0.0316804407713499	726	8202	9134,1030,23043,7311,7295,3397,23466,1026,2353,8726,1912,3725,1031,4193,2114,653604,1027,51434,5594,6774,4343,11065,7014	CCNE2,CDKN2B,TNIK,UBA52,TXN,ID1,CBX6,CDKN1A,FOS,EED,PHC2,JUN,CDKN2C,MDM2,ETS2,HIST2H3D,CDKN1B,ANAPC7,MAPK1,STAT3,MOV10,UBE2C,TERF2
R-HSA-5620924	Intraflagellar transport	0.0659492966666138	-2.71886906452142	41	7	0.00964187327823691	726	8202	64792,79659,89891,51098,56912,8655,79989	IFT22,DYNC2H1,WDR34,IFT52,IFT46,DYNLL1,TTC26
R-HSA-73847	Purine metabolism	0.0665224418824347	-2.71021591633486	33	6	0.00826446280991736	726	8202	847,9615,51292,3615,2876,4907	CAT,GDA,GMPR2,IMPDH2,GPX1,NT5E
R-HSA-199983	Golgi to ER Retrograde Transport	0.0665690156509473	-2.70951604015532	11	3	0.00413223140495868	726	8202	1314,1315,11316	COPA,COPB1,COPE
R-HSA-199997	COPI Mediated Transport	0.0665690156509473	-2.70951604015532	11	3	0.00413223140495868	726	8202	1314,1315,11316	COPA,COPB1,COPE
R-HSA-3371378	Regulation by c-FLIP	0.0665690156509473	-2.70951604015532	11	3	0.00413223140495868	726	8202	8737,8795,355	RIPK1,TNFRSF10B,FAS
R-HSA-5218900	CASP8 activity is inhibited	0.0665690156509473	-2.70951604015532	11	3	0.00413223140495868	726	8202	8737,8795,355	RIPK1,TNFRSF10B,FAS
R-HSA-200425	Import of palmitoyl-CoA into the mitochondrial matrix	0.0665690156509473	-2.70951604015532	11	3	0.00413223140495868	726	8202	1376,5565,788	CPT2,PRKAB2,SLC25A20
R-HSA-1236977	Endosomal/Vacuolar pathway	0.0665690156509473	-2.70951604015532	11	3	0.00413223140495868	726	8202	3106,3107,3105	HLA-B,HLA-C,HLA-A
R-HSA-69416	Dimerization of procaspase-8	0.0665690156509473	-2.70951604015532	11	3	0.00413223140495868	726	8202	8737,8795,355	RIPK1,TNFRSF10B,FAS
R-HSA-141430	Inactivation of APC/C via direct inhibition of the APC/C complex	0.0685599290128177	-2.68004704009546	18	4	0.00550964187327824	726	8202	51434,9184,11065,991	ANAPC7,BUB3,UBE2C,CDC20
R-HSA-418457	cGMP effects	0.0685599290128177	-2.68004704009546	18	4	0.00550964187327824	726	8202	8654,27345,10846,5139	PDE5A,KCNMB4,PDE10A,PDE3A
R-HSA-1234176	Oxygen-dependent proline hydroxylation of Hypoxia-inducible Factor Alpha	0.0685599290128177	-2.68004704009546	18	4	0.00550964187327824	726	8202	7311,112399,3091,8453	UBA52,EGLN3,HIF1A,CUL2
R-HSA-141405	Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components	0.0685599290128177	-2.68004704009546	18	4	0.00550964187327824	726	8202	51434,9184,11065,991	ANAPC7,BUB3,UBE2C,CDC20
R-HSA-109581	Apoptosis	0.0717474389656869	-2.63460311883747	160	20	0.0275482093663912	726	8202	836,7311,63967,5721,8655,8795,8737,7431,5588,5720,4000,355,572,2934,840,581,27113,317,2810,6709	CASP3,UBA52,CLSPN,PSME2,DYNLL1,TNFRSF10B,RIPK1,VIM,PRKCQ,PSME1,LMNA,FAS,BAD,GSN,CASP7,BAX,BBC3,APAF1,SFN,SPTAN1
R-HSA-3371453	Regulation of HSF1-mediated heat shock response	0.0748057073241196	-2.59286109578789	68	10	0.0137741046831956	726	8202	6118,10808,6767,55746,3312,3337,5594,3306,3303,3304	RPA2,HSPH1,ST13,NUP133,HSPA8,DNAJB1,MAPK1,HSPA2,HSPA1A,HSPA1B
R-HSA-597592	Post-translational protein modification	0.0769502767804665	-2.56459582181656	411	45	0.0619834710743802	726	8202	9945,4351,7508,9091,1798,79642,4121,410,1912,4245,55746,9632,5238,8733,5627,3998,10484,9761,8615,10678,51604,4597,7039,11253,80267,6612,25870,672,26503,55741,10610,8869,29926,2517,11196,79694,1650,3703,4905,5371,6400,6483,55568,85365,140838	GFPT2,MPI,XPC,PIGQ,DPAGT1,ARSJ,MAN1A1,ARSA,PHC2,MGAT1,NUP133,SEC24C,PGM3,GPAA1,PROS1,LMAN1,SEC23A,MLEC,USO1,B3GNT2,PIGT,MVD,TGFA,MAN1B1,EDEM3,SUMO3,SUMF2,BRCA1,SLC17A5,EDEM2,ST6GALNAC2,ST3GAL5,GMPPA,FUCA1,SEC23IP,MANEA,DDOST,STT3A,NSF,PML,SEL1L,ST3GAL2,GALNT10,ALG2,NANP
R-HSA-1428517	The citric acid (TCA) cycle and respiratory electron transport	0.0800323767897187	-2.52532401630972	143	18	0.0247933884297521	726	8202	516,4719,4712,54704,9123,682,7384,54539,6389,5162,8050,5164,10476,9167,7385,4728,1738,4702	ATP5G1,NDUFS1,NDUFB6,PDP1,SLC16A3,BSG,UQCRC1,NDUFB11,SDHA,PDHB,PDHX,PDK2,ATP5H,COX7A2L,UQCRC2,NDUFS8,DLD,NDUFA8
R-HSA-69618	Mitotic Spindle Checkpoint	0.081015485990898	-2.51311495751042	19	4	0.00550964187327824	726	8202	51434,9184,11065,991	ANAPC7,BUB3,UBE2C,CDC20
R-HSA-5651801	PCNA-Dependent Long Patch Base Excision Repair	0.081015485990898	-2.51311495751042	19	4	0.00550964187327824	726	8202	3978,6118,5111,5982	LIG1,RPA2,PCNA,RFC2
R-HSA-3928664	Ephrin signaling	0.081015485990898	-2.51311495751042	19	4	0.00550964187327824	726	8202	1948,6386,2051,1947	EFNB2,SDCBP,EPHB6,EFNB1
R-HSA-174414	Processive synthesis on the C-strand of the telomere	0.0831178177436125	-2.48749618682344	12	3	0.00413223140495868	726	8202	3978,6118,5111	LIG1,RPA2,PCNA
R-HSA-5357801	Programmed Cell Death	0.0832725464989434	-2.48563635797295	163	20	0.0275482093663912	726	8202	836,7311,63967,5721,8655,8795,8737,7431,5588,5720,4000,355,572,2934,840,581,27113,317,2810,6709	CASP3,UBA52,CLSPN,PSME2,DYNLL1,TNFRSF10B,RIPK1,VIM,PRKCQ,PSME1,LMNA,FAS,BAD,GSN,CASP7,BAX,BBC3,APAF1,SFN,SPTAN1
R-HSA-73933	Resolution of Abasic Sites (AP sites)	0.0841012721519259	-2.47573358545978	35	6	0.00826446280991736	726	8202	3978,6118,5111,4350,5982,4595	LIG1,RPA2,PCNA,MPG,RFC2,MUTYH
R-HSA-73884	Base Excision Repair	0.0841012721519259	-2.47573358545978	35	6	0.00826446280991736	726	8202	3978,6118,5111,4350,5982,4595	LIG1,RPA2,PCNA,MPG,RFC2,MUTYH
R-HSA-75153	Apoptotic execution  phase	0.0848969956056157	-2.46631657373956	52	8	0.0110192837465565	726	8202	836,2934,840,63967,5588,7431,4000,6709	CASP3,GSN,CASP7,CLSPN,PRKCQ,VIM,LMNA,SPTAN1
R-HSA-373760	L1CAM interactions	0.0850557794184227	-2.46444800926353	97	13	0.0179063360881543	726	8202	286,160,3912,3312,6386,3685,5594,214,1175,2260,1956,6709,1272	ANK1,AP2A1,LAMB1,HSPA8,SDCBP,ITGAV,MAPK1,ALCAM,AP2S1,FGFR1,EGFR,SPTAN1,CNTN1
R-HSA-1280215	Cytokine Signaling in Immune system	0.0862603359112415	-2.45038539359843	539	57	0.0785123966942149	726	8202	23586,3636,23321,2335,5721,3635,9039,1326,2064,5720,3105,2261,6464,7706,55746,2905,3572,28956,5290,11221,103,3107,4940,960,3459,6774,7414,6709,2254,7311,3841,10410,11274,5295,23087,246330,3664,3570,8638,3437,1956,9636,6773,2260,9021,3667,3106,817,3433,1398,2263,3656,6772,5371,3838,5594,3659	DDX58,INPPL1,TRIM2,FN1,PSME2,INPP5D,UBA3,MAP3K8,ERBB2,PSME1,HLA-A,FGFR3,SHC1,TRIM25,NUP133,GRIN2C,IL6ST,LAMTOR2,PIK3CA,DUSP10,ADAR,HLA-C,OAS3,CD44,IFNGR1,STAT3,VCL,SPTAN1,FGF9,UBA52,KPNA5,IFITM3,USP18,PIK3R1,TRIM35,PELI3,IRF6,IL6R,OASL,IFIT3,EGFR,ISG15,STAT2,FGFR1,SOCS3,IRS1,HLA-B,CAMK2D,IFIT2,CRK,FGFR2,IRAK2,STAT1,PML,KPNA2,MAPK1,IRF1
R-HSA-2219530	Constitutive Signaling by Aberrant PI3K in Cancer	0.0867107078138191	-2.44517789862536	61	9	0.012396694214876	726	8202	3667,2261,2254,2263,5295,5290,2064,2260,1956	IRS1,FGFR3,FGF9,FGFR2,PIK3R1,PIK3CA,ERBB2,FGFR1,EGFR
R-HSA-1839120	Signaling by FGFR1 amplification mutants	0.0885149963411696	-2.42458329114061	1	1	0.00137741046831956	726	8202	2260	FGFR1
R-HSA-2023837	Signaling by FGFR2 amplification mutants	0.0885149963411696	-2.42458329114061	1	1	0.00137741046831956	726	8202	2263	FGFR2
R-HSA-2033515	t(4;14) translocations of FGFR3	0.0885149963411696	-2.42458329114061	1	1	0.00137741046831956	726	8202	2261	FGFR3
R-HSA-193670	p75NTR negatively regulates cell cycle via SC1	0.0923553318275633	-2.3821118390001	6	2	0.00275482093663912	726	8202	3065,8841	HDAC1,HDAC3
R-HSA-390247	Beta-oxidation of very long chain fatty acids	0.0923553318275633	-2.3821118390001	6	2	0.00275482093663912	726	8202	1384,51	CRAT,ACOX1
R-HSA-1237112	Methionine salvage pathway	0.0923553318275633	-2.3821118390001	6	2	0.00275482093663912	726	8202	51074,84245	APIP,MRI1
R-HSA-174362	Transport and synthesis of PAPS	0.0923553318275633	-2.3821118390001	6	2	0.00275482093663912	726	8202	9060,9061	PAPSS2,PAPSS1
R-HSA-211916	Vitamins	0.0923553318275633	-2.3821118390001	6	2	0.00275482093663912	726	8202	56603,1591	CYP26B1,CYP24A1
R-HSA-1912422	Pre-NOTCH Expression and Processing	0.0985559663140803	-2.31713070623085	45	7	0.00964187327823691	726	8202	3725,595,4851,5986,4343,6400,55534	JUN,CCND1,NOTCH1,RFNG,MOV10,SEL1L,MAML3
R-HSA-69206	G1/S Transition	0.0996515882375907	-2.30607529429088	109	14	0.0192837465564738	726	8202	9134,6118,7465,5111,7311,5721,81620,1027,1163,7298,5720,1026,891,983	CCNE2,RPA2,WEE1,PCNA,UBA52,PSME2,CDT1,CDKN1B,CKS1B,TYMS,PSME1,CDKN1A,CCNB1,CDK1
R-HSA-2565942	Regulation of PLK1 Activity at G2/M Transition	0.0998804308458005	-2.3037814999455	81	11	0.0151515151515152	726	8202	7311,5108,5116,10383,8655,6790,891,10121,983,10133,1639	UBA52,PCM1,PCNT,TUBB4B,DYNLL1,AURKA,CCNB1,ACTR1A,CDK1,OPTN,DCTN1
R-HSA-168928	RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways	0.0998804308458005	-2.3037814999455	81	11	0.0151515151515152	726	8202	23586,7311,7706,10010,4792,1660,8737,64135,9636,4214,3659	DDX58,UBA52,TRIM25,TANK,NFKBIA,DHX9,RIPK1,IFIH1,ISG15,MAP3K1,IRF1
R-HSA-400511	Synthesis, secretion, and inactivation of Glucose-dependent Insulinotropic Polypeptide (GIP)	0.101223298360446	-2.29042632767253	13	3	0.00413223140495868	726	8202	23478,3670,60559	SEC11A,ISL1,SPCS3
R-HSA-75205	Dissolution of Fibrin Clot	0.101223298360446	-2.29042632767253	13	3	0.00413223140495868	726	8202	302,5328,6281	ANXA2,PLAU,S100A10
R-HSA-174403	Glutathione synthesis and recycling	0.101223298360446	-2.29042632767253	13	3	0.00413223140495868	726	8202	2730,55748,2937	GCLM,CNDP2,GSS
R-HSA-5140745	WNT5A-dependent internalization of FZD2, FZD5 and ROR2	0.101223298360446	-2.29042632767253	13	3	0.00413223140495868	726	8202	7855,1175,160	FZD5,AP2S1,AP2A1
R-HSA-1663150	The activation of arylsulfatases	0.101223298360446	-2.29042632767253	13	3	0.00413223140495868	726	8202	25870,79642,410	SUMF2,ARSJ,ARSA
R-HSA-1168372	Downstream signaling events of B Cell Receptor (BCR)	0.10507067615411	-2.25312204902939	168	20	0.0275482093663912	726	8202	2254,7311,4303,2308,5721,5295,2064,5720,1026,1956,2260,3667,572,2261,4193,2263,4792,5290,1027,4343	FGF9,UBA52,FOXO4,FOXO1,PSME2,PIK3R1,ERBB2,PSME1,CDKN1A,EGFR,FGFR1,IRS1,BAD,FGFR3,MDM2,FGFR2,NFKBIA,PIK3CA,CDKN1B,MOV10
R-HSA-15869	Metabolism of nucleotides	0.106668479664507	-2.23802957514616	82	11	0.0151515151515152	726	8202	847,51292,1890,2936,7295,50484,7298,9615,3615,2876,4907	CAT,GMPR2,TYMP,GSR,TXN,RRM2B,TYMS,GDA,IMPDH2,GPX1,NT5E
R-HSA-975871	MyD88 cascade initiated on plasma membrane	0.106668479664507	-2.23802957514616	82	11	0.0151515151515152	726	8202	3725,7311,1845,4792,1326,3656,1660,246330,2353,5594,4214	JUN,UBA52,DUSP3,NFKBIA,MAP3K8,IRAK2,DHX9,PELI3,FOS,MAPK1,MAP3K1
R-HSA-168176	Toll Like Receptor 5 (TLR5) Cascade	0.106668479664507	-2.23802957514616	82	11	0.0151515151515152	726	8202	3725,7311,1845,4792,1326,3656,1660,246330,2353,5594,4214	JUN,UBA52,DUSP3,NFKBIA,MAP3K8,IRAK2,DHX9,PELI3,FOS,MAPK1,MAP3K1
R-HSA-168142	Toll Like Receptor 10 (TLR10) Cascade	0.106668479664507	-2.23802957514616	82	11	0.0151515151515152	726	8202	3725,7311,1845,4792,1326,3656,1660,246330,2353,5594,4214	JUN,UBA52,DUSP3,NFKBIA,MAP3K8,IRAK2,DHX9,PELI3,FOS,MAPK1,MAP3K1
R-HSA-73893	DNA Damage Bypass	0.107876237112347	-2.22677066162718	46	7	0.00964187327823691	726	8202	6118,5111,7311,5982,7706,5429,9636	RPA2,PCNA,UBA52,RFC2,TRIM25,POLH,ISG15
R-HSA-1912408	Pre-NOTCH Transcription and Translation	0.108120923164509	-2.22450501927785	29	5	0.0068870523415978	726	8202	3725,595,4851,4343,55534	JUN,CCND1,NOTCH1,MOV10,MAML3
R-HSA-379726	Mitochondrial tRNA aminoacylation	0.108967201493137	-2.21670834576629	21	4	0.00550964187327824	726	8202	25973,5859,55699,55157	PARS2,QARS,IARS2,DARS2
R-HSA-69186	Lagging Strand Synthesis	0.108967201493137	-2.21670834576629	21	4	0.00550964187327824	726	8202	3978,6118,5111,5982	LIG1,RPA2,PCNA,RFC2
R-HSA-445144	Signal transduction by L1	0.108967201493137	-2.21670834576629	21	4	0.00550964187327824	726	8202	3685,5594,2260,1956	ITGAV,MAPK1,FGFR1,EGFR
R-HSA-69620	Cell Cycle Checkpoints	0.110437588531979	-2.20330472725474	179	21	0.0289256198347107	726	8202	9134,7311,63967,9184,5721,991,5720,672,1026,891,5982,995,983,6118,7465,4193,7158,1027,51434,11065,2810	CCNE2,UBA52,CLSPN,BUB3,PSME2,CDC20,PSME1,BRCA1,CDKN1A,CCNB1,RFC2,CDC25C,CDK1,RPA2,WEE1,MDM2,TP53BP1,CDKN1B,ANAPC7,UBE2C,SFN
R-HSA-975138	TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation	0.113718580789923	-2.17402847214071	83	11	0.0151515151515152	726	8202	3725,7311,1845,4792,1326,3656,1660,246330,2353,5594,4214	JUN,UBA52,DUSP3,NFKBIA,MAP3K8,IRAK2,DHX9,PELI3,FOS,MAPK1,MAP3K1
R-HSA-1989781	PPARA activates gene expression	0.117550826836946	-2.14088447010377	112	14	0.0192837465564738	726	8202	123,3992,85441,5468,1376,27242,51,8800,8841,2274,54797,51129,2222,3156	PLIN2,FADS1,HELZ2,PPARG,CPT2,TNFRSF21,ACOX1,PEX11A,HDAC3,FHL2,MED18,ANGPTL4,FDFT1,HMGCR
R-HSA-5358565	Mismatch repair (MMR) directed by MSH2:MSH6 (MutSalpha)	0.120731527110776	-2.11418598274264	14	3	0.00413223140495868	726	8202	3978,6118,5111	LIG1,RPA2,PCNA
R-HSA-5358606	Mismatch repair (MMR) directed by MSH2:MSH3 (MutSbeta)	0.120731527110776	-2.11418598274264	14	3	0.00413223140495868	726	8202	3978,6118,5111	LIG1,RPA2,PCNA
R-HSA-918233	TRAF3-dependent IRF activation pathway	0.120731527110776	-2.11418598274264	14	3	0.00413223140495868	726	8202	23586,64135,7706	DDX58,IFIH1,TRIM25
R-HSA-5675482	Regulation of necroptotic cell death	0.120731527110776	-2.11418598274264	14	3	0.00413223140495868	726	8202	8737,8795,355	RIPK1,TNFRSF10B,FAS
R-HSA-877312	Regulation of IFNG signaling	0.120731527110776	-2.11418598274264	14	3	0.00413223140495868	726	8202	3459,6772,9021	IFNGR1,STAT1,SOCS3
R-HSA-399719	Trafficking of AMPA receptors	0.120830297744674	-2.11336821578413	30	5	0.0068870523415978	726	8202	817,4193,4905,1175,160	CAMK2D,MDM2,NSF,AP2S1,AP2A1
R-HSA-399721	Glutamate Binding, Activation of AMPA Receptors and Synaptic Plasticity	0.120830297744674	-2.11336821578413	30	5	0.0068870523415978	726	8202	817,4193,4905,1175,160	CAMK2D,MDM2,NSF,AP2S1,AP2A1
R-HSA-182218	Nef Mediated CD8 Down-regulation	0.12192627603857	-2.10433871167437	7	2	0.00275482093663912	726	8202	1175,160	AP2S1,AP2A1
R-HSA-162791	Attachment of GPI anchor to uPAR	0.12192627603857	-2.10433871167437	7	2	0.00275482093663912	726	8202	8733,51604	GPAA1,PIGT
R-HSA-190371	FGFR3b ligand binding and activation	0.12192627603857	-2.10433871167437	7	2	0.00275482093663912	726	8202	2261,2254	FGFR3,FGF9
R-HSA-2660826	Constitutive Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.12192627603857	-2.10433871167437	7	2	0.00275482093663912	726	8202	4851,182	NOTCH1,JAG1
R-HSA-2660825	Signaling by NOTCH1 t(7;9)(NOTCH1:M1580_K2555) Translocation Mutant	0.12192627603857	-2.10433871167437	7	2	0.00275482093663912	726	8202	4851,182	NOTCH1,JAG1
R-HSA-427601	Multifunctional anion exchangers	0.12192627603857	-2.10433871167437	7	2	0.00275482093663912	726	8202	115111,65010	SLC26A7,SLC26A6
R-HSA-2980767	Activation of NIMA Kinases NEK9, NEK6, NEK7	0.12192627603857	-2.10433871167437	7	2	0.00275482093663912	726	8202	891,983	CCNB1,CDK1
R-HSA-168256	Immune System	0.123381854304866	-2.092471226096	1371	133	0.183195592286501	726	8202	81622,23321,7295,9820,6890,79654,65264,9666,5720,11004,1026,9867,998,3572,5290,11221,3459,64167,7311,3841,11274,127544,572,3433,1398,1535,27297,3838,23586,3636,2335,2308,23480,9039,1660,9520,29127,3725,6494,112,3107,9114,10112,26999,3437,9636,1956,3667,1845,160,4792,3656,64135,3659,7317,523,5721,3635,8655,8737,2064,526,162,10121,55824,4179,4193,55845,6464,7706,55746,2905,28956,1027,51434,103,4940,5627,64219,7414,1639,10484,10952,5441,991,5588,3664,837,2260,6773,9021,6892,817,1650,10312,6778,6772,1174,22954,4343,5594,1175,9903,1326,9354,3105,2261,9632,10010,79659,960,6774,6709,4214,2254,4303,10410,5295,23087,3570,246330,8638,2353,3106,2263,8453,23220,5371,51752,3685,164,11065,10489	UNC93B1,TRIM2,TXN,CUL7,TAP1,HECTD3,UBE2Z,DZIP3,PSME1,KIF2C,CDKN1A,PJA2,CDC42,IL6ST,PIK3CA,DUSP10,IFNGR1,ERAP2,UBA52,KPNA5,USP18,RNF19B,BAD,IFIT2,CRK,CYBA,CRCP,KPNA2,DDX58,INPPL1,FN1,FOXO1,SEC61G,UBA3,DHX9,NPEPPS,RACGAP1,JUN,SIPA1,ADCY6,HLA-C,ATP6V0D1,KIF20A,CYFIP2,IFIT3,ISG15,EGFR,IRS1,DUSP3,AP2A1,NFKBIA,IRAK2,IFIH1,IRF1,UBA1,ATP6V1A,PSME2,INPP5D,DYNLL1,RIPK1,ERBB2,ATP6V1B2,AP1B1,ACTR1A,PAG1,CD46,MDM2,BRK1,SHC1,TRIM25,NUP133,GRIN2C,LAMTOR2,CDKN1B,ANAPC7,ADAR,OAS3,PROS1,PJA1,VCL,DCTN1,SEC23A,SEC61B,POLR2L,CDC20,PRKCQ,IRF6,CASP4,FGFR1,STAT2,SOCS3,TAPBP,CAMK2D,DDOST,TCIRG1,STAT6,STAT1,AP1S1,TRIM32,MOV10,MAPK1,AP2S1,KLHL21,MAP3K8,UBE4A,HLA-A,FGFR3,SEC24C,TANK,DYNC2H1,CD44,STAT3,SPTAN1,MAP3K1,FGF9,FOXO4,IFITM3,PIK3R1,TRIM35,IL6R,PELI3,OASL,FOS,HLA-B,FGFR2,CUL2,DTX4,PML,ERAP1,ITGAV,AP1G1,UBE2C,LRRC41
R-HSA-110373	Resolution of AP sites via the multiple-nucleotide patch replacement pathway	0.124354511038091	-2.08461883244587	22	4	0.00550964187327824	726	8202	3978,6118,5111,5982	LIG1,RPA2,PCNA,RFC2
R-HSA-69273	Cyclin A/B1 associated events during G2/M transition	0.124354511038091	-2.08461883244587	22	4	0.00550964187327824	726	8202	7465,891,995,983	WEE1,CCNB1,CDC25C,CDK1
R-HSA-5655332	Signaling by FGFR3 in disease	0.124354511038091	-2.08461883244587	22	4	0.00550964187327824	726	8202	2261,2254,5295,5290	FGFR3,FGF9,PIK3R1,PIK3CA
R-HSA-373753	Nephrin interactions	0.124354511038091	-2.08461883244587	22	4	0.00550964187327824	726	8202	87,5295,5290,6709	ACTN1,PIK3R1,PIK3CA,SPTAN1
R-HSA-1834949	Cytosolic sensors of pathogen-associated DNA	0.126074734999323	-2.07088041295039	66	9	0.012396694214876	726	8202	7311,5441,6778,4792,23220,1660,8737,27297,22954	UBA52,POLR2L,STAT6,NFKBIA,DTX4,DHX9,RIPK1,CRCP,TRIM32
R-HSA-3928665	EPH-ephrin mediated repulsion of cells	0.12786555891064	-2.05677588804679	48	7	0.00964187327823691	726	8202	1948,2051,51107,7074,1175,160,1947	EFNB2,EPHB6,APH1A,TIAM1,AP2S1,AP2A1,EFNB1
R-HSA-73762	RNA Polymerase I Transcription Initiation	0.12786555891064	-2.05677588804679	48	7	0.00964187327823691	726	8202	3065,54700,5441,30834,9219,64425,221830	HDAC1,RRN3,POLR2L,ZNRD1,MTA2,POLR1E,TWISTNB
R-HSA-975155	MyD88 dependent cascade initiated on endosome	0.128595478900043	-2.05108362409488	85	11	0.0151515151515152	726	8202	3725,7311,1845,4792,1326,3656,1660,246330,2353,5594,4214	JUN,UBA52,DUSP3,NFKBIA,MAP3K8,IRAK2,DHX9,PELI3,FOS,MAPK1,MAP3K1
R-HSA-168181	Toll Like Receptor 7/8 (TLR7/8) Cascade	0.128595478900043	-2.05108362409488	85	11	0.0151515151515152	726	8202	3725,7311,1845,4792,1326,3656,1660,246330,2353,5594,4214	JUN,UBA52,DUSP3,NFKBIA,MAP3K8,IRAK2,DHX9,PELI3,FOS,MAPK1,MAP3K1
R-HSA-2682334	EPH-Ephrin signaling	0.132281368862027	-2.02282404270598	95	12	0.0165289256198347	726	8202	1948,998,51107,160,4637,6386,2051,4628,7074,1175,1947,9475	EFNB2,CDC42,APH1A,AP2A1,MYL6,SDCBP,EPHB6,MYH10,TIAM1,AP2S1,EFNB1,ROCK2
R-HSA-73772	RNA Polymerase I Promoter Escape	0.134201125430035	-2.00841566826485	31	5	0.0068870523415978	726	8202	54700,5441,30834,64425,221830	RRN3,POLR2L,ZNRD1,POLR1E,TWISTNB
R-HSA-216083	Integrin cell surface interactions	0.13493207708998	-2.00298375982423	67	9	0.012396694214876	726	8202	3675,2335,375790,2200,961,682,50848,3685,960	ITGA3,FN1,AGRN,FBN1,CD47,BSG,F11R,ITGAV,CD44
R-HSA-211859	Biological oxidations	0.135208886472709	-2.00093438918485	194	22	0.0303030303030303	726	8202	56603,1591,2730,6819,9060,7358,9446,2950,2937,196743,373156,8824,54498,9061,2232,191,2941,113612,55748,66002,1545,2052	CYP26B1,CYP24A1,GCLM,SULT1C2,PAPSS2,UGDH,GSTO1,GSTP1,GSS,PAOX,GSTK1,CES2,SMOX,PAPSS1,FDXR,AHCY,GSTA4,CYP2U1,CNDP2,CYP4F12,CYP1B1,EPHX1
R-HSA-3371556	Cellular response to heat stress	0.136415931954819	-1.99204673720591	86	11	0.0151515151515152	726	8202	6118,10808,817,6767,55746,3312,3337,5594,3306,3303,3304	RPA2,HSPH1,CAMK2D,ST13,NUP133,HSPA8,DNAJB1,MAPK1,HSPA2,HSPA1A,HSPA1B
R-HSA-400206	Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)	0.137208885837829	-1.98625080020571	115	14	0.0192837465564738	726	8202	123,3992,85441,5468,1376,27242,51,8800,8841,2274,54797,51129,2222,3156	PLIN2,FADS1,HELZ2,PPARG,CPT2,TNFRSF21,ACOX1,PEX11A,HDAC3,FHL2,MED18,ANGPTL4,FDFT1,HMGCR
R-HSA-174417	Telomere C-strand (Lagging Strand) Synthesis	0.140598805219024	-1.96184479737266	23	4	0.00550964187327824	726	8202	3978,6118,5111,5982	LIG1,RPA2,PCNA,RFC2
R-HSA-3322077	Glycogen synthesis	0.141481455735387	-1.95558662536087	15	3	0.00413223140495868	726	8202	5236,7311,55276	PGM1,UBA52,PGM2
R-HSA-3134975	Regulation of innate immune responses to cytosolic DNA	0.141481455735387	-1.95558662536087	15	3	0.00413223140495868	726	8202	22954,7311,23220	TRIM32,UBA52,DTX4
R-HSA-372708	p130Cas linkage to MAPK signaling for integrins	0.141481455735387	-1.95558662536087	15	3	0.00413223140495868	726	8202	2335,1398,9564	FN1,CRK,BCAR1
R-HSA-5358508	Mismatch Repair	0.141481455735387	-1.95558662536087	15	3	0.00413223140495868	726	8202	3978,6118,5111	LIG1,RPA2,PCNA
R-HSA-5099900	WNT5A-dependent internalization of FZD4	0.141481455735387	-1.95558662536087	15	3	0.00413223140495868	726	8202	8322,1175,160	FZD4,AP2S1,AP2A1
R-HSA-1474244	Extracellular matrix organization	0.143728456870269	-1.9398294757859	267	29	0.0399449035812672	726	8202	3910,836,1308,1292,2335,375790,682,87,50848,780,650,64175,3909,3675,7076,2200,1462,3912,961,1291,8751,3913,59277,84171,3685,3691,960,4325,823	LAMA4,CASP3,COL17A1,COL6A2,FN1,AGRN,BSG,ACTN1,F11R,DDR1,BMP2,P3H1,LAMA3,ITGA3,TIMP1,FBN1,VCAN,LAMB1,CD47,COL6A1,ADAM15,LAMB2,NTN4,LOXL4,ITGAV,ITGB4,CD44,MMP16,CAPN1
R-HSA-75109	Triglyceride Biosynthesis	0.144103896205364	-1.93722073813702	68	9	0.012396694214876	726	8202	51703,60481,84803,83401,26027,51495,57678,8694,6576	ACSL5,ELOVL5,GPAT3,ELOVL3,ACOT11,HACD3,GPAM,DGAT1,SLC25A1
R-HSA-5687128	MAPK6/MAPK4 signaling	0.152800289784826	-1.87862350575396	88	11	0.0151515151515152	726	8202	3725,7311,998,2308,5721,5720,10642,3337,4343,3315,983	JUN,UBA52,CDC42,FOXO1,PSME2,PSME1,IGF2BP1,DNAJB1,MOV10,HSPB1,CDK1
R-HSA-444473	Formyl peptide receptors bind formyl peptides and many other ligands	0.153377804803384	-1.87485108889164	8	2	0.00275482093663912	726	8202	50865,301	HEBP1,ANXA1
R-HSA-196836	Vitamin C (ascorbate) metabolism	0.153377804803384	-1.87485108889164	8	2	0.00275482093663912	726	8202	9446,6513	GSTO1,SLC2A1
R-HSA-111453	BH3-only proteins associate with and inactivate anti-apoptotic BCL-2 members	0.153377804803384	-1.87485108889164	8	2	0.00275482093663912	726	8202	572,27113	BAD,BBC3
R-HSA-2142670	Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)	0.153377804803384	-1.87485108889164	8	2	0.00275482093663912	726	8202	2053,1545	EPHX2,CYP1B1
R-HSA-1614558	Degradation of cysteine and homocysteine	0.153377804803384	-1.87485108889164	8	2	0.00275482093663912	726	8202	6821,7263	SUOX,TST
R-HSA-1236973	Cross-presentation of particulate exogenous antigens (phagosomes)	0.153377804803384	-1.87485108889164	8	2	0.00275482093663912	726	8202	3685,1535	ITGAV,CYBA
R-HSA-156580	Phase II conjugation	0.155455999320267	-1.86139254997494	98	12	0.0165289256198347	726	8202	373156,2730,6819,9060,7358,9061,191,9446,2941,55748,2950,2937	GSTK1,GCLM,SULT1C2,PAPSS2,UGDH,PAPSS1,AHCY,GSTO1,GSTA4,CNDP2,GSTP1,GSS
R-HSA-392154	Nitric oxide stimulates guanylate cyclase	0.157630686494271	-1.84750040925407	24	4	0.00550964187327824	726	8202	8654,27345,10846,5139	PDE5A,KCNMB4,PDE10A,PDE3A
R-HSA-186763	Downstream signal transduction	0.158321206648189	-1.84312935613912	322	34	0.046831955922865	726	8202	2335,2308,5721,2064,5720,1026,2261,4193,6464,2905,28956,5290,11221,112,1027,7414,6774,6709,2254,7311,4303,5295,9564,1956,2260,3667,572,817,1398,2263,6778,6772,4343,5594	FN1,FOXO1,PSME2,ERBB2,PSME1,CDKN1A,FGFR3,MDM2,SHC1,GRIN2C,LAMTOR2,PIK3CA,DUSP10,ADCY6,CDKN1B,VCL,STAT3,SPTAN1,FGF9,UBA52,FOXO4,PIK3R1,BCAR1,EGFR,FGFR1,IRS1,BAD,CAMK2D,CRK,FGFR2,STAT6,STAT1,MOV10,MAPK1
R-HSA-168138	Toll Like Receptor 9 (TLR9) Cascade	0.16135416587005	-1.82415354197613	89	11	0.0151515151515152	726	8202	3725,7311,1845,4792,1326,3656,1660,246330,2353,5594,4214	JUN,UBA52,DUSP3,NFKBIA,MAP3K8,IRAK2,DHX9,PELI3,FOS,MAPK1,MAP3K1
R-HSA-113510	E2F mediated regulation of DNA replication	0.16278315709403	-1.81533628841919	33	5	0.0068870523415978	726	8202	7298,5111,891,983,81620	TYMS,PCNA,CCNB1,CDK1,CDT1
R-HSA-933541	TRAF6 mediated IRF7 activation	0.16278315709403	-1.81533628841919	33	5	0.0068870523415978	726	8202	23586,64135,7706,10010,3659	DDX58,IFIH1,TRIM25,TANK,IRF1
R-HSA-4085001	Sialic acid metabolism	0.16278315709403	-1.81533628841919	33	5	0.0068870523415978	726	8202	6483,26503,140838,10610,8869	ST3GAL2,SLC17A5,NANP,ST6GALNAC2,ST3GAL5
R-HSA-1660499	Synthesis of PIPs at the plasma membrane	0.16278315709403	-1.81533628841919	33	5	0.0068870523415978	726	8202	3636,3635,5295,8821,5290	INPPL1,INPP5D,PIK3R1,INPP4B,PIK3CA
R-HSA-3928662	EPHB-mediated forward signaling	0.163115125837069	-1.81329903400428	42	6	0.00826446280991736	726	8202	1948,2051,998,7074,9475,1947	EFNB2,EPHB6,CDC42,TIAM1,ROCK2,EFNB1
R-HSA-156711	Polo-like kinase mediated events	0.163309325517263	-1.81210917397817	16	3	0.00413223140495868	726	8202	7465,891,995	WEE1,CCNB1,CDC25C
R-HSA-5218859	Regulated Necrosis	0.163309325517263	-1.81210917397817	16	3	0.00413223140495868	726	8202	8737,8795,355	RIPK1,TNFRSF10B,FAS
R-HSA-416993	Trafficking of GluR2-containing AMPA receptors	0.163309325517263	-1.81210917397817	16	3	0.00413223140495868	726	8202	4905,1175,160	NSF,AP2S1,AP2A1
R-HSA-5213460	RIPK1-mediated regulated necrosis	0.163309325517263	-1.81210917397817	16	3	0.00413223140495868	726	8202	8737,8795,355	RIPK1,TNFRSF10B,FAS
R-HSA-69183	Processive synthesis on the lagging strand	0.163309325517263	-1.81210917397817	16	3	0.00413223140495868	726	8202	3978,6118,5111	LIG1,RPA2,PCNA
R-HSA-1169410	Antiviral mechanism by IFN-stimulated genes	0.163358665835908	-1.81180709161733	70	9	0.012396694214876	726	8202	23586,7311,3841,55746,7706,11274,6772,3838,9636	DDX58,UBA52,KPNA5,NUP133,TRIM25,USP18,STAT1,KPNA2,ISG15
R-HSA-1169408	ISG15 antiviral mechanism	0.163358665835908	-1.81180709161733	70	9	0.012396694214876	726	8202	23586,7311,3841,55746,7706,11274,6772,3838,9636	DDX58,UBA52,KPNA5,NUP133,TRIM25,USP18,STAT1,KPNA2,ISG15
R-HSA-2559580	Oxidative Stress Induced Senescence	0.166065634861815	-1.79537217803808	119	14	0.0192837465564738	726	8202	1912,3725,1031,1030,23043,4193,7311,7295,23466,653604,5594,2353,4343,8726	PHC2,JUN,CDKN2C,CDKN2B,TNIK,MDM2,UBA52,TXN,CBX6,HIST2H3D,MAPK1,FOS,MOV10,EED
R-HSA-186797	Signaling by PDGF	0.167624935243924	-1.78602632369551	345	36	0.0495867768595041	726	8202	2335,2308,5721,2064,5720,1026,2261,4193,6464,2905,28956,1291,5290,11221,112,1027,7414,6774,6709,2254,7311,1292,4303,5295,9564,1956,2260,3667,572,817,1398,2263,6778,6772,4343,5594	FN1,FOXO1,PSME2,ERBB2,PSME1,CDKN1A,FGFR3,MDM2,SHC1,GRIN2C,LAMTOR2,COL6A1,PIK3CA,DUSP10,ADCY6,CDKN1B,VCL,STAT3,SPTAN1,FGF9,UBA52,COL6A2,FOXO4,PIK3R1,BCAR1,EGFR,FGFR1,IRS1,BAD,CAMK2D,CRK,FGFR2,STAT6,STAT1,MOV10,MAPK1
R-HSA-916853	Degradation of GABA	0.169204925937142	-1.77664471913012	2	1	0.00137741046831956	726	8202	7915	ALDH5A1
R-HSA-69560	Transcriptional activation of p53 responsive genes	0.169204925937142	-1.77664471913012	2	1	0.00137741046831956	726	8202	1026	CDKN1A
R-HSA-75102	C6 deamination of adenosine	0.169204925937142	-1.77664471913012	2	1	0.00137741046831956	726	8202	103	ADAR
R-HSA-5638303	Inhibition of Signaling by Overexpressed EGFR	0.169204925937142	-1.77664471913012	2	1	0.00137741046831956	726	8202	1956	EGFR
R-HSA-69895	Transcriptional  activation of  cell cycle inhibitor p21	0.169204925937142	-1.77664471913012	2	1	0.00137741046831956	726	8202	1026	CDKN1A
R-HSA-75064	mRNA Editing: A to I Conversion	0.169204925937142	-1.77664471913012	2	1	0.00137741046831956	726	8202	103	ADAR
R-HSA-114294	Activation, translocation and oligomerization of BAX	0.169204925937142	-1.77664471913012	2	1	0.00137741046831956	726	8202	581	BAX
R-HSA-211736	Stimulation of the cell death response by PAK-2p34	0.169204925937142	-1.77664471913012	2	1	0.00137741046831956	726	8202	836	CASP3
R-HSA-111995	phospho-PLA2 pathway	0.169204925937142	-1.77664471913012	2	1	0.00137741046831956	726	8202	5594	MAPK1
R-HSA-77042	Formation of editosomes by ADAR proteins	0.169204925937142	-1.77664471913012	2	1	0.00137741046831956	726	8202	103	ADAR
R-HSA-163754	Insulin effects increased synthesis of Xylulose-5-Phosphate	0.169204925937142	-1.77664471913012	2	1	0.00137741046831956	726	8202	7086	TKT
R-HSA-5638302	Signaling by Overexpressed Wild-Type EGFR in Cancer	0.169204925937142	-1.77664471913012	2	1	0.00137741046831956	726	8202	1956	EGFR
R-HSA-5617833	Assembly of the primary cilium	0.170661997387877	-1.76807030204041	180	20	0.0275482093663912	726	8202	64792,123016,5116,79867,51098,10383,84747,8655,55212,23265,89891,10121,983,5108,79989,149371,6102,79659,56912,1639	IFT22,TTC8,PCNT,TCTN2,IFT52,TUBB4B,UNC119B,DYNLL1,BBS7,EXOC7,WDR34,ACTR1A,CDK1,PCM1,TTC26,EXOC8,RP2,DYNC2H1,IFT46,DCTN1
R-HSA-109582	Hemostasis	0.171001808600454	-1.76608114592457	515	52	0.0716253443526171	726	8202	2335,967,3635,1609,9123,682,29127,50848,11004,2783,5139,965,2152,3833,7465,5328,6464,3675,998,7076,6281,10846,5290,653604,50808,5627,960,2149,7414,3920,152,10112,9948,5295,8654,5588,87,9564,7114,388,54331,27345,1398,5547,961,10544,3065,302,3685,5594,3659,10938	FN1,CD63,INPP5D,DGKQ,SLC16A3,BSG,RACGAP1,F11R,KIF2C,GNB2,PDE3A,CD58,F3,KIFC1,WEE1,PLAU,SHC1,ITGA3,CDC42,TIMP1,S100A10,PDE10A,PIK3CA,HIST2H3D,AK3,PROS1,CD44,F2R,VCL,LAMP2,ADRA2C,KIF20A,WDR1,PIK3R1,PDE5A,PRKCQ,ACTN1,BCAR1,TMSB4X,RHOB,GNG2,KCNMB4,CRK,PRCP,CD47,PROCR,HDAC1,ANXA2,ITGAV,MAPK1,IRF1,EHD1
R-HSA-2500257	Resolution of Sister Chromatid Cohesion	0.171992856027826	-1.76030233775321	100	12	0.0165289256198347	726	8202	9184,332,55746,991,54821,55143,6232,5905,9735,11004,891,983	BUB3,BIRC5,NUP133,CDC20,ERCC6L,CDCA8,RPS27,RANGAP1,KNTC1,KIF2C,CCNB1,CDK1
R-HSA-5683057	MAPK family signaling cascades	0.172674385866859	-1.75634762059742	273	29	0.0399449035812672	726	8202	2254,7311,2335,2308,5721,2064,5720,3337,3570,983,2260,1956,3725,3667,2261,817,6464,998,2905,2263,3572,28956,11221,10642,5594,7414,4343,3315,6709	FGF9,UBA52,FN1,FOXO1,PSME2,ERBB2,PSME1,DNAJB1,IL6R,CDK1,FGFR1,EGFR,JUN,IRS1,FGFR3,CAMK2D,SHC1,CDC42,GRIN2C,FGFR2,IL6ST,LAMTOR2,DUSP10,IGF2BP1,MAPK1,VCL,MOV10,HSPB1,SPTAN1
R-HSA-114452	Activation of BH3-only proteins	0.175377212967847	-1.74081612214819	25	4	0.00550964187327824	726	8202	572,27113,8655,2810	BAD,BBC3,DYNLL1,SFN
R-HSA-75876	Synthesis of very long-chain fatty acyl-CoAs	0.175377212967847	-1.74081612214819	25	4	0.00550964187327824	726	8202	51703,51495,60481,83401	ACSL5,HACD3,ELOVL5,ELOVL3
R-HSA-917937	Iron uptake and transport	0.176381193448856	-1.73510775419475	43	6	0.00826446280991736	726	8202	2495,30061,10312,526,523,9114	FTH1,SLC40A1,TCIRG1,ATP6V1B2,ATP6V1A,ATP6V0D1
R-HSA-1222556	ROS production in response to bacteria	0.177915001344594	-1.72644936327528	34	5	0.0068870523415978	726	8202	10312,1535,526,523,9114	TCIRG1,CYBA,ATP6V1B2,ATP6V1A,ATP6V0D1
R-HSA-936440	Negative regulators of RIG-I/MDA5 signaling	0.177915001344594	-1.72644936327528	34	5	0.0068870523415978	726	8202	23586,7311,64135,7706,9636	DDX58,UBA52,IFIH1,TRIM25,ISG15
R-HSA-176409	APC/C:Cdc20 mediated degradation of mitotic proteins	0.18376566070727	-1.69409391618203	72	9	0.012396694214876	726	8202	7311,9184,5721,991,5720,51434,891,11065,983	UBA52,BUB3,PSME2,CDC20,PSME1,ANAPC7,CCNB1,UBE2C,CDK1
R-HSA-1640170	Cell Cycle	0.184157563025008	-1.69196356701854	572	57	0.0785123966942149	726	8202	9134,1030,5116,55355,63967,10383,5721,8655,81620,54821,55143,3978,5720,11004,1026,891,10121,4000,7153,6118,1031,595,7465,4193,5111,55746,1163,1027,653604,51434,9735,3306,7014,1639,7112,8615,7311,10112,9184,23224,991,6232,5905,672,995,5982,983,10133,5108,332,7158,6790,3065,7298,5594,11065,2810	CCNE2,CDKN2B,PCNT,HJURP,CLSPN,TUBB4B,PSME2,DYNLL1,CDT1,ERCC6L,CDCA8,LIG1,PSME1,KIF2C,CDKN1A,CCNB1,ACTR1A,LMNA,TOP2A,RPA2,CDKN2C,CCND1,WEE1,MDM2,PCNA,NUP133,CKS1B,CDKN1B,HIST2H3D,ANAPC7,KNTC1,HSPA2,TERF2,DCTN1,TMPO,USO1,UBA52,KIF20A,BUB3,SYNE2,CDC20,RPS27,RANGAP1,BRCA1,CDC25C,RFC2,CDK1,OPTN,PCM1,BIRC5,TP53BP1,AURKA,HDAC1,TYMS,MAPK1,UBE2C,SFN
R-HSA-176407	Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase	0.186052181573575	-1.68172809852015	17	3	0.00413223140495868	726	8202	51434,11065,991	ANAPC7,UBE2C,CDC20
R-HSA-140534	Ligand-dependent caspase activation	0.186052181573575	-1.68172809852015	17	3	0.00413223140495868	726	8202	8737,8795,355	RIPK1,TNFRSF10B,FAS
R-HSA-435354	Zinc transporters	0.186052181573575	-1.68172809852015	17	3	0.00413223140495868	726	8202	64924,27173,7922	SLC30A5,SLC39A1,SLC39A7
R-HSA-422085	Synthesis, secretion, and deacylation of Ghrelin	0.186052181573575	-1.68172809852015	17	3	0.00413223140495868	726	8202	23478,60559,7941	SEC11A,SPCS3,PLA2G7
R-HSA-2142816	Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)	0.186146439674047	-1.68122160495941	9	2	0.00275482093663912	726	8202	113612,1545	CYP2U1,CYP1B1
R-HSA-5666185	RHO GTPases Activate Rhotekin and Rhophilins	0.186146439674047	-1.68122160495941	9	2	0.00275482093663912	726	8202	389,388	RHOC,RHOB
R-HSA-110357	Displacement of DNA glycosylase by APEX1	0.186146439674047	-1.68122160495941	9	2	0.00275482093663912	726	8202	4350,4595	MPG,MUTYH
R-HSA-167590	Nef Mediated CD4 Down-regulation	0.186146439674047	-1.68122160495941	9	2	0.00275482093663912	726	8202	1175,160	AP2S1,AP2A1
R-HSA-428543	Inactivation of Cdc42 and Rac	0.186146439674047	-1.68122160495941	9	2	0.00275482093663912	726	8202	998,9353	CDC42,SLIT2
R-HSA-1234158	Regulation of gene expression by Hypoxia-inducible Factor	0.186146439674047	-1.68122160495941	9	2	0.00275482093663912	726	8202	3091,405	HIF1A,ARNT
R-HSA-447041	CHL1 interactions	0.186146439674047	-1.68122160495941	9	2	0.00275482093663912	726	8202	286,3312	ANK1,HSPA8
R-HSA-198693	AKT phosphorylates targets in the nucleus	0.186146439674047	-1.68122160495941	9	2	0.00275482093663912	726	8202	4303,2308	FOXO4,FOXO1
R-HSA-1296052	Ca2+ activated K+ channels	0.186146439674047	-1.68122160495941	9	2	0.00275482093663912	726	8202	27345,3783	KCNMB4,KCNN4
R-HSA-166058	MyD88:Mal cascade initiated on plasma membrane	0.188390569212753	-1.66923797534993	92	11	0.0151515151515152	726	8202	3725,7311,1845,4792,1326,3656,1660,246330,2353,5594,4214	JUN,UBA52,DUSP3,NFKBIA,MAP3K8,IRAK2,DHX9,PELI3,FOS,MAPK1,MAP3K1
R-HSA-168188	Toll Like Receptor TLR6:TLR2 Cascade	0.188390569212753	-1.66923797534993	92	11	0.0151515151515152	726	8202	3725,7311,1845,4792,1326,3656,1660,246330,2353,5594,4214	JUN,UBA52,DUSP3,NFKBIA,MAP3K8,IRAK2,DHX9,PELI3,FOS,MAPK1,MAP3K1
R-HSA-181438	Toll Like Receptor 2 (TLR2) Cascade	0.188390569212753	-1.66923797534993	92	11	0.0151515151515152	726	8202	3725,7311,1845,4792,1326,3656,1660,246330,2353,5594,4214	JUN,UBA52,DUSP3,NFKBIA,MAP3K8,IRAK2,DHX9,PELI3,FOS,MAPK1,MAP3K1
R-HSA-168179	Toll Like Receptor TLR1:TLR2 Cascade	0.188390569212753	-1.66923797534993	92	11	0.0151515151515152	726	8202	3725,7311,1845,4792,1326,3656,1660,246330,2353,5594,4214	JUN,UBA52,DUSP3,NFKBIA,MAP3K8,IRAK2,DHX9,PELI3,FOS,MAPK1,MAP3K1
R-HSA-69278	Cell Cycle, Mitotic	0.188971074490977	-1.66616132065637	477	48	0.0661157024793388	726	8202	9134,1030,5116,10383,5721,8655,81620,54821,55143,3978,5720,11004,1026,891,10121,4000,7153,6118,1031,595,7465,5111,55746,1163,1027,653604,51434,9735,1639,7112,8615,7311,10112,9184,991,6232,5905,995,5982,983,10133,5108,332,6790,3065,7298,11065,5594	CCNE2,CDKN2B,PCNT,TUBB4B,PSME2,DYNLL1,CDT1,ERCC6L,CDCA8,LIG1,PSME1,KIF2C,CDKN1A,CCNB1,ACTR1A,LMNA,TOP2A,RPA2,CDKN2C,CCND1,WEE1,PCNA,NUP133,CKS1B,CDKN1B,HIST2H3D,ANAPC7,KNTC1,DCTN1,TMPO,USO1,UBA52,KIF20A,BUB3,CDC20,RPS27,RANGAP1,CDC25C,RFC2,CDK1,OPTN,PCM1,BIRC5,AURKA,HDAC1,TYMS,UBE2C,MAPK1
R-HSA-166054	Activated TLR4 signalling	0.189704043908174	-1.66229008488212	112	13	0.0179063360881543	726	8202	3725,7311,1845,10010,4792,1326,3656,1660,8737,246330,2353,5594,4214	JUN,UBA52,DUSP3,TANK,NFKBIA,MAP3K8,IRAK2,DHX9,RIPK1,PELI3,FOS,MAPK1,MAP3K1
R-HSA-212436	Generic Transcription Pathway	0.193356931835346	-1.64321741034134	553	55	0.0757575757575758	726	8202	1030,5564,7559,57343,7295,860,5565,9422,55659,7576,79898,51058,79818,158399,85441,143686,2936,22869,126070,94039,28956,253639,7769,55534,171392,4851,7050,10780,7311,7561,5468,79862,5571,388561,204851,57547,27244,81856,7025,148254,155054,58492,10520,50484,115509,25824,9167,7768,90338,80818,10670,3065,7596,29959,2810	CDKN2B,PRKAB1,ZNF12,ZNF304,TXN,RUNX2,PRKAB2,ZNF264,ZNF416,ZNF28,ZNF613,ZNF691,ZNF552,ZNF483,HELZ2,SESN3,GSR,ZNF510,ZNF440,ZNF101,LAMTOR2,ZNF620,ZNF226,MAML3,ZNF675,NOTCH1,TGIF1,ZNF234,UBA52,ZNF14,PPARG,ZNF669,PRKAG1,ZNF761,HIPK1,ZNF624,SESN1,ZNF611,NR2F1,ZNF555,ZNF425,ZNF77,ZNF211,RRM2B,ZNF689,PRDX5,COX7A2L,ZNF225,ZNF160,ZNF436,RRAGA,HDAC1,ZNF45,NRBP1,SFN
R-HSA-432720	Lysosome Vesicle Biogenesis	0.193550622877144	-1.6422161837919	35	5	0.0068870523415978	726	8202	2799,1174,162,164,3312	GNS,AP1S1,AP1B1,AP1G1,HSPA8
R-HSA-1606322	ZBP1(DAI) mediated induction of type I IFNs	0.193763089488885	-1.64111905437836	26	4	0.00550964187327824	726	8202	8737,4792,23220,1660	RIPK1,NFKBIA,DTX4,DHX9
R-HSA-264876	Insulin processing	0.193763089488885	-1.64111905437836	26	4	0.00550964187327824	726	8202	23265,64924,1363,149371	EXOC7,SLC30A5,CPE,EXOC8
R-HSA-912694	Regulation of IFNA signaling	0.193763089488885	-1.64111905437836	26	4	0.00550964187327824	726	8202	11274,6773,6772,9021	USP18,STAT2,STAT1,SOCS3
R-HSA-983189	Kinesins	0.193763089488885	-1.64111905437836	26	4	0.00550964187327824	726	8202	3833,29127,11004,10112	KIFC1,RACGAP1,KIF2C,KIF20A
R-HSA-77387	Insulin receptor recycling	0.193763089488885	-1.64111905437836	26	4	0.00550964187327824	726	8202	10312,526,523,9114	TCIRG1,ATP6V1B2,ATP6V1A,ATP6V0D1
R-HSA-176814	Activation of APC/C and APC/C:Cdc20 mediated degradation of mitotic proteins	0.194374747241446	-1.63796729641503	73	9	0.012396694214876	726	8202	7311,9184,5721,991,5720,51434,891,11065,983	UBA52,BUB3,PSME2,CDC20,PSME1,ANAPC7,CCNB1,UBE2C,CDK1
R-HSA-453276	Regulation of mitotic cell cycle	0.196608929484708	-1.62653865274452	83	10	0.0137741046831956	726	8202	7311,9184,5721,991,6790,5720,51434,891,11065,983	UBA52,BUB3,PSME2,CDC20,AURKA,PSME1,ANAPC7,CCNB1,UBE2C,CDK1
R-HSA-174143	APC/C-mediated degradation of cell cycle proteins	0.196608929484708	-1.62653865274452	83	10	0.0137741046831956	726	8202	7311,9184,5721,991,6790,5720,51434,891,11065,983	UBA52,BUB3,PSME2,CDC20,AURKA,PSME1,ANAPC7,CCNB1,UBE2C,CDK1
R-HSA-5696399	Global Genome Nucleotide Excision Repair (GG-NER)	0.196608929484708	-1.62653865274452	83	10	0.0137741046831956	726	8202	6118,1643,5111,7311,7508,3978,6612,79913,4798,5982	RPA2,DDB2,PCNA,UBA52,XPC,LIG1,SUMO3,ACTR5,NFRKB,RFC2
R-HSA-1852241	Organelle biogenesis and maintenance	0.203864818010028	-1.59029816160558	321	33	0.0454545454545455	726	8202	123016,5564,5116,79867,10383,84747,5565,8655,54148,55212,23265,89891,10121,85441,740,55037,149371,6102,79659,56912,1639,64792,51098,8841,5571,55173,28973,983,10573,5108,79989,51021,5442	TTC8,PRKAB1,PCNT,TCTN2,TUBB4B,UNC119B,PRKAB2,DYNLL1,MRPL39,BBS7,EXOC7,WDR34,ACTR1A,HELZ2,MRPL49,PTCD3,EXOC8,RP2,DYNC2H1,IFT46,DCTN1,IFT22,IFT52,HDAC3,PRKAG1,MRPS10,MRPS18B,CDK1,MRPL28,PCM1,TTC26,MRPS16,POLRMT
R-HSA-449147	Signaling by Interleukins	0.206778907849402	-1.57610513454079	311	32	0.0440771349862259	726	8202	3636,2335,5721,3635,1326,2064,5720,2261,6464,2905,3572,28956,5290,11221,7414,6774,6709,2254,7311,5295,3570,246330,2260,1956,9021,3667,817,1398,2263,3656,6772,5594	INPPL1,FN1,PSME2,INPP5D,MAP3K8,ERBB2,PSME1,FGFR3,SHC1,GRIN2C,IL6ST,LAMTOR2,PIK3CA,DUSP10,VCL,STAT3,SPTAN1,FGF9,UBA52,PIK3R1,IL6R,PELI3,FGFR1,EGFR,SOCS3,IRS1,CAMK2D,CRK,FGFR2,IRAK2,STAT1,MAPK1
R-HSA-351202	Metabolism of polyamines	0.206822496782633	-1.57589435704872	84	10	0.0137741046831956	726	8202	196743,1728,5721,54498,548596,84245,6303,51582,5720,51074	PAOX,NQO1,PSME2,SMOX,CKMT1A,MRI1,SAT1,AZIN1,PSME1,APIP
R-HSA-5663220	RHO GTPases Activate Formins	0.206983241906524	-1.57511744596728	114	13	0.0179063360881543	726	8202	9184,998,332,55746,389,991,54821,55143,5905,6232,9735,11004,388	BUB3,CDC42,BIRC5,NUP133,RHOC,CDC20,ERCC6L,CDCA8,RANGAP1,RPS27,KNTC1,KIF2C,RHOB
R-HSA-5654704	SHC-mediated cascade:FGFR3	0.209550632080226	-1.56278988824612	18	3	0.00413223140495868	726	8202	2261,2254,6464	FGFR3,FGF9,SHC1
R-HSA-912631	Regulation of signaling by CBL	0.209550632080226	-1.56278988824612	18	3	0.00413223140495868	726	8202	1398,5295,5290	CRK,PIK3R1,PIK3CA
R-HSA-156584	Cytosolic sulfonation of small molecules	0.209550632080226	-1.56278988824612	18	3	0.00413223140495868	726	8202	6819,9060,9061	SULT1C2,PAPSS2,PAPSS1
R-HSA-1912420	Pre-NOTCH Processing in Golgi	0.209550632080226	-1.56278988824612	18	3	0.00413223140495868	726	8202	4851,5986,6400	NOTCH1,RFNG,SEL1L
R-HSA-210993	Tie2 Signaling	0.209550632080226	-1.56278988824612	18	3	0.00413223140495868	726	8202	6464,5295,5290	SHC1,PIK3R1,PIK3CA
R-HSA-391251	Protein folding	0.210509614100494	-1.55822395421623	55	7	0.00964187327823691	726	8202	84790,84617,8237,6903,10383,6904,84261	TUBA1C,TUBB6,USP11,TBCC,TUBB4B,TBCD,FBXW9
R-HSA-450408	AUF1 (hnRNP D0) binds and destabilizes mRNA	0.210509614100494	-1.55822395421623	55	7	0.00964187327823691	726	8202	5720,7311,3315,5721,3303,3312,3304	PSME1,UBA52,HSPB1,PSME2,HSPA1A,HSPA8,HSPA1B
R-HSA-354192	Integrin alphaIIb beta3 signaling	0.212711743091473	-1.54781734865503	27	4	0.00550964187327824	726	8202	2335,6464,1398,9564	FN1,SHC1,CRK,BCAR1
R-HSA-5357769	Caspase activation via extrinsic apoptotic signalig pathway	0.212711743091473	-1.54781734865503	27	4	0.00550964187327824	726	8202	8737,836,8795,355	RIPK1,CASP3,TNFRSF10B,FAS
R-HSA-5655253	Signaling by FGFR2 in disease	0.212711743091473	-1.54781734865503	27	4	0.00550964187327824	726	8202	2254,2263,5295,5290	FGF9,FGFR2,PIK3R1,PIK3CA
R-HSA-69202	Cyclin E associated events during G1/S transition	0.214275829026994	-1.54049117321859	65	8	0.0110192837465565	726	8202	9134,7465,7311,5721,1027,1163,5720,1026	CCNE2,WEE1,UBA52,PSME2,CDKN1B,CKS1B,PSME1,CDKN1A
R-HSA-69242	S Phase	0.214592127648815	-1.53901613329431	125	14	0.0192837465564738	726	8202	9134,6118,595,7465,5111,7311,5721,81620,3978,1027,1163,5720,1026,5982	CCNE2,RPA2,CCND1,WEE1,PCNA,UBA52,PSME2,CDT1,LIG1,CDKN1B,CKS1B,PSME1,CDKN1A,RFC2
R-HSA-69275	G2/M Transition	0.215876051992893	-1.53305086936959	115	13	0.0179063360881543	726	8202	7465,7311,5108,5116,10383,8655,6790,891,10121,995,983,10133,1639	WEE1,UBA52,PCM1,PCNT,TUBB4B,DYNLL1,AURKA,CCNB1,ACTR1A,CDC25C,CDK1,OPTN,DCTN1
R-HSA-416482	G alpha (12/13) signalling events	0.216344878374658	-1.53088148546107	75	9	0.012396694214876	726	8202	54331,998,389,5295,5290,7074,9475,2783,388	GNG2,CDC42,RHOC,PIK3R1,PIK3CA,TIAM1,ROCK2,GNB2,RHOB
R-HSA-2559582	Senescence-Associated Secretory Phenotype (SASP)	0.216828285534125	-1.52864954959606	105	12	0.0165289256198347	726	8202	3725,1031,1030,7311,653604,1027,51434,1026,5594,2353,6774,11065	JUN,CDKN2C,CDKN2B,UBA52,HIST2H3D,CDKN1B,ANAPC7,CDKN1A,MAPK1,FOS,STAT3,UBE2C
R-HSA-948021	Transport to the Golgi and subsequent modification	0.217338856270111	-1.52629759376069	95	11	0.0151515151515152	726	8202	2517,10484,8615,11196,79694,4245,4905,9632,7039,3998,4121	FUCA1,SEC23A,USO1,SEC23IP,MANEA,MGAT1,NSF,SEC24C,TGFA,LMAN1,MAN1A1
R-HSA-75105	Fatty Acyl-CoA Biosynthesis	0.218587462140685	-1.52056906014219	46	6	0.00826446280991736	726	8202	51703,51495,60481,83401,6576,26027	ACSL5,HACD3,ELOVL5,ELOVL3,SLC25A1,ACOT11
R-HSA-111367	SLBP independent Processing of Histone Pre-mRNAs	0.219753488446107	-1.51524886793031	10	2	0.00275482093663912	726	8202	134353,6628	LSM11,SNRPB
R-HSA-73929	Base-Excision Repair, AP Site Formation	0.219753488446107	-1.51524886793031	10	2	0.00275482093663912	726	8202	4350,4595	MPG,MUTYH
R-HSA-113507	E2F-enabled inhibition of pre-replication complex formation	0.219753488446107	-1.51524886793031	10	2	0.00275482093663912	726	8202	891,983	CCNB1,CDK1
R-HSA-442380	Zinc influx into cells by the SLC39 gene family	0.219753488446107	-1.51524886793031	10	2	0.00275482093663912	726	8202	27173,7922	SLC39A1,SLC39A7
R-HSA-937042	IRAK2 mediated activation of TAK1 complex	0.219753488446107	-1.51524886793031	10	2	0.00275482093663912	726	8202	7311,3656	UBA52,IRAK2
R-HSA-174437	Removal of the Flap Intermediate from the C-strand	0.219753488446107	-1.51524886793031	10	2	0.00275482093663912	726	8202	6118,5111	RPA2,PCNA
R-HSA-2465910	MASTL Facilitates Mitotic Progression	0.219753488446107	-1.51524886793031	10	2	0.00275482093663912	726	8202	891,983	CCNB1,CDK1
R-HSA-975163	IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation	0.219753488446107	-1.51524886793031	10	2	0.00275482093663912	726	8202	7311,3656	UBA52,IRAK2
R-HSA-983705	Signaling by the B Cell Receptor (BCR)	0.221275885840999	-1.50834500378644	198	21	0.0289256198347107	726	8202	2254,7311,4303,2308,5721,5295,2064,5720,1026,1956,2260,3667,572,2261,4193,6464,2263,4792,5290,1027,4343	FGF9,UBA52,FOXO4,FOXO1,PSME2,PIK3R1,ERBB2,PSME1,CDKN1A,EGFR,FGFR1,IRS1,BAD,FGFR3,MDM2,SHC1,FGFR2,NFKBIA,PIK3CA,CDKN1B,MOV10
R-HSA-187577	SCF(Skp2)-mediated degradation of p27/p21	0.223684637183787	-1.49751808882206	56	7	0.00964187327823691	726	8202	9134,1163,1027,5720,1026,7311,5721	CCNE2,CKS1B,CDKN1B,PSME1,CDKN1A,UBA52,PSME2
R-HSA-3000178	ECM proteoglycans	0.223684637183787	-1.49751808882206	56	7	0.00964187327823691	726	8202	3910,3913,3685,3909,375790,1462,3912	LAMA4,LAMB2,ITGAV,LAMA3,AGRN,VCAN,LAMB1
R-HSA-76009	Platelet Aggregation (Plug Formation)	0.226153112992256	-1.48654301798718	37	5	0.0068870523415978	726	8202	152,2335,6464,1398,9564	ADRA2C,FN1,SHC1,CRK,BCAR1
R-HSA-74752	Signaling by Insulin receptor	0.226317222547392	-1.48581762430082	304	31	0.0426997245179063	726	8202	2254,5564,7311,2335,523,5721,5565,5295,2064,5571,5720,526,2260,1956,3667,2261,817,6464,10312,2905,2263,28956,5290,10670,11221,51719,6794,5594,7414,9114,6709	FGF9,PRKAB1,UBA52,FN1,ATP6V1A,PSME2,PRKAB2,PIK3R1,ERBB2,PRKAG1,PSME1,ATP6V1B2,FGFR1,EGFR,IRS1,FGFR3,CAMK2D,SHC1,TCIRG1,GRIN2C,FGFR2,LAMTOR2,PIK3CA,RRAGA,DUSP10,CAB39,STK11,MAPK1,VCL,ATP6V0D1,SPTAN1
R-HSA-69656	Cyclin A:Cdk2-associated events at S phase entry	0.226441497166096	-1.48526865807924	66	8	0.0110192837465565	726	8202	9134,7465,7311,5721,1027,1163,5720,1026	CCNE2,WEE1,UBA52,PSME2,CDKN1B,CKS1B,PSME1,CDKN1A
R-HSA-177929	Signaling by EGFR	0.227040173851175	-1.48262829984142	336	34	0.046831955922865	726	8202	2335,2308,5721,2064,5720,1026,55824,2261,4193,6464,998,2905,28956,5290,11221,112,1027,7414,6709,2254,7311,4303,5295,1956,2260,3667,572,817,2263,160,4343,5594,1175,10252	FN1,FOXO1,PSME2,ERBB2,PSME1,CDKN1A,PAG1,FGFR3,MDM2,SHC1,CDC42,GRIN2C,LAMTOR2,PIK3CA,DUSP10,ADCY6,CDKN1B,VCL,SPTAN1,FGF9,UBA52,FOXO4,PIK3R1,EGFR,FGFR1,IRS1,BAD,CAMK2D,FGFR2,AP2A1,MOV10,MAPK1,AP2S1,SPRY1
R-HSA-110314	Recognition of DNA damage by PCNA-containing replication complex	0.232146281901023	-1.46038758057803	28	4	0.00550964187327824	726	8202	6118,5111,7311,5982	RPA2,PCNA,UBA52,RFC2
R-HSA-400042	Adrenaline,noradrenaline inhibits insulin secretion	0.232146281901023	-1.46038758057803	28	4	0.00550964187327824	726	8202	54331,152,112,2783	GNG2,ADRA2C,ADCY6,GNB2
R-HSA-888590	GABA synthesis, release, reuptake and degradation	0.233650971968502	-1.45392684991068	19	3	0.00413223140495868	726	8202	7915,80331,3312	ALDH5A1,DNAJC5,HSPA8
R-HSA-453274	Mitotic G2-G2/M phases	0.234137212704759	-1.4518479563973	117	13	0.0179063360881543	726	8202	7465,7311,5108,5116,10383,8655,6790,891,10121,995,983,10133,1639	WEE1,UBA52,PCM1,PCNT,TUBB4B,DYNLL1,AURKA,CCNB1,ACTR1A,CDC25C,CDK1,OPTN,DCTN1
R-HSA-69580	p53-Dependent G1/S DNA damage checkpoint	0.237138234532479	-1.43911203981218	57	7	0.00964187327823691	726	8202	9134,1027,5720,4193,1026,7311,5721	CCNE2,CDKN1B,PSME1,MDM2,CDKN1A,UBA52,PSME2
R-HSA-69563	p53-Dependent G1 DNA Damage Response	0.237138234532479	-1.43911203981218	57	7	0.00964187327823691	726	8202	9134,1027,5720,4193,1026,7311,5721	CCNE2,CDKN1B,PSME1,MDM2,CDKN1A,UBA52,PSME2
R-HSA-937061	TRIF-mediated TLR3/TLR4 signaling	0.237590939876876	-1.43720482405201	97	11	0.0151515151515152	726	8202	3725,7311,1845,10010,4792,1326,3656,1660,8737,2353,5594	JUN,UBA52,DUSP3,TANK,NFKBIA,MAP3K8,IRAK2,DHX9,RIPK1,FOS,MAPK1
R-HSA-166166	MyD88-independent TLR3/TLR4 cascade	0.237590939876876	-1.43720482405201	97	11	0.0151515151515152	726	8202	3725,7311,1845,10010,4792,1326,3656,1660,8737,2353,5594	JUN,UBA52,DUSP3,TANK,NFKBIA,MAP3K8,IRAK2,DHX9,RIPK1,FOS,MAPK1
R-HSA-168164	Toll Like Receptor 3 (TLR3) Cascade	0.237590939876876	-1.43720482405201	97	11	0.0151515151515152	726	8202	3725,7311,1845,10010,4792,1326,3656,1660,8737,2353,5594	JUN,UBA52,DUSP3,TANK,NFKBIA,MAP3K8,IRAK2,DHX9,RIPK1,FOS,MAPK1
R-HSA-373755	Semaphorin interactions	0.238849554129739	-1.43192140588545	67	8	0.0110192837465565	726	8202	998,389,2064,4637,4628,10371,9475,388	CDC42,RHOC,ERBB2,MYL6,MYH10,SEMA3A,ROCK2,RHOB
R-HSA-70326	Glucose metabolism	0.239231627618703	-1.43032304316007	77	9	0.012396694214876	726	8202	5236,7311,55276,5211,5836,4190,5223,6576,5834	PGM1,UBA52,PGM2,PFKL,PYGL,MDH1,PGAM1,SLC25A1,PYGB
R-HSA-176408	Regulation of APC/C activators between G1/S and early anaphase	0.239231627618703	-1.43032304316007	77	9	0.012396694214876	726	8202	7311,9184,5721,991,5720,51434,891,11065,983	UBA52,BUB3,PSME2,CDC20,PSME1,ANAPC7,CCNB1,UBE2C,CDK1
R-HSA-5653890	Lactose synthesis	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	6513	SLC2A1
R-HSA-1368071	NR1D1 (REV-ERBA) represses gene expression	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	8841	HDAC3
R-HSA-964827	Progressive trimming of alpha-1,2-linked mannose residues from Man9/8/7GlcNAc2 to produce Man5GlcNAc2	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	4121	MAN1A1
R-HSA-77108	Utilization of Ketone Bodies	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	38	ACAT1
R-HSA-77285	Beta oxidation of myristoyl-CoA to lauroyl-CoA	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	3032	HADHB
R-HSA-111458	Formation of apoptosome	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	317	APAF1
R-HSA-73843	5-Phosphoribose 1-diphosphate biosynthesis	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	5631	PRPS1
R-HSA-163282	Mitochondrial transcription initiation	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	5442	POLRMT
R-HSA-428359	Insulin-like Growth Factor-2 mRNA Binding Proteins (IGF2BPs/IMPs/VICKZs) bind RNA	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	10642	IGF2BP1
R-HSA-198745	Signalling to STAT3	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	6774	STAT3
R-HSA-2395516	Electron transport from NADPH to Ferredoxin	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	2232	FDXR
R-HSA-111446	Activation of BIM and translocation to mitochondria	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	8655	DYNLL1
R-HSA-3249367	STAT6-mediated induction of chemokines	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	6778	STAT6
R-HSA-352238	Breakdown of the nuclear lamina	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	4000	LMNA
R-HSA-173599	Formation of the active cofactor, UDP-glucuronate	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	7358	UGDH
R-HSA-392023	Adrenaline signalling through Alpha-2 adrenergic receptor	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	152	ADRA2C
R-HSA-180897	Vpr-mediated induction of apoptosis by mitochondrial outer membrane permeabilization	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	292	SLC25A5
R-HSA-190374	FGFR1c and Klotho ligand binding and activation	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	2260	FGFR1
R-HSA-964975	Vitamins B6 activation to pyridoxal phosphate	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	8566	PDXK
R-HSA-170145	Phosphorylation of proteins involved in the G2/M transition by Cyclin A:Cdc2 complexes	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	983	CDK1
R-HSA-1234162	Oxygen-dependent asparagine hydroxylation of Hypoxia-inducible Factor Alpha	0.242760684932939	-1.41567915657778	3	1	0.00137741046831956	726	8202	3091	HIF1A
R-HSA-5696394	DNA Damage Recognition in GG-NER	0.243027491438395	-1.41458070854936	38	5	0.0068870523415978	726	8202	79913,1643,7311,4798,7508	ACTR5,DDB2,UBA52,NFRKB,XPC
R-HSA-68877	Mitotic Prometaphase	0.245859274490688	-1.40299596165152	108	12	0.0165289256198347	726	8202	9184,332,55746,991,54821,55143,6232,5905,9735,11004,891,983	BUB3,BIRC5,NUP133,CDC20,ERCC6L,CDCA8,RPS27,RANGAP1,KNTC1,KIF2C,CCNB1,CDK1
R-HSA-445355	Smooth Muscle Contraction	0.25199033930113	-1.37836452831219	29	4	0.00550964187327824	726	8202	59,4637,7414,4636	ACTA2,MYL6,VCL,MYL5
R-HSA-917977	Transferrin endocytosis and recycling	0.25199033930113	-1.37836452831219	29	4	0.00550964187327824	726	8202	10312,526,523,9114	TCIRG1,ATP6V1B2,ATP6V1A,ATP6V0D1
R-HSA-5654732	Negative regulation of FGFR3 signaling	0.25199033930113	-1.37836452831219	29	4	0.00550964187327824	726	8202	2261,2254,7311,5594	FGFR3,FGF9,UBA52,MAPK1
R-HSA-180786	Extension of Telomeres	0.25199033930113	-1.37836452831219	29	4	0.00550964187327824	726	8202	3978,6118,5111,5982	LIG1,RPA2,PCNA,RFC2
R-HSA-380320	Recruitment of NuMA to mitotic centrosomes	0.253794482401505	-1.37123046388495	11	2	0.00275482093663912	726	8202	891,983	CCNB1,CDK1
R-HSA-1980148	Signaling by NOTCH3	0.253794482401505	-1.37123046388495	11	2	0.00275482093663912	726	8202	182,51107	JAG1,APH1A
R-HSA-71064	Lysine catabolism	0.253794482401505	-1.37123046388495	11	2	0.00275482093663912	726	8202	501,1738	ALDH7A1,DLD
R-HSA-174490	Membrane binding and targetting of GAG proteins	0.253794482401505	-1.37123046388495	11	2	0.00275482093663912	726	8202	155382,7311	VPS37D,UBA52
R-HSA-174495	Synthesis And Processing Of GAG, GAGPOL Polyproteins	0.253794482401505	-1.37123046388495	11	2	0.00275482093663912	726	8202	155382,7311	VPS37D,UBA52
R-HSA-5655291	Signaling by FGFR4 in disease	0.253794482401505	-1.37123046388495	11	2	0.00275482093663912	726	8202	5295,5290	PIK3R1,PIK3CA
R-HSA-1855183	Synthesis of IP2, IP, and Ins in the cytosol	0.253794482401505	-1.37123046388495	11	2	0.00275482093663912	726	8202	51477,8821	ISYNA1,INPP4B
R-HSA-2514853	Condensation of Prometaphase Chromosomes	0.253794482401505	-1.37123046388495	11	2	0.00275482093663912	726	8202	891,983	CCNB1,CDK1
R-HSA-196807	Nicotinate metabolism	0.253794482401505	-1.37123046388495	11	2	0.00275482093663912	726	8202	55191,93100	NADSYN1,NAPRT
R-HSA-1839122	Signaling by activated point mutants of FGFR1	0.253794482401505	-1.37123046388495	11	2	0.00275482093663912	726	8202	2254,2260	FGF9,FGFR1
R-HSA-5668599	RHO GTPases Activate NADPH Oxidases	0.253794482401505	-1.37123046388495	11	2	0.00275482093663912	726	8202	10811,1535	NOXA1,CYBA
R-HSA-1980150	Signaling by NOTCH4	0.253794482401505	-1.37123046388495	11	2	0.00275482093663912	726	8202	182,51107	JAG1,APH1A
R-HSA-77588	SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs	0.253794482401505	-1.37123046388495	11	2	0.00275482093663912	726	8202	134353,6628	LSM11,SNRPB
R-HSA-1483191	Synthesis of PC	0.258206774002522	-1.3539945654276	20	3	0.00413223140495868	726	8202	204962,126969,1119	SLC44A5,SLC44A3,CHKA
R-HSA-3000170	Syndecan interactions	0.258206774002522	-1.3539945654276	20	3	0.00413223140495868	726	8202	87,3685,3691	ACTN1,ITGAV,ITGB4
R-HSA-418217	G beta:gamma signalling through PLC beta	0.258206774002522	-1.3539945654276	20	3	0.00413223140495868	726	8202	54331,2783,5331	GNG2,GNB2,PLCB3
R-HSA-140877	Formation of Fibrin Clot (Clotting Cascade)	0.26022151380904	-1.3462220345037	39	5	0.0068870523415978	726	8202	10544,5627,2149,5547,2152	PROCR,PROS1,F2R,PRCP,F3
R-HSA-1474228	Degradation of the extracellular matrix	0.260923860366002	-1.34352663695442	89	10	0.0137741046831956	726	8202	836,1308,3909,7076,3912,8751,682,960,4325,823	CASP3,COL17A1,LAMA3,TIMP1,LAMB1,ADAM15,BSG,CD44,MMP16,CAPN1
R-HSA-211945	Phase 1 - Functionalization of compounds	0.260923860366002	-1.34352663695442	89	10	0.0137741046831956	726	8202	56603,1591,196743,8824,54498,2232,113612,66002,1545,2052	CYP26B1,CYP24A1,PAOX,CES2,SMOX,FDXR,CYP2U1,CYP4F12,CYP1B1,EPHX1
R-HSA-174184	Cdc20:Phospho-APC/C mediated degradation of Cyclin A	0.264321648036073	-1.33058855366566	69	8	0.0110192837465565	726	8202	7311,9184,5721,991,5720,51434,11065,983	UBA52,BUB3,PSME2,CDC20,PSME1,ANAPC7,UBE2C,CDK1
R-HSA-450282	MAPK targets/ Nuclear events mediated by MAP kinases	0.272168807230941	-1.30133279036824	30	4	0.00550964187327824	726	8202	3725,1845,5594,2353	JUN,DUSP3,MAPK1,FOS
R-HSA-166016	Toll Like Receptor 4 (TLR4) Cascade	0.272372401736848	-1.30058502504932	121	13	0.0179063360881543	726	8202	3725,7311,1845,10010,4792,1326,3656,1660,8737,246330,2353,5594,4214	JUN,UBA52,DUSP3,TANK,NFKBIA,MAP3K8,IRAK2,DHX9,RIPK1,PELI3,FOS,MAPK1,MAP3K1
R-HSA-179419	APC:Cdc20 mediated degradation of cell cycle proteins prior to satisfation of the cell cycle checkpoint	0.277349129611624	-1.28247817071685	70	8	0.0110192837465565	726	8202	7311,9184,5721,991,5720,51434,11065,983	UBA52,BUB3,PSME2,CDC20,PSME1,ANAPC7,UBE2C,CDK1
R-HSA-5696400	Dual Incision in GG-NER	0.277688336803132	-1.2812558848199	40	5	0.0068870523415978	726	8202	6118,1643,5111,7311,5982	RPA2,DDB2,PCNA,UBA52,RFC2
R-HSA-69615	G1/S DNA Damage Checkpoints	0.278936967611083	-1.27676944522604	60	7	0.00964187327823691	726	8202	9134,1027,5720,4193,1026,7311,5721	CCNE2,CDKN1B,PSME1,MDM2,CDKN1A,UBA52,PSME2
R-HSA-450294	MAP kinase activation in TLR cascade	0.278936967611083	-1.27676944522604	60	7	0.00964187327823691	726	8202	3725,7311,1845,5594,2353,1326,3656	JUN,UBA52,DUSP3,MAPK1,FOS,MAP3K8,IRAK2
R-HSA-112310	Neurotransmitter Release Cycle	0.279338602026843	-1.27533060567477	50	6	0.00826446280991736	726	8202	7915,80331,8541,10550,6505,3312	ALDH5A1,DNAJC5,PPFIA3,ARL6IP5,SLC1A1,HSPA8
R-HSA-2022870	Chondroitin sulfate biosynthesis	0.283080036094149	-1.26202560826944	21	3	0.00413223140495868	726	8202	1462,51363,79586	VCAN,CHST15,CHPF
R-HSA-500657	Presynaptic function of Kainate receptors	0.283080036094149	-1.26202560826944	21	3	0.00413223140495868	726	8202	54331,2783,5331	GNG2,GNB2,PLCB3
R-HSA-5654688	SHC-mediated cascade:FGFR1	0.283080036094149	-1.26202560826944	21	3	0.00413223140495868	726	8202	2254,6464,2260	FGF9,SHC1,FGFR1
R-HSA-389357	CD28 dependent PI3K/Akt signaling	0.283080036094149	-1.26202560826944	21	3	0.00413223140495868	726	8202	1326,5295,5290	MAP3K8,PIK3R1,PIK3CA
R-HSA-1810476	RIP-mediated NFkB activation via ZBP1	0.283080036094149	-1.26202560826944	21	3	0.00413223140495868	726	8202	8737,4792,1660	RIPK1,NFKBIA,DHX9
R-HSA-390918	Peroxisomal lipid metabolism	0.283080036094149	-1.26202560826944	21	3	0.00413223140495868	726	8202	1384,51,5264	CRAT,ACOX1,PHYH
R-HSA-389960	Formation of tubulin folding intermediates by CCT/TriC	0.283080036094149	-1.26202560826944	21	3	0.00413223140495868	726	8202	84790,84617,10383	TUBA1C,TUBB6,TUBB4B
R-HSA-499943	Synthesis and interconversion of nucleotide di- and triphosphates	0.283080036094149	-1.26202560826944	21	3	0.00413223140495868	726	8202	2936,7295,50484	GSR,TXN,RRM2B
R-HSA-611105	Respiratory electron transport	0.287308758974627	-1.24719782625442	81	9	0.012396694214876	726	8202	4719,4712,9167,7385,7384,4728,54539,4702,6389	NDUFS1,NDUFB6,COX7A2L,UQCRC2,UQCRC1,NDUFS8,NDUFB11,NDUFA8,SDHA
R-HSA-114608	Platelet degranulation	0.287308758974627	-1.24719782625442	81	9	0.012396694214876	726	8202	3920,2335,7076,967,9948,87,5627,7414,7114	LAMP2,FN1,TIMP1,CD63,WDR1,ACTN1,PROS1,VCL,TMSB4X
R-HSA-156581	Methylation	0.287929815336012	-1.24503852529503	12	2	0.00275482093663912	726	8202	9446,191	GSTO1,AHCY
R-HSA-2160916	Hyaluronan uptake and degradation	0.287929815336012	-1.24503852529503	12	2	0.00275482093663912	726	8202	960,3074	CD44,HEXB
R-HSA-1839130	Signaling by activated point mutants of FGFR3	0.287929815336012	-1.24503852529503	12	2	0.00275482093663912	726	8202	2261,2254	FGFR3,FGF9
R-HSA-2022857	Keratan sulfate degradation	0.287929815336012	-1.24503852529503	12	2	0.00275482093663912	726	8202	2799,3074	GNS,HEXB
R-HSA-190373	FGFR1c ligand binding and activation	0.287929815336012	-1.24503852529503	12	2	0.00275482093663912	726	8202	2254,2260	FGF9,FGFR1
R-HSA-210990	PECAM1 interactions	0.287929815336012	-1.24503852529503	12	2	0.00275482093663912	726	8202	3685,3635	ITGAV,INPP5D
R-HSA-73621	Pyrimidine catabolism	0.287929815336012	-1.24503852529503	12	2	0.00275482093663912	726	8202	1890,4907	TYMP,NT5E
R-HSA-190239	FGFR3 ligand binding and activation	0.287929815336012	-1.24503852529503	12	2	0.00275482093663912	726	8202	2261,2254	FGFR3,FGF9
R-HSA-2033514	FGFR3 mutant receptor activation	0.287929815336012	-1.24503852529503	12	2	0.00275482093663912	726	8202	2261,2254	FGFR3,FGF9
R-HSA-202670	ERKs are inactivated	0.287929815336012	-1.24503852529503	12	2	0.00275482093663912	726	8202	1845,5594	DUSP3,MAPK1
R-HSA-190372	FGFR3c ligand binding and activation	0.287929815336012	-1.24503852529503	12	2	0.00275482093663912	726	8202	2261,2254	FGFR3,FGF9
R-HSA-163200	Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins.	0.291012203052438	-1.23439007780178	102	11	0.0151515151515152	726	8202	516,4719,4712,10476,9167,7385,7384,4728,54539,4702,6389	ATP5G1,NDUFS1,NDUFB6,ATP5H,COX7A2L,UQCRC2,UQCRC1,NDUFS8,NDUFB11,NDUFA8,SDHA
R-HSA-1630316	Glycosaminoglycan metabolism	0.292230481174592	-1.23021246897128	123	13	0.0179063360881543	726	8202	2799,10678,9060,375790,3038,57214,1462,51363,9061,3074,6483,960,79586	GNS,B3GNT2,PAPSS2,AGRN,HAS3,CEMIP,VCAN,CHST15,PAPSS1,HEXB,ST3GAL2,CD44,CHPF
R-HSA-2173796	SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription	0.292608463793189	-1.22891986465866	31	4	0.00550964187327824	726	8202	3065,1030,7050,7311	HDAC1,CDKN2B,TGIF1,UBA52
R-HSA-397795	G-protein beta:gamma signalling	0.295112554748456	-1.22039845389059	51	6	0.00826446280991736	726	8202	54331,6464,2783,5295,5331,5290	GNG2,SHC1,GNB2,PIK3R1,PLCB3,PIK3CA
R-HSA-5620920	Cargo trafficking to the periciliary membrane	0.295112554748456	-1.22039845389059	51	6	0.00826446280991736	726	8202	123016,6102,55212,23265,84747,149371	TTC8,RP2,BBS7,EXOC7,UNC119B,EXOC8
R-HSA-1592230	Mitochondrial biogenesis	0.295112554748456	-1.22039845389059	51	6	0.00826446280991736	726	8202	5571,5564,85441,5565,8841,5442	PRKAG1,PRKAB1,HELZ2,PRKAB2,HDAC3,POLRMT
R-HSA-76002	Platelet activation, signaling and aggregation	0.299150835342129	-1.20680736676447	230	23	0.0316804407713499	726	8202	3920,152,2335,967,9948,1609,5295,5588,87,9564,2783,7114,388,54331,6464,7076,998,1398,5290,5627,2149,7414,5594	LAMP2,ADRA2C,FN1,CD63,WDR1,DGKQ,PIK3R1,PRKCQ,ACTN1,BCAR1,GNB2,TMSB4X,RHOB,GNG2,SHC1,TIMP1,CDC42,CRK,PIK3CA,PROS1,F2R,VCL,MAPK1
R-HSA-71387	Metabolism of carbohydrates	0.306052619280873	-1.18399823337869	274	27	0.0371900826446281	726	8202	5236,10678,7311,9060,375790,55276,57214,6513,3074,7086,5836,79586,5834,2799,3038,55746,5211,51363,1462,9061,4190,6483,960,5223,5631,6576,2582	PGM1,B3GNT2,UBA52,PAPSS2,AGRN,PGM2,CEMIP,SLC2A1,HEXB,TKT,PYGL,CHPF,PYGB,GNS,HAS3,NUP133,PFKL,CHST15,VCAN,PAPSS1,MDH1,ST3GAL2,CD44,PGAM1,PRPS1,SLC25A1,GALE
R-HSA-140875	Common Pathway of Fibrin Clot Formation	0.308141961095387	-1.17719468954881	22	3	0.00413223140495868	726	8202	10544,5627,2149	PROCR,PROS1,F2R
R-HSA-446343	Localization of the PINCH-ILK-PARVIN complex to focal adhesions	0.309812245213861	-1.17178882558987	4	1	0.00137741046831956	726	8202	3611	ILK
R-HSA-71262	Carnitine synthesis	0.309812245213861	-1.17178882558987	4	1	0.00137741046831956	726	8202	223	ALDH9A1
R-HSA-428542	Regulation of Commissural axon pathfinding by Slit and Robo	0.309812245213861	-1.17178882558987	4	1	0.00137741046831956	726	8202	9353	SLIT2
R-HSA-210455	Astrocytic Glutamate-Glutamine Uptake And Metabolism	0.309812245213861	-1.17178882558987	4	1	0.00137741046831956	726	8202	2752	GLUL
R-HSA-75072	mRNA Editing	0.309812245213861	-1.17178882558987	4	1	0.00137741046831956	726	8202	103	ADAR
R-HSA-69200	Phosphorylation of proteins involved in G1/S transition by active Cyclin E:Cdk2 complexes	0.309812245213861	-1.17178882558987	4	1	0.00137741046831956	726	8202	9134	CCNE2
R-HSA-6783984	Glycine degradation	0.309812245213861	-1.17178882558987	4	1	0.00137741046831956	726	8202	1738	DLD
R-HSA-211163	AKT-mediated inactivation of FOXO1A	0.309812245213861	-1.17178882558987	4	1	0.00137741046831956	726	8202	2308	FOXO1
R-HSA-5579026	Defective CYP11A1 causes Adrenal insufficiency, congenital, with 46,XY sex reversal (AICSR)	0.309812245213861	-1.17178882558987	4	1	0.00137741046831956	726	8202	2232	FDXR
R-HSA-389599	Alpha-oxidation of phytanate	0.309812245213861	-1.17178882558987	4	1	0.00137741046831956	726	8202	5264	PHYH
R-HSA-417973	Adenosine P1 receptors	0.309812245213861	-1.17178882558987	4	1	0.00137741046831956	726	8202	136	ADORA2B
R-HSA-112126	ALKBH3 mediated reversal of alkylation damage	0.309812245213861	-1.17178882558987	4	1	0.00137741046831956	726	8202	10973	ASCC3
R-HSA-433692	Proton-coupled monocarboxylate transport	0.309812245213861	-1.17178882558987	4	1	0.00137741046831956	726	8202	9123	SLC16A3
R-HSA-75944	Transcription from mitochondrial promoters	0.309812245213861	-1.17178882558987	4	1	0.00137741046831956	726	8202	5442	POLRMT
R-HSA-139915	Activation of PUMA and translocation to mitochondria	0.309812245213861	-1.17178882558987	4	1	0.00137741046831956	726	8202	27113	BBC3
R-HSA-112313	Neurotransmitter uptake and Metabolism In Glial Cells	0.309812245213861	-1.17178882558987	4	1	0.00137741046831956	726	8202	2752	GLUL
R-HSA-1433557	Signaling by SCF-KIT	0.309844339244566	-1.17168523908231	307	30	0.0413223140495868	726	8202	2254,7311,2335,4303,2308,5721,5295,2064,5720,1026,2260,1956,572,3667,2261,817,4193,6464,2905,2263,28956,6772,5290,11221,1027,5594,7414,6774,4343,6709	FGF9,UBA52,FN1,FOXO4,FOXO1,PSME2,PIK3R1,ERBB2,PSME1,CDKN1A,FGFR1,EGFR,BAD,IRS1,FGFR3,CAMK2D,MDM2,SHC1,GRIN2C,FGFR2,LAMTOR2,STAT1,PIK3CA,DUSP10,CDKN1B,MAPK1,VCL,STAT3,MOV10,SPTAN1
R-HSA-1483257	Phospholipid metabolism	0.310688106727589	-1.16896574227431	146	15	0.0206611570247934	726	8202	3636,8760,3635,84803,5295,8821,5290,3032,10162,57678,8694,8895,204962,126969,1119	INPPL1,CDS2,INPP5D,GPAT3,PIK3R1,INPP4B,PIK3CA,HADHB,LPCAT3,GPAM,DGAT1,CPNE3,SLC44A5,SLC44A3,CHKA
R-HSA-456926	Thrombin signalling through proteinase activated receptors (PARs)	0.313238501444082	-1.16079039316115	32	4	0.00550964187327824	726	8202	54331,2149,5594,2783	GNG2,F2R,MAPK1,GNB2
R-HSA-5654726	Negative regulation of FGFR1 signaling	0.313238501444082	-1.16079039316115	32	4	0.00550964187327824	726	8202	2254,7311,5594,2260	FGF9,UBA52,MAPK1,FGFR1
R-HSA-73863	RNA Polymerase I Transcription Termination	0.313238501444082	-1.16079039316115	32	4	0.00550964187327824	726	8202	5441,30834,64425,221830	POLR2L,ZNRD1,POLR1E,TWISTNB
R-HSA-389356	CD28 co-stimulation	0.313238501444082	-1.16079039316115	32	4	0.00550964187327824	726	8202	998,1326,5295,5290	CDC42,MAP3K8,PIK3R1,PIK3CA
R-HSA-1368108	BMAL1:CLOCK,NPAS2 activates circadian gene expression	0.31325536397184	-1.16073656173935	42	5	0.0068870523415978	726	8202	1408,85441,8204,3091,8841	CRY2,HELZ2,NRIP1,HIF1A,HDAC3
R-HSA-380287	Centrosome maturation	0.317372863912443	-1.14767796946457	73	8	0.0110192837465565	726	8202	5108,5116,10383,8655,891,10121,983,1639	PCM1,PCNT,TUBB4B,DYNLL1,CCNB1,ACTR1A,CDK1,DCTN1
R-HSA-380270	Recruitment of mitotic centrosome proteins and complexes	0.317372863912443	-1.14767796946457	73	8	0.0110192837465565	726	8202	5108,5116,10383,8655,891,10121,983,1639	PCM1,PCNT,TUBB4B,DYNLL1,CCNB1,ACTR1A,CDK1,DCTN1
R-HSA-209560	NF-kB is activated and signals survival	0.321876454786137	-1.13358748785043	13	2	0.00275482093663912	726	8202	7311,4792	UBA52,NFKBIA
R-HSA-350054	Notch-HLH transcription pathway	0.321876454786137	-1.13358748785043	13	2	0.00275482093663912	726	8202	4851,55534	NOTCH1,MAML3
R-HSA-428790	Facilitative Na+-independent glucose transporters	0.321876454786137	-1.13358748785043	13	2	0.00275482093663912	726	8202	29988,6513	SLC2A8,SLC2A1
R-HSA-879415	Advanced glycosylation endproduct receptor signaling	0.321876454786137	-1.13358748785043	13	2	0.00275482093663912	726	8202	1650,5594	DDOST,MAPK1
R-HSA-2995383	Initiation of Nuclear Envelope Reformation	0.321876454786137	-1.13358748785043	13	2	0.00275482093663912	726	8202	4000,7112	LMNA,TMPO
R-HSA-1358803	Downregulation of ERBB2:ERBB3 signaling	0.321876454786137	-1.13358748785043	13	2	0.00275482093663912	726	8202	2064,7311	ERBB2,UBA52
R-HSA-2995410	Nuclear Envelope Reassembly	0.321876454786137	-1.13358748785043	13	2	0.00275482093663912	726	8202	4000,7112	LMNA,TMPO
R-HSA-5626467	RHO GTPases activate IQGAPs	0.321876454786137	-1.13358748785043	13	2	0.00275482093663912	726	8202	998,10788	CDC42,IQGAP2
R-HSA-4641265	Repression of WNT target genes	0.321876454786137	-1.13358748785043	13	2	0.00275482093663912	726	8202	3065,7088	HDAC1,TLE1
R-HSA-190375	FGFR2c ligand binding and activation	0.321876454786137	-1.13358748785043	13	2	0.00275482093663912	726	8202	2254,2263	FGF9,FGFR2
R-HSA-177504	Retrograde neurotrophin signalling	0.321876454786137	-1.13358748785043	13	2	0.00275482093663912	726	8202	1175,160	AP2S1,AP2A1
R-HSA-175474	Assembly Of The HIV Virion	0.321876454786137	-1.13358748785043	13	2	0.00275482093663912	726	8202	155382,7311	VPS37D,UBA52
R-HSA-380259	Loss of Nlp from mitotic centrosomes	0.322389618367893	-1.13199446996027	63	7	0.00964187327823691	726	8202	5108,5116,10121,10383,983,8655,1639	PCM1,PCNT,ACTR1A,TUBB4B,CDK1,DYNLL1,DCTN1
R-HSA-400253	Circadian Clock	0.322389618367893	-1.13199446996027	63	7	0.00964187327823691	726	8202	1408,85441,7311,5499,8204,3091,8841	CRY2,HELZ2,UBA52,PPP1CA,NRIP1,HIF1A,HDAC3
R-HSA-4608870	Asymmetric localization of PCP proteins	0.322389618367893	-1.13199446996027	63	7	0.00964187327823691	726	8202	23513,5720,7311,7855,8322,5721,8324	SCRIB,PSME1,UBA52,FZD5,FZD4,PSME2,FZD7
R-HSA-380284	Loss of proteins required for interphase microtubule organizationfrom the centrosome	0.322389618367893	-1.13199446996027	63	7	0.00964187327823691	726	8202	5108,5116,10121,10383,983,8655,1639	PCM1,PCNT,ACTR1A,TUBB4B,CDK1,DYNLL1,DCTN1
R-HSA-194138	Signaling by VEGF	0.323800805518739	-1.12762675003713	320	31	0.0426997245179063	726	8202	2254,7311,2335,5721,5295,2064,5720,26999,9564,2260,1956,5228,3667,2261,817,6464,55845,1398,998,1535,2905,2263,28956,5290,11221,3685,5594,7414,3315,9475,6709	FGF9,UBA52,FN1,PSME2,PIK3R1,ERBB2,PSME1,CYFIP2,BCAR1,FGFR1,EGFR,PGF,IRS1,FGFR3,CAMK2D,SHC1,BRK1,CRK,CDC42,CYBA,GRIN2C,FGFR2,LAMTOR2,PIK3CA,DUSP10,ITGAV,MAPK1,VCL,HSPB1,ROCK2,SPTAN1
R-HSA-2454202	Fc epsilon receptor (FCERI) signaling	0.325285205701301	-1.12305292547554	342	33	0.0454545454545455	726	8202	2335,2308,5721,2064,5720,1026,3725,2261,4193,6464,2905,28956,5290,1027,11221,7414,4214,6709,2254,7311,4303,5295,5588,2353,2260,1956,3667,572,817,2263,4792,5594,4343	FN1,FOXO1,PSME2,ERBB2,PSME1,CDKN1A,JUN,FGFR3,MDM2,SHC1,GRIN2C,LAMTOR2,PIK3CA,CDKN1B,DUSP10,VCL,MAP3K1,SPTAN1,FGF9,UBA52,FOXO4,PIK3R1,PRKCQ,FOS,FGFR1,EGFR,IRS1,BAD,CAMK2D,FGFR2,NFKBIA,MAPK1,MOV10
R-HSA-112399	IRS-mediated signalling	0.326811081866065	-1.11837300633235	277	27	0.0371900826446281	726	8202	2254,5564,7311,2335,5721,5565,5295,2064,5571,5720,2260,1956,3667,2261,817,6464,2263,2905,28956,5290,10670,11221,51719,6794,5594,7414,6709	FGF9,PRKAB1,UBA52,FN1,PSME2,PRKAB2,PIK3R1,ERBB2,PRKAG1,PSME1,FGFR1,EGFR,IRS1,FGFR3,CAMK2D,SHC1,FGFR2,GRIN2C,LAMTOR2,PIK3CA,RRAGA,DUSP10,CAB39,STK11,MAPK1,VCL,SPTAN1
R-HSA-983168	Antigen processing: Ubiquitination & Proteasome degradation	0.327693773461632	-1.11567572418528	223	22	0.0303030303030303	726	8202	7311,9820,7317,9903,5721,9039,991,79654,65264,9666,9520,5720,9354,9867,127544,9021,8453,51434,22954,64219,11065,10489	UBA52,CUL7,UBA1,KLHL21,PSME2,UBA3,CDC20,HECTD3,UBE2Z,DZIP3,NPEPPS,PSME1,UBE4A,PJA2,RNF19B,SOCS3,CUL2,ANAPC7,TRIM32,PJA1,UBE2C,LRRC41
R-HSA-199991	Membrane Trafficking	0.33174971909799	-1.10337445249817	256	25	0.034435261707989	726	8202	10484,5564,8615,7311,1314,5565,7039,11316,3312,5571,2495,23265,162,55330,2799,155382,11196,4905,9632,149371,1174,3998,164,2810,1315	SEC23A,PRKAB1,USO1,UBA52,COPA,PRKAB2,TGFA,COPE,HSPA8,PRKAG1,FTH1,EXOC7,AP1B1,BLOC1S4,GNS,VPS37D,SEC23IP,NSF,SEC24C,EXOC8,AP1S1,LMAN1,AP1G1,SFN,COPB1
R-HSA-162909	Host Interactions of HIV factors	0.333118187848839	-1.09925793350537	127	13	0.0179063360881543	726	8202	7311,55746,5721,160,1174,5905,5720,162,164,292,60489,1175,3105	UBA52,NUP133,PSME2,AP2A1,AP1S1,RANGAP1,PSME1,AP1B1,AP1G1,SLC25A5,APOBEC3G,AP2S1,HLA-A
R-HSA-73980	RNA Polymerase III Transcription Termination	0.333273434480425	-1.0987920013742	23	3	0.00413223140495868	726	8202	27297,5441,4781	CRCP,POLR2L,NFIB
R-HSA-400508	Incretin synthesis, secretion, and inactivation	0.333273434480425	-1.0987920013742	23	3	0.00413223140495868	726	8202	23478,3670,60559	SEC11A,ISL1,SPCS3
R-HSA-70614	Amino acid synthesis and interconversion (transamination)	0.333273434480425	-1.0987920013742	23	3	0.00413223140495868	726	8202	4942,2752,65263	OAT,GLUL,PYCRL
R-HSA-5627123	RHO GTPases activate PAKs	0.333273434480425	-1.0987920013742	23	3	0.00413223140495868	726	8202	4637,998,4628	MYL6,CDC42,MYH10
R-HSA-2173795	Downregulation of SMAD2/3:SMAD4 transcriptional activity	0.333273434480425	-1.0987920013742	23	3	0.00413223140495868	726	8202	3065,7050,7311	HDAC1,TGIF1,UBA52
R-HSA-167242	Abortive elongation of HIV-1 transcript in the absence of Tat	0.333273434480425	-1.0987920013742	23	3	0.00413223140495868	726	8202	6827,6829,5441	SUPT4H1,SUPT5H,POLR2L
R-HSA-75067	Processing of Capped Intronless Pre-mRNA	0.333273434480425	-1.0987920013742	23	3	0.00413223140495868	726	8202	134353,6628,10978	LSM11,SNRPB,CLP1
R-HSA-69190	DNA strand elongation	0.333990962732192	-1.09664134405955	33	4	0.00550964187327824	726	8202	3978,6118,5111,5982	LIG1,RPA2,PCNA,RFC2
R-HSA-1638074	Keratan sulfate/keratin metabolism	0.333990962732192	-1.09664134405955	33	4	0.00550964187327824	726	8202	2799,6483,10678,3074	GNS,ST3GAL2,B3GNT2,HEXB
R-HSA-5694530	Cargo concentration in the ER	0.333990962732192	-1.09664134405955	33	4	0.00550964187327824	726	8202	10484,3998,7039,9632	SEC23A,LMAN1,TGFA,SEC24C
R-HSA-187037	NGF signalling via TRKA from the plasma membrane	0.338399152918336	-1.08352915444961	355	34	0.046831955922865	726	8202	2335,2308,5721,2064,5720,1026,2261,4193,6464,2905,28956,5290,11221,112,1027,7414,6774,6709,2254,7311,4303,5295,1956,2260,3667,572,817,1398,2263,1845,160,4343,5594,1175	FN1,FOXO1,PSME2,ERBB2,PSME1,CDKN1A,FGFR3,MDM2,SHC1,GRIN2C,LAMTOR2,PIK3CA,DUSP10,ADCY6,CDKN1B,VCL,STAT3,SPTAN1,FGF9,UBA52,FOXO4,PIK3R1,EGFR,FGFR1,IRS1,BAD,CAMK2D,CRK,FGFR2,DUSP3,AP2A1,MOV10,MAPK1,AP2S1
R-HSA-4420097	VEGFA-VEGFR2 Pathway	0.342903046591126	-1.07030753477254	312	30	0.0413223140495868	726	8202	2254,7311,2335,5721,5295,2064,5720,26999,9564,2260,1956,3667,2261,817,6464,55845,1398,998,1535,2905,2263,28956,5290,11221,3685,5594,7414,3315,9475,6709	FGF9,UBA52,FN1,PSME2,PIK3R1,ERBB2,PSME1,CYFIP2,BCAR1,FGFR1,EGFR,IRS1,FGFR3,CAMK2D,SHC1,BRK1,CRK,CDC42,CYBA,GRIN2C,FGFR2,LAMTOR2,PIK3CA,DUSP10,ITGAV,MAPK1,VCL,HSPB1,ROCK2,SPTAN1
R-HSA-1483206	Glycerophospholipid biosynthesis	0.343026933449688	-1.06994631172205	96	10	0.0137741046831956	726	8202	8760,84803,3032,10162,57678,8694,8895,204962,1119,126969	CDS2,GPAT3,HADHB,LPCAT3,GPAM,DGAT1,CPNE3,SLC44A5,CHKA,SLC44A3
R-HSA-432722	Golgi Associated Vesicle Biogenesis	0.343325491379632	-1.06907632732927	54	6	0.00826446280991736	726	8202	1174,2495,162,164,55330,3312	AP1S1,FTH1,AP1B1,AP1G1,BLOC1S4,HSPA8
R-HSA-74751	Insulin receptor signalling cascade	0.347961052140817	-1.05566472460666	280	27	0.0371900826446281	726	8202	2254,5564,7311,2335,5721,5565,5295,2064,5571,5720,2260,1956,3667,2261,817,6464,2263,2905,28956,5290,10670,11221,51719,6794,5594,7414,6709	FGF9,PRKAB1,UBA52,FN1,PSME2,PRKAB2,PIK3R1,ERBB2,PRKAG1,PSME1,FGFR1,EGFR,IRS1,FGFR3,CAMK2D,SHC1,FGFR2,GRIN2C,LAMTOR2,PIK3CA,RRAGA,DUSP10,CAB39,STK11,MAPK1,VCL,SPTAN1
R-HSA-5696395	Formation of Incision Complex in GG-NER	0.349367308188504	-1.05163145123354	44	5	0.0068870523415978	726	8202	6118,6612,1643,7311,7508	RPA2,SUMO3,DDB2,UBA52,XPC
R-HSA-446728	Cell junction organization	0.35049639659232	-1.04840485332405	86	9	0.012396694214876	726	8202	81607,1308,3909,25945,5818,50848,87,3691,3611	PVRL4,COL17A1,LAMA3,PVRL3,PVRL1,F11R,ACTN1,ITGB4,ILK
R-HSA-2980736	Peptide hormone metabolism	0.35049639659232	-1.04840485332405	86	9	0.012396694214876	726	8202	23478,3670,7941,64924,149371,23265,60559,1363,10159	SEC11A,ISL1,PLA2G7,SLC30A5,EXOC8,EXOC7,SPCS3,CPE,ATP6AP2
R-HSA-76005	Response to elevated platelet cytosolic Ca2+	0.35049639659232	-1.04840485332405	86	9	0.012396694214876	726	8202	3920,2335,7076,967,9948,87,5627,7414,7114	LAMP2,FN1,TIMP1,CD63,WDR1,ACTN1,PROS1,VCL,TMSB4X
R-HSA-5685942	HDR through Homologous Recombination (HRR)	0.35195599824453	-1.04424911618494	65	7	0.00964187327823691	726	8202	6118,672,5111,7311,5982,5429,197342	RPA2,BRCA1,PCNA,UBA52,RFC2,POLH,EME2
R-HSA-397014	Muscle contraction	0.35195599824453	-1.04424911618494	65	7	0.00964187327823691	726	8202	59,4637,7431,302,7414,4636,301	ACTA2,MYL6,VIM,ANXA2,VCL,MYL5,ANXA1
R-HSA-68882	Mitotic Anaphase	0.35300607107584	-1.04127002368161	172	17	0.0234159779614325	726	8202	7311,9184,5721,991,54821,55143,5905,5720,6232,11004,4000,55746,332,51434,9735,11065,7112	UBA52,BUB3,PSME2,CDC20,ERCC6L,CDCA8,RANGAP1,PSME1,RPS27,KIF2C,LMNA,NUP133,BIRC5,ANAPC7,KNTC1,UBE2C,TMPO
R-HSA-5654727	Negative regulation of FGFR2 signaling	0.354801090920912	-1.03619795380253	34	4	0.00550964187327824	726	8202	2254,7311,5594,2263	FGF9,UBA52,MAPK1,FGFR2
R-HSA-2428924	IGF1R signaling cascade	0.355086596158002	-1.03539358641406	281	27	0.0371900826446281	726	8202	2254,5564,7311,2335,5721,5565,5295,2064,5571,5720,2260,1956,3667,2261,817,6464,2263,2905,28956,5290,10670,11221,51719,6794,5594,7414,6709	FGF9,PRKAB1,UBA52,FN1,PSME2,PRKAB2,PIK3R1,ERBB2,PRKAG1,PSME1,FGFR1,EGFR,IRS1,FGFR3,CAMK2D,SHC1,FGFR2,GRIN2C,LAMTOR2,PIK3CA,RRAGA,DUSP10,CAB39,STK11,MAPK1,VCL,SPTAN1
R-HSA-2428928	IRS-related events triggered by IGF1R	0.355086596158002	-1.03539358641406	281	27	0.0371900826446281	726	8202	2254,5564,7311,2335,5721,5565,5295,2064,5571,5720,2260,1956,3667,2261,817,6464,2263,2905,28956,5290,10670,11221,51719,6794,5594,7414,6709	FGF9,PRKAB1,UBA52,FN1,PSME2,PRKAB2,PIK3R1,ERBB2,PRKAG1,PSME1,FGFR1,EGFR,IRS1,FGFR3,CAMK2D,SHC1,FGFR2,GRIN2C,LAMTOR2,PIK3CA,RRAGA,DUSP10,CAB39,STK11,MAPK1,VCL,SPTAN1
R-HSA-2404192	Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	0.355086596158002	-1.03539358641406	281	27	0.0371900826446281	726	8202	2254,5564,7311,2335,5721,5565,5295,2064,5571,5720,2260,1956,3667,2261,817,6464,2263,2905,28956,5290,10670,11221,51719,6794,5594,7414,6709	FGF9,PRKAB1,UBA52,FN1,PSME2,PRKAB2,PIK3R1,ERBB2,PRKAG1,PSME1,FGFR1,EGFR,IRS1,FGFR3,CAMK2D,SHC1,FGFR2,GRIN2C,LAMTOR2,PIK3CA,RRAGA,DUSP10,CAB39,STK11,MAPK1,VCL,SPTAN1
R-HSA-2024101	CS/DS degradation	0.355400609393077	-1.03450964859486	14	2	0.00275482093663912	726	8202	1462,3074	VCAN,HEXB
R-HSA-69166	Removal of the Flap Intermediate	0.355400609393077	-1.03450964859486	14	2	0.00275482093663912	726	8202	6118,5111	RPA2,PCNA
R-HSA-174411	Polymerase switching on the C-strand of the telomere	0.355400609393077	-1.03450964859486	14	2	0.00275482093663912	726	8202	5111,5982	PCNA,RFC2
R-HSA-69091	Polymerase switching	0.355400609393077	-1.03450964859486	14	2	0.00275482093663912	726	8202	5111,5982	PCNA,RFC2
R-HSA-69109	Leading Strand Synthesis	0.355400609393077	-1.03450964859486	14	2	0.00275482093663912	726	8202	5111,5982	PCNA,RFC2
R-HSA-168898	Toll-Like Receptors Cascades	0.356558747056844	-1.03125626432566	140	14	0.0192837465564738	726	8202	3725,81622,7311,1845,10010,4792,1326,3656,1660,8737,246330,2353,5594,4214	JUN,UNC93B1,UBA52,DUSP3,TANK,NFKBIA,MAP3K8,IRAK2,DHX9,RIPK1,PELI3,FOS,MAPK1,MAP3K1
R-HSA-73848	Pyrimidine metabolism	0.358365255617341	-1.02620254561261	24	3	0.00413223140495868	726	8202	7298,1890,4907	TYMS,TYMP,NT5E
R-HSA-210500	Glutamate Neurotransmitter Release Cycle	0.358365255617341	-1.02620254561261	24	3	0.00413223140495868	726	8202	8541,10550,6505	PPFIA3,ARL6IP5,SLC1A1
R-HSA-6784531	tRNA processing in the nucleus	0.359588660025414	-1.02279451185017	55	6	0.00826446280991736	726	8202	10940,79074,55746,10557,79042,10978	POP1,C2orf49,NUP133,RPP38,TSEN34,CLP1
R-HSA-912526	Interleukin receptor SHC signaling	0.360009336563869	-1.02162531296865	238	23	0.0316804407713499	726	8202	2254,3636,7311,2335,5721,3635,5295,2064,5720,1956,2260,3667,817,2261,6464,2905,2263,28956,5290,11221,7414,5594,6709	FGF9,INPPL1,UBA52,FN1,PSME2,INPP5D,PIK3R1,ERBB2,PSME1,EGFR,FGFR1,IRS1,CAMK2D,FGFR3,SHC1,GRIN2C,FGFR2,LAMTOR2,PIK3CA,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-2555396	Mitotic Metaphase and Anaphase	0.362118974954473	-1.01578246105804	173	17	0.0234159779614325	726	8202	7311,9184,5721,991,54821,55143,5905,5720,6232,11004,4000,55746,332,51434,9735,11065,7112	UBA52,BUB3,PSME2,CDC20,ERCC6L,CDCA8,RANGAP1,PSME1,RPS27,KIF2C,LMNA,NUP133,BIRC5,ANAPC7,KNTC1,UBE2C,TMPO
R-HSA-450531	Regulation of mRNA stability by proteins that bind AU-rich elements	0.363393580385793	-1.01226878859769	87	9	0.012396694214876	726	8202	7311,5721,3312,5720,677,54512,3315,3303,3304	UBA52,PSME2,HSPA8,PSME1,ZFP36L1,EXOSC4,HSPB1,HSPA1A,HSPA1B
R-HSA-204005	COPII (Coat Protein 2) Mediated Vesicle Transport	0.366847549216963	-1.00280891445788	66	7	0.00964187327823691	726	8202	10484,8615,11196,3998,4905,9632,7039	SEC23A,USO1,SEC23IP,LMAN1,NSF,SEC24C,TGFA
R-HSA-69239	Synthesis of DNA	0.367324444505727	-1.00150977649044	98	10	0.0137741046831956	726	8202	6118,5111,7311,5721,81620,1027,3978,5720,1026,5982	RPA2,PCNA,UBA52,PSME2,CDT1,CDKN1B,LIG1,PSME1,CDKN1A,RFC2
R-HSA-5696398	Nucleotide Excision Repair	0.370477975740906	-0.992961280706812	109	11	0.0151515151515152	726	8202	6118,1643,5111,7311,5441,7508,3978,6612,79913,4798,5982	RPA2,DDB2,PCNA,UBA52,POLR2L,XPC,LIG1,SUMO3,ACTR5,NFRKB,RFC2
R-HSA-73943	Reversal of alkylation damage by DNA dioxygenases	0.370934020033944	-0.99173107576502	5	1	0.00137741046831956	726	8202	10973	ASCC3
R-HSA-140834	Extrinsic Pathway of Fibrin Clot Formation	0.370934020033944	-0.99173107576502	5	1	0.00137741046831956	726	8202	2152	F3
R-HSA-75157	FasL/ CD95L signaling	0.370934020033944	-0.99173107576502	5	1	0.00137741046831956	726	8202	355	FAS
R-HSA-74713	IRS activation	0.370934020033944	-0.99173107576502	5	1	0.00137741046831956	726	8202	3667	IRS1
R-HSA-2161517	Abacavir transmembrane transport	0.370934020033944	-0.99173107576502	5	1	0.00137741046831956	726	8202	5243	ABCB1
R-HSA-197264	Nicotinamide salvaging	0.370934020033944	-0.99173107576502	5	1	0.00137741046831956	726	8202	93100	NAPRT
R-HSA-1306955	GRB7 events in ERBB2 signaling	0.370934020033944	-0.99173107576502	5	1	0.00137741046831956	726	8202	2064	ERBB2
R-HSA-180689	APOBEC3G mediated resistance to HIV-1 infection	0.370934020033944	-0.99173107576502	5	1	0.00137741046831956	726	8202	60489	APOBEC3G
R-HSA-196843	Vitamin B2 (riboflavin) metabolism	0.370934020033944	-0.99173107576502	5	1	0.00137741046831956	726	8202	113278	SLC52A3
R-HSA-2644607	Loss of Function of FBXW7 in Cancer and NOTCH1 Signaling	0.370934020033944	-0.99173107576502	5	1	0.00137741046831956	726	8202	4851	NOTCH1
R-HSA-2644605	FBXW7 Mutants and NOTCH1 in Cancer	0.370934020033944	-0.99173107576502	5	1	0.00137741046831956	726	8202	4851	NOTCH1
R-HSA-446199	Synthesis of Dolichyl-phosphate	0.370934020033944	-0.99173107576502	5	1	0.00137741046831956	726	8202	4597	MVD
R-HSA-3065676	SUMO is conjugated to E1 (UBA2:SAE1)	0.370934020033944	-0.99173107576502	5	1	0.00137741046831956	726	8202	6612	SUMO3
R-HSA-1500931	Cell-Cell communication	0.375137271310705	-0.980463263165634	131	13	0.0179063360881543	726	8202	81607,1308,3909,25945,5818,961,5295,5290,87,50848,3691,3611,6709	PVRL4,COL17A1,LAMA3,PVRL3,PVRL1,CD47,PIK3R1,PIK3CA,ACTN1,F11R,ITGB4,ILK,SPTAN1
R-HSA-1632852	Macroautophagy	0.381780648652523	-0.962909053489077	67	7	0.00964187327823691	726	8202	5571,5564,55062,5565,8655,28956,10670	PRKAG1,PRKAB1,WIPI1,PRKAB2,DYNLL1,LAMTOR2,RRAGA
R-HSA-163125	Post-translational modification: synthesis of GPI-anchored proteins	0.383318170531066	-0.958889902211626	25	3	0.00413223140495868	726	8202	8733,51604,9091	GPAA1,PIGT,PIGQ
R-HSA-210991	Basigin interactions	0.383318170531066	-0.958889902211626	25	3	0.00413223140495868	726	8202	682,3675,9123	BSG,ITGA3,SLC16A3
R-HSA-195258	RHO GTPase Effectors	0.383899498260695	-0.957374483929364	285	27	0.0371900826446281	726	8202	9184,389,991,54821,55143,5905,6232,11004,26999,4628,995,388,10788,55845,998,1535,10811,332,55746,9928,4637,653604,1027,9735,5594,9475,2810	BUB3,RHOC,CDC20,ERCC6L,CDCA8,RANGAP1,RPS27,KIF2C,CYFIP2,MYH10,CDC25C,RHOB,IQGAP2,BRK1,CDC42,CYBA,NOXA1,BIRC5,NUP133,KIF14,MYL6,HIST2H3D,CDKN1B,KNTC1,MAPK1,ROCK2,SFN
R-HSA-1483249	Inositol phosphate metabolism	0.385682351210345	-0.952741172630938	46	5	0.0068870523415978	726	8202	51477,3636,3635,8821,5331	ISYNA1,INPPL1,INPP5D,INPP4B,PLCB3
R-HSA-418597	G alpha (z) signalling events	0.385682351210345	-0.952741172630938	46	5	0.0068870523415978	726	8202	54331,152,112,5588,2783	GNG2,ADRA2C,ADCY6,PRKCQ,GNB2
R-HSA-430039	mRNA decay by 5' to 3' exoribonuclease	0.388311248420064	-0.945948074288958	15	2	0.00275482093663912	726	8202	1656,196513	DDX6,DCP1B
R-HSA-111447	Activation of BAD and translocation to mitochondria	0.388311248420064	-0.945948074288958	15	2	0.00275482093663912	726	8202	572,2810	BAD,SFN
R-HSA-205043	NRIF signals cell death from the nucleus	0.388311248420064	-0.945948074288958	15	2	0.00275482093663912	726	8202	7311,51107	UBA52,APH1A
R-HSA-69298	Association of licensing factors with the pre-replicative complex	0.388311248420064	-0.945948074288958	15	2	0.00275482093663912	726	8202	7311,81620	UBA52,CDT1
R-HSA-166520	Signalling by NGF	0.393240853005071	-0.933332997314089	430	40	0.0550964187327824	726	8202	836,2335,2308,5721,2064,5720,1026,2261,4193,6464,2905,28956,5290,11221,112,1027,7414,7074,6774,6709,2254,7311,4303,51107,5295,8841,2260,1956,3667,572,817,1398,1845,2263,160,4792,3065,4343,5594,1175	CASP3,FN1,FOXO1,PSME2,ERBB2,PSME1,CDKN1A,FGFR3,MDM2,SHC1,GRIN2C,LAMTOR2,PIK3CA,DUSP10,ADCY6,CDKN1B,VCL,TIAM1,STAT3,SPTAN1,FGF9,UBA52,FOXO4,APH1A,PIK3R1,HDAC3,FGFR1,EGFR,IRS1,BAD,CAMK2D,CRK,DUSP3,FGFR2,AP2A1,NFKBIA,HDAC1,MOV10,MAPK1,AP2S1
R-HSA-163841	Gamma carboxylation, hypusine formation and arylsulfatase activation	0.396352892139706	-0.925450322791808	36	4	0.00550964187327824	726	8202	25870,5627,79642,410	SUMF2,PROS1,ARSJ,ARSA
R-HSA-5663213	RHO GTPases Activate WASPs and WAVEs	0.396352892139706	-0.925450322791808	36	4	0.00550964187327824	726	8202	55845,26999,998,5594	BRK1,CYFIP2,CDC42,MAPK1
R-HSA-199977	ER to Golgi Anterograde Transport	0.396732917189044	-0.924491977367005	68	7	0.00964187327823691	726	8202	10484,8615,11196,3998,4905,9632,7039	SEC23A,USO1,SEC23IP,LMAN1,NSF,SEC24C,TGFA
R-HSA-512988	Interleukin-3, 5 and GM-CSF signaling	0.399152301483799	-0.918412226944785	254	24	0.0330578512396694	726	8202	2254,3636,7311,2335,5721,3635,5295,2064,5720,1956,2260,3667,817,2261,6464,1398,2905,2263,28956,5290,11221,7414,5594,6709	FGF9,INPPL1,UBA52,FN1,PSME2,INPP5D,PIK3R1,ERBB2,PSME1,EGFR,FGFR1,IRS1,CAMK2D,FGFR3,SHC1,CRK,GRIN2C,FGFR2,LAMTOR2,PIK3CA,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-425366	Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds	0.404090363281008	-0.906116754544081	101	10	0.0137741046831956	726	8202	1317,30061,64924,29988,7922,6513,9123,27173,204962,126969	SLC31A1,SLC40A1,SLC30A5,SLC2A8,SLC39A7,SLC2A1,SLC16A3,SLC39A1,SLC44A5,SLC44A3
R-HSA-5654716	Downstream signaling of activated FGFR4	0.404889577950869	-0.90414089608545	310	29	0.0399449035812672	726	8202	2254,7311,2335,4303,2308,5721,5295,2064,5720,1026,2260,1956,572,3667,2261,817,4193,6464,2905,2263,28956,5290,11221,112,1027,5594,7414,4343,6709	FGF9,UBA52,FN1,FOXO4,FOXO1,PSME2,PIK3R1,ERBB2,PSME1,CDKN1A,FGFR1,EGFR,BAD,IRS1,FGFR3,CAMK2D,MDM2,SHC1,GRIN2C,FGFR2,LAMTOR2,PIK3CA,DUSP10,ADCY6,CDKN1B,MAPK1,VCL,MOV10,SPTAN1
R-HSA-5654687	Downstream signaling of activated FGFR1	0.404889577950869	-0.90414089608545	310	29	0.0399449035812672	726	8202	2254,7311,2335,4303,2308,5721,5295,2064,5720,1026,2260,1956,572,3667,2261,817,4193,6464,2905,2263,28956,5290,11221,112,1027,5594,7414,4343,6709	FGF9,UBA52,FN1,FOXO4,FOXO1,PSME2,PIK3R1,ERBB2,PSME1,CDKN1A,FGFR1,EGFR,BAD,IRS1,FGFR3,CAMK2D,MDM2,SHC1,GRIN2C,FGFR2,LAMTOR2,PIK3CA,DUSP10,ADCY6,CDKN1B,MAPK1,VCL,MOV10,SPTAN1
R-HSA-5654708	Downstream signaling of activated FGFR3	0.404889577950869	-0.90414089608545	310	29	0.0399449035812672	726	8202	2254,7311,2335,4303,2308,5721,5295,2064,5720,1026,2260,1956,572,3667,2261,817,4193,6464,2905,2263,28956,5290,11221,112,1027,5594,7414,4343,6709	FGF9,UBA52,FN1,FOXO4,FOXO1,PSME2,PIK3R1,ERBB2,PSME1,CDKN1A,FGFR1,EGFR,BAD,IRS1,FGFR3,CAMK2D,MDM2,SHC1,GRIN2C,FGFR2,LAMTOR2,PIK3CA,DUSP10,ADCY6,CDKN1B,MAPK1,VCL,MOV10,SPTAN1
R-HSA-5654696	Downstream signaling of activated FGFR2	0.404889577950869	-0.90414089608545	310	29	0.0399449035812672	726	8202	2254,7311,2335,4303,2308,5721,5295,2064,5720,1026,2260,1956,572,3667,2261,817,4193,6464,2905,2263,28956,5290,11221,112,1027,5594,7414,4343,6709	FGF9,UBA52,FN1,FOXO4,FOXO1,PSME2,PIK3R1,ERBB2,PSME1,CDKN1A,FGFR1,EGFR,BAD,IRS1,FGFR3,CAMK2D,MDM2,SHC1,GRIN2C,FGFR2,LAMTOR2,PIK3CA,DUSP10,ADCY6,CDKN1B,MAPK1,VCL,MOV10,SPTAN1
R-HSA-445989	TAK1 activates NFkB by phosphorylation and activation of IKKs complex	0.408042746314313	-0.896383339687789	26	3	0.00413223140495868	726	8202	4792,3656,1660	NFKBIA,IRAK2,DHX9
R-HSA-5654699	SHC-mediated cascade:FGFR2	0.408042746314313	-0.896383339687789	26	3	0.00413223140495868	726	8202	2254,6464,2263	FGF9,SHC1,FGFR2
R-HSA-2173788	Downregulation of TGF-beta receptor signaling	0.408042746314313	-0.896383339687789	26	3	0.00413223140495868	726	8202	7311,5499,25805	UBA52,PPP1CA,BAMBI
R-HSA-174178	APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1	0.411682576608378	-0.887502671703283	69	7	0.00964187327823691	726	8202	6790,51434,5720,7311,11065,5721,991	AURKA,ANAPC7,PSME1,UBA52,UBE2C,PSME2,CDC20
R-HSA-451927	Interleukin-2 signaling	0.415183981391703	-0.879033528337847	245	23	0.0316804407713499	726	8202	2254,3636,7311,2335,5721,3635,5295,2064,5720,1956,2260,3667,817,2261,6464,2905,2263,28956,5290,11221,7414,5594,6709	FGF9,INPPL1,UBA52,FN1,PSME2,INPP5D,PIK3R1,ERBB2,PSME1,EGFR,FGFR1,IRS1,CAMK2D,FGFR3,SHC1,GRIN2C,FGFR2,LAMTOR2,PIK3CA,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-4086400	PCP/CE pathway	0.415345735994737	-0.878644006803113	91	9	0.012396694214876	726	8202	7311,8322,5721,160,5720,23513,7855,1175,8324	UBA52,FZD4,PSME2,AP2A1,PSME1,SCRIB,FZD5,AP2S1,FZD7
R-HSA-5684996	MAPK1/MAPK3 signaling	0.415657165903394	-0.877894478919334	234	22	0.0303030303030303	726	8202	2254,7311,2335,5721,2064,5720,3570,983,2260,1956,3667,2261,817,6464,2263,2905,3572,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,IL6R,CDK1,FGFR1,EGFR,IRS1,FGFR3,CAMK2D,SHC1,FGFR2,GRIN2C,IL6ST,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-176187	Activation of ATR in response to replication stress	0.416983168407514	-0.874709421529107	37	4	0.00550964187327824	726	8202	6118,63967,5982,995	RPA2,CLSPN,RFC2,CDC25C
R-HSA-1236394	Signaling by ERBB4	0.419027740769606	-0.869818154164226	312	29	0.0399449035812672	726	8202	2254,7311,2335,4303,2308,51107,5721,5295,2064,5720,1026,2260,1956,572,3667,2261,817,4193,6464,2905,2263,28956,5290,11221,1027,5594,7414,4343,6709	FGF9,UBA52,FN1,FOXO4,FOXO1,APH1A,PSME2,PIK3R1,ERBB2,PSME1,CDKN1A,FGFR1,EGFR,BAD,IRS1,FGFR3,CAMK2D,MDM2,SHC1,GRIN2C,FGFR2,LAMTOR2,PIK3CA,DUSP10,CDKN1B,MAPK1,VCL,MOV10,SPTAN1
R-HSA-5684264	MAP3K8 (TPL2)-dependent MAPK1/3 activation	0.420454380264339	-0.866419294718875	16	2	0.00275482093663912	726	8202	7311,1326	UBA52,MAP3K8
R-HSA-193639	p75NTR signals via NF-kB	0.420454380264339	-0.866419294718875	16	2	0.00275482093663912	726	8202	7311,4792	UBA52,NFKBIA
R-HSA-1295596	Spry regulation of FGF signaling	0.420454380264339	-0.866419294718875	16	2	0.00275482093663912	726	8202	7311,5594	UBA52,MAPK1
R-HSA-446353	Cell-extracellular matrix interactions	0.420454380264339	-0.866419294718875	16	2	0.00275482093663912	726	8202	87,3611	ACTN1,ILK
R-HSA-163210	Formation of ATP by chemiosmotic coupling	0.420454380264339	-0.866419294718875	16	2	0.00275482093663912	726	8202	516,10476	ATP5G1,ATP5H
R-HSA-2173791	TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition)	0.420454380264339	-0.866419294718875	16	2	0.00275482093663912	726	8202	50848,7311	F11R,UBA52
R-HSA-1834941	STING mediated induction of host immune responses	0.420454380264339	-0.866419294718875	16	2	0.00275482093663912	726	8202	6778,23220	STAT6,DTX4
R-HSA-190242	FGFR1 ligand binding and activation	0.420454380264339	-0.866419294718875	16	2	0.00275482093663912	726	8202	2254,2260	FGF9,FGFR1
R-HSA-392451	G beta:gamma signalling through PI3Kgamma	0.42188433252218	-0.863024096065963	48	5	0.0068870523415978	726	8202	54331,6464,2783,5295,5290	GNG2,SHC1,GNB2,PIK3R1,PIK3CA
R-HSA-5654741	Signaling by FGFR3	0.426114346578799	-0.853047549531697	313	29	0.0399449035812672	726	8202	2254,7311,2335,4303,2308,5721,5295,2064,5720,1026,2260,1956,572,3667,2261,817,4193,6464,2905,2263,28956,5290,11221,112,1027,5594,7414,4343,6709	FGF9,UBA52,FN1,FOXO4,FOXO1,PSME2,PIK3R1,ERBB2,PSME1,CDKN1A,FGFR1,EGFR,BAD,IRS1,FGFR3,CAMK2D,MDM2,SHC1,GRIN2C,FGFR2,LAMTOR2,PIK3CA,DUSP10,ADCY6,CDKN1B,MAPK1,VCL,MOV10,SPTAN1
R-HSA-5654743	Signaling by FGFR4	0.426114346578799	-0.853047549531697	313	29	0.0399449035812672	726	8202	2254,7311,2335,4303,2308,5721,5295,2064,5720,1026,2260,1956,572,3667,2261,817,4193,6464,2905,2263,28956,5290,11221,112,1027,5594,7414,4343,6709	FGF9,UBA52,FN1,FOXO4,FOXO1,PSME2,PIK3R1,ERBB2,PSME1,CDKN1A,FGFR1,EGFR,BAD,IRS1,FGFR3,CAMK2D,MDM2,SHC1,GRIN2C,FGFR2,LAMTOR2,PIK3CA,DUSP10,ADCY6,CDKN1B,MAPK1,VCL,MOV10,SPTAN1
R-HSA-421837	Clathrin derived vesicle budding	0.426608515164774	-0.851888512607822	70	7	0.00964187327823691	726	8202	2799,1174,2495,162,164,55330,3312	GNS,AP1S1,FTH1,AP1B1,AP1G1,BLOC1S4,HSPA8
R-HSA-69473	G2/M DNA damage checkpoint	0.426608515164774	-0.851888512607822	70	7	0.00964187327823691	726	8202	7465,672,891,7158,995,983,2810	WEE1,BRCA1,CCNB1,TP53BP1,CDC25C,CDK1,SFN
R-HSA-199992	trans-Golgi Network Vesicle Budding	0.426608515164774	-0.851888512607822	70	7	0.00964187327823691	726	8202	2799,1174,2495,162,164,55330,3312	GNS,AP1S1,FTH1,AP1B1,AP1G1,BLOC1S4,HSPA8
R-HSA-1482883	Acyl chain remodeling of DAG and TAG	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	8694	DGAT1
R-HSA-6782861	Synthesis of wybutosine at G37 of tRNA(Phe)	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	57570	TRMT5
R-HSA-500753	Pyrimidine biosynthesis	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	7298	TYMS
R-HSA-190370	FGFR1b ligand binding and activation	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	2260	FGFR1
R-HSA-1482798	Acyl chain remodeling of CL	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	3032	HADHB
R-HSA-1566977	Fibronectin matrix formation	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	2335	FN1
R-HSA-975578	Reactions specific to the complex N-glycan synthesis pathway	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	2517	FUCA1
R-HSA-5693548	Sensing of DNA Double Strand Breaks	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	3838	KPNA2
R-HSA-2142712	Synthesis of 12-eicosatetraenoic acid derivatives	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	2876	GPX1
R-HSA-77111	Synthesis of Ketone Bodies	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	38	ACAT1
R-HSA-5579029	Metabolic disorders of biological oxidation enzymes	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	2232	FDXR
R-HSA-3065678	SUMO is transferred from E1 to E2 (UBE2I, UBC9)	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	6612	SUMO3
R-HSA-205025	NADE modulates death signalling	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	836	CASP3
R-HSA-1606341	IRF3 mediated activation of type 1 IFN	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	23220	DTX4
R-HSA-2142688	Synthesis of 5-eicosatetraenoic acids	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	2876	GPX1
R-HSA-3065679	SUMO is proteolytically processed	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	6612	SUMO3
R-HSA-77288	mitochondrial fatty acid beta-oxidation of unsaturated fatty acids	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	3032	HADHB
R-HSA-2142770	Synthesis of 15-eicosatetraenoic acid derivatives	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	2876	GPX1
R-HSA-73942	DNA Damage Reversal	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	10973	ASCC3
R-HSA-444257	RSK activation	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	5594	MAPK1
R-HSA-5674499	Negative feedback regulation of MAPK pathway	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	5594	MAPK1
R-HSA-1912399	Pre-NOTCH Processing in the Endoplasmic Reticulum	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	4851	NOTCH1
R-HSA-3000484	Scavenging by Class F Receptors	0.426649757672877	-0.851791841976085	6	1	0.00137741046831956	726	8202	10808	HSPH1
R-HSA-389957	Prefoldin mediated transfer of substrate  to CCT/TriC	0.432459121713464	-0.838267473346595	27	3	0.00413223140495868	726	8202	84790,84617,10383	TUBA1C,TUBB6,TUBB4B
R-HSA-437239	Recycling pathway of L1	0.432459121713464	-0.838267473346595	27	3	0.00413223140495868	726	8202	5594,1175,160	MAPK1,AP2S1,AP2A1
R-HSA-1855204	Synthesis of IP3 and IP4 in the cytosol	0.432459121713464	-0.838267473346595	27	3	0.00413223140495868	726	8202	3636,3635,5331	INPPL1,INPP5D,PLCB3
R-HSA-1368082	RORA activates gene expression	0.432459121713464	-0.838267473346595	27	3	0.00413223140495868	726	8202	85441,8204,8841	HELZ2,NRIP1,HDAC3
R-HSA-5654736	Signaling by FGFR1	0.433209560205177	-0.836533695296467	314	29	0.0399449035812672	726	8202	2254,7311,2335,4303,2308,5721,5295,2064,5720,1026,2260,1956,572,3667,2261,817,4193,6464,2905,2263,28956,5290,11221,112,1027,5594,7414,4343,6709	FGF9,UBA52,FN1,FOXO4,FOXO1,PSME2,PIK3R1,ERBB2,PSME1,CDKN1A,FGFR1,EGFR,BAD,IRS1,FGFR3,CAMK2D,MDM2,SHC1,GRIN2C,FGFR2,LAMTOR2,PIK3CA,DUSP10,ADCY6,CDKN1B,MAPK1,VCL,MOV10,SPTAN1
R-HSA-5674135	MAP2K and MAPK activation	0.437448542169589	-0.826796198000077	38	4	0.00550964187327824	726	8202	2335,5594,7414,28956	FN1,MAPK1,VCL,LAMTOR2
R-HSA-168276	NS1 Mediated Effects on Host Pathways	0.437448542169589	-0.826796198000077	38	4	0.00550964187327824	726	8202	3838,3841,55746,9636	KPNA2,KPNA5,NUP133,ISG15
R-HSA-390466	Chaperonin-mediated protein folding	0.439852244704521	-0.821316415955515	49	5	0.0068870523415978	726	8202	84790,84617,8237,10383,84261	TUBA1C,TUBB6,USP11,TUBB4B,FBXW9
R-HSA-193704	p75 NTR receptor-mediated signalling	0.441548500414891	-0.817467411257237	82	8	0.0110192837465565	726	8202	572,836,7311,51107,4792,8841,3065,7074	BAD,CASP3,UBA52,APH1A,NFKBIA,HDAC3,HDAC1,TIAM1
R-HSA-5654738	Signaling by FGFR2	0.44741662444621	-0.804265072712535	316	29	0.0399449035812672	726	8202	2254,7311,2335,4303,2308,5721,5295,2064,5720,1026,2260,1956,572,3667,2261,817,4193,6464,2905,2263,28956,5290,11221,112,1027,5594,7414,4343,6709	FGF9,UBA52,FN1,FOXO4,FOXO1,PSME2,PIK3R1,ERBB2,PSME1,CDKN1A,FGFR1,EGFR,BAD,IRS1,FGFR3,CAMK2D,MDM2,SHC1,GRIN2C,FGFR2,LAMTOR2,PIK3CA,DUSP10,ADCY6,CDKN1B,MAPK1,VCL,MOV10,SPTAN1
R-HSA-2033519	Activated point mutants of FGFR2	0.451708006762474	-0.79471931063747	17	2	0.00275482093663912	726	8202	2254,2263	FGF9,FGFR2
R-HSA-1839126	FGFR2 mutant receptor activation	0.451708006762474	-0.79471931063747	17	2	0.00275482093663912	726	8202	2254,2263	FGF9,FGFR2
R-HSA-442729	CREB phosphorylation through the activation of CaMKII	0.451708006762474	-0.79471931063747	17	2	0.00275482093663912	726	8202	817,2905	CAMK2D,GRIN2C
R-HSA-438066	Unblocking of NMDA receptor, glutamate binding and activation	0.451708006762474	-0.79471931063747	17	2	0.00275482093663912	726	8202	817,2905	CAMK2D,GRIN2C
R-HSA-450385	Butyrate Response Factor 1 (BRF1) binds and destabilizes mRNA	0.451708006762474	-0.79471931063747	17	2	0.00275482093663912	726	8202	677,54512	ZFP36L1,EXOSC4
R-HSA-69481	G2/M Checkpoints	0.453195409828719	-0.791431878236333	105	10	0.0137741046831956	726	8202	6118,7465,63967,7158,672,891,995,5982,983,2810	RPA2,WEE1,CLSPN,TP53BP1,BRCA1,CCNB1,CDC25C,RFC2,CDK1,SFN
R-HSA-72306	tRNA processing	0.454289166636493	-0.789021352777811	94	9	0.012396694214876	726	8202	10940,57570,55746,10557,55621,10978,8270,79074,79042	POP1,TRMT5,NUP133,RPP38,TRMT1,CLP1,LAGE3,C2orf49,TSEN34
R-HSA-190236	Signaling by FGFR	0.454523905506467	-0.788504769373833	317	29	0.0399449035812672	726	8202	2254,7311,2335,4303,2308,5721,5295,2064,5720,1026,2260,1956,572,3667,2261,817,4193,6464,2905,2263,28956,5290,11221,112,1027,5594,7414,4343,6709	FGF9,UBA52,FN1,FOXO4,FOXO1,PSME2,PIK3R1,ERBB2,PSME1,CDKN1A,FGFR1,EGFR,BAD,IRS1,FGFR3,CAMK2D,MDM2,SHC1,GRIN2C,FGFR2,LAMTOR2,PIK3CA,DUSP10,ADCY6,CDKN1B,MAPK1,VCL,MOV10,SPTAN1
R-HSA-170834	Signaling by TGF-beta Receptor Complex	0.456308454457481	-0.784586262933157	72	7	0.00964187327823691	726	8202	3065,1030,7050,50848,7311,5499,25805	HDAC1,CDKN2B,TGIF1,F11R,UBA52,PPP1CA,BAMBI
R-HSA-389958	Cooperation of Prefoldin and TriC/CCT  in actin and tubulin folding	0.456496662496868	-0.784173890043133	28	3	0.00413223140495868	726	8202	84790,84617,10383	TUBA1C,TUBB6,TUBB4B
R-HSA-4086398	Ca2+ pathway	0.457132793803343	-0.782781353047121	61	6	0.00826446280991736	726	8202	54331,7855,8322,4343,2783,5331	GNG2,FZD5,FZD4,MOV10,GNB2,PLCB3
R-HSA-211897	Cytochrome P450 - arranged by substrate type	0.457132793803343	-0.782781353047121	61	6	0.00826446280991736	726	8202	56603,1591,113612,66002,2232,1545	CYP26B1,CYP24A1,CYP2U1,CYP4F12,FDXR,CYP1B1
R-HSA-2467813	Separation of Sister Chromatids	0.457498066160436	-0.781982621247219	161	15	0.0206611570247934	726	8202	7311,9184,332,55746,5721,991,54821,55143,5905,5720,51434,6232,9735,11004,11065	UBA52,BUB3,BIRC5,NUP133,PSME2,CDC20,ERCC6L,CDCA8,RANGAP1,PSME1,ANAPC7,RPS27,KNTC1,KIF2C,UBE2C
R-HSA-2980766	Nuclear Envelope Breakdown	0.457687093896891	-0.781569529454667	50	5	0.0068870523415978	726	8202	891,55746,983,4000,7112	CCNB1,NUP133,CDK1,LMNA,TMPO
R-HSA-72165	mRNA Splicing - Minor Pathway	0.457687093896891	-0.781569529454667	50	5	0.0068870523415978	726	8202	6427,55599,5441,6628,83443	SRSF2,RNPC3,POLR2L,SNRPB,SF3B5
R-HSA-6783310	Fanconi Anemia Pathway	0.457703059698078	-0.781534646402612	39	4	0.00550964187327824	726	8202	6118,7311,2189,197342	RPA2,UBA52,FANCG,EME2
R-HSA-2172127	DAP12 interactions	0.458832731436035	-0.77906955486786	340	31	0.0426997245179063	726	8202	2254,7311,2335,4303,2308,5721,5295,2064,5720,1026,1956,2260,572,3667,3106,2261,817,4193,6464,2905,2263,28956,5290,1027,11221,112,3107,4343,7414,5594,6709	FGF9,UBA52,FN1,FOXO4,FOXO1,PSME2,PIK3R1,ERBB2,PSME1,CDKN1A,EGFR,FGFR1,BAD,IRS1,HLA-B,FGFR3,CAMK2D,MDM2,SHC1,GRIN2C,FGFR2,LAMTOR2,PIK3CA,CDKN1B,DUSP10,ADCY6,HLA-C,MOV10,VCL,MAPK1,SPTAN1
R-HSA-69306	DNA Replication	0.465408927741133	-0.764838845356094	106	10	0.0137741046831956	726	8202	6118,5111,7311,5721,81620,1027,3978,5720,1026,5982	RPA2,PCNA,UBA52,PSME2,CDT1,CDKN1B,LIG1,PSME1,CDKN1A,RFC2
R-HSA-1445148	Translocation of GLUT4 to the plasma membrane	0.47313682270815	-0.748370666551722	62	6	0.00826446280991736	726	8202	5571,5564,23265,5565,2810,149371	PRKAG1,PRKAB1,EXOC7,PRKAB2,SFN,EXOC8
R-HSA-1793185	Chondroitin sulfate/dermatan sulfate metabolism	0.475358239447613	-0.743686570893823	51	5	0.0068870523415978	726	8202	375790,1462,51363,3074,79586	AGRN,VCAN,CHST15,HEXB,CHPF
R-HSA-1483255	PI Metabolism	0.475358239447613	-0.743686570893823	51	5	0.0068870523415978	726	8202	3636,3635,5295,8821,5290	INPPL1,INPP5D,PIK3R1,INPP4B,PIK3CA
R-HSA-1227986	Signaling by ERBB2	0.475833595947619	-0.742687074216306	320	29	0.0399449035812672	726	8202	2254,7311,2335,4303,2308,5721,5295,2064,5720,1026,2260,1956,572,3667,2261,817,4193,6464,2905,2263,28956,5290,11221,112,1027,5594,7414,4343,6709	FGF9,UBA52,FN1,FOXO4,FOXO1,PSME2,PIK3R1,ERBB2,PSME1,CDKN1A,FGFR1,EGFR,BAD,IRS1,FGFR3,CAMK2D,MDM2,SHC1,GRIN2C,FGFR2,LAMTOR2,PIK3CA,DUSP10,ADCY6,CDKN1B,MAPK1,VCL,MOV10,SPTAN1
R-HSA-2993913	Clearance of Nuclear Envelope Membranes from Chromatin	0.477437004623843	-0.739323055253883	7	1	0.00137741046831956	726	8202	7112	TMPO
R-HSA-435368	Zinc efflux and compartmentalization by the SLC30 family	0.477437004623843	-0.739323055253883	7	1	0.00137741046831956	726	8202	64924	SLC30A5
R-HSA-447038	NrCAM interactions	0.477437004623843	-0.739323055253883	7	1	0.00137741046831956	726	8202	286	ANK1
R-HSA-75158	TRAIL  signaling	0.477437004623843	-0.739323055253883	7	1	0.00137741046831956	726	8202	8795	TNFRSF10B
R-HSA-196791	Vitamin D (calciferol) metabolism	0.477437004623843	-0.739323055253883	7	1	0.00137741046831956	726	8202	1591	CYP24A1
R-HSA-3595177	Defective CHSY1 causes TPBS	0.477437004623843	-0.739323055253883	7	1	0.00137741046831956	726	8202	1462	VCAN
R-HSA-110362	POLB-Dependent Long Patch Base Excision Repair	0.477437004623843	-0.739323055253883	7	1	0.00137741046831956	726	8202	3978	LIG1
R-HSA-426117	Cation-coupled Chloride cotransporters	0.477437004623843	-0.739323055253883	7	1	0.00137741046831956	726	8202	6560	SLC12A4
R-HSA-210744	Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells	0.477437004623843	-0.739323055253883	7	1	0.00137741046831956	726	8202	4851	NOTCH1
R-HSA-3595174	Defective CHST14 causes EDS, musculocontractural type	0.477437004623843	-0.739323055253883	7	1	0.00137741046831956	726	8202	1462	VCAN
R-HSA-74182	Ketone body metabolism	0.477437004623843	-0.739323055253883	7	1	0.00137741046831956	726	8202	38	ACAT1
R-HSA-2187335	The retinoid cycle in cones (daylight vision)	0.477437004623843	-0.739323055253883	7	1	0.00137741046831956	726	8202	9249	DHRS3
R-HSA-5603029	IkBA variant leads to EDA-ID	0.477437004623843	-0.739323055253883	7	1	0.00137741046831956	726	8202	4792	NFKBIA
R-HSA-3595172	Defective CHST3 causes SEDCJD	0.477437004623843	-0.739323055253883	7	1	0.00137741046831956	726	8202	1462	VCAN
R-HSA-71336	Pentose phosphate pathway (hexose monophosphate shunt)	0.477437004623843	-0.739323055253883	7	1	0.00137741046831956	726	8202	7086	TKT
R-HSA-2214320	Anchoring fibril formation	0.477437004623843	-0.739323055253883	7	1	0.00137741046831956	726	8202	3909	LAMA3
R-HSA-4411364	Binding of TCF/LEF:CTNNB1 to target gene promoters	0.477437004623843	-0.739323055253883	7	1	0.00137741046831956	726	8202	8313	AXIN2
R-HSA-163685	Integration of energy metabolism	0.477575290665155	-0.739033454705365	107	10	0.0137741046831956	726	8202	54331,152,5565,6513,7086,112,6794,292,2783,5331	GNG2,ADRA2C,PRKAB2,SLC2A1,TKT,ADCY6,STK11,SLC25A5,GNB2,PLCB3
R-HSA-1660662	Glycosphingolipid metabolism	0.477704695567941	-0.738762529101474	40	4	0.00550964187327824	726	8202	25870,79642,3074,410	SUMF2,ARSJ,HEXB,ARSA
R-HSA-168253	Host Interactions with Influenza Factors	0.477704695567941	-0.738762529101474	40	4	0.00550964187327824	726	8202	3838,3841,55746,9636	KPNA2,KPNA5,NUP133,ISG15
R-HSA-2032785	YAP1- and WWTR1 (TAZ)-stimulated gene expression	0.480093545947065	-0.733774306678562	29	3	0.00413223140495868	726	8202	85441,860,204851	HELZ2,RUNX2,HIPK1
R-HSA-442742	CREB phosphorylation through the activation of Ras	0.480093545947065	-0.733774306678562	29	3	0.00413223140495868	726	8202	817,5594,2905	CAMK2D,MAPK1,GRIN2C
R-HSA-936964	Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon	0.481977678585716	-0.729857475992019	18	2	0.00275482093663912	726	8202	7311,10010	UBA52,TANK
R-HSA-73780	RNA Polymerase III Chain Elongation	0.481977678585716	-0.729857475992019	18	2	0.00275482093663912	726	8202	27297,5441	CRCP,POLR2L
R-HSA-6782210	Gap-filling DNA repair synthesis and ligation in TC-NER	0.489004949484046	-0.715382667914223	63	6	0.00826446280991736	726	8202	3978,6118,5111,7311,5441,5982	LIG1,RPA2,PCNA,UBA52,POLR2L,RFC2
R-HSA-167238	Pausing and recovery of Tat-mediated HIV elongation	0.503196294690339	-0.686774937115984	30	3	0.00413223140495868	726	8202	6827,6829,5441	SUPT4H1,SUPT5H,POLR2L
R-HSA-167243	Tat-mediated HIV elongation arrest and recovery	0.503196294690339	-0.686774937115984	30	3	0.00413223140495868	726	8202	6827,6829,5441	SUPT4H1,SUPT5H,POLR2L
R-HSA-422475	Axon guidance	0.503415217799989	-0.686339966702105	516	46	0.0633608815426997	726	8202	1948,2335,375790,5721,389,2064,5720,4628,1947,2261,286,6464,998,2905,28956,1291,11221,4637,59277,6386,2051,7414,7074,9353,9475,6709,2254,7311,1292,51107,3312,5588,214,2260,388,1956,3667,817,2263,160,3912,3685,5594,10371,1175,1272	EFNB2,FN1,AGRN,PSME2,RHOC,ERBB2,PSME1,MYH10,EFNB1,FGFR3,ANK1,SHC1,CDC42,GRIN2C,LAMTOR2,COL6A1,DUSP10,MYL6,NTN4,SDCBP,EPHB6,VCL,TIAM1,SLIT2,ROCK2,SPTAN1,FGF9,UBA52,COL6A2,APH1A,HSPA8,PRKCQ,ALCAM,FGFR1,RHOB,EGFR,IRS1,CAMK2D,FGFR2,AP2A1,LAMB1,ITGAV,MAPK1,SEMA3A,AP2S1,CNTN1
R-HSA-174154	APC/C:Cdc20 mediated degradation of Securin	0.50471626462829	-0.683758859826091	64	6	0.00826446280991736	726	8202	51434,5720,7311,11065,5721,991	ANAPC7,PSME1,UBA52,UBE2C,PSME2,CDC20
R-HSA-2424491	DAP12 signaling	0.511176392178031	-0.671040558170581	325	29	0.0399449035812672	726	8202	2254,7311,2335,4303,2308,5721,5295,2064,5720,1026,1956,2260,572,3667,817,2261,4193,6464,2905,2263,28956,5290,1027,11221,112,4343,7414,5594,6709	FGF9,UBA52,FN1,FOXO4,FOXO1,PSME2,PIK3R1,ERBB2,PSME1,CDKN1A,EGFR,FGFR1,BAD,IRS1,CAMK2D,FGFR3,MDM2,SHC1,GRIN2C,FGFR2,LAMTOR2,PIK3CA,CDKN1B,DUSP10,ADCY6,MOV10,VCL,MAPK1,SPTAN1
R-HSA-3560801	Defective B3GAT3 causes JDSSDHD	0.511192585248604	-0.671008880623761	19	2	0.00275482093663912	726	8202	375790,1462	AGRN,VCAN
R-HSA-392851	Prostacyclin signalling through prostacyclin receptor	0.511192585248604	-0.671008880623761	19	2	0.00275482093663912	726	8202	54331,2783	GNG2,GNB2
R-HSA-3560783	Defective B4GALT7 causes EDS, progeroid type	0.511192585248604	-0.671008880623761	19	2	0.00275482093663912	726	8202	375790,1462	AGRN,VCAN
R-HSA-4420332	Defective B3GALT6 causes EDSP2 and SEMDJL1	0.511192585248604	-0.671008880623761	19	2	0.00275482093663912	726	8202	375790,1462	AGRN,VCAN
R-HSA-71403	Citric acid cycle (TCA cycle)	0.511192585248604	-0.671008880623761	19	2	0.00275482093663912	726	8202	1738,6389	DLD,SDHA
R-HSA-442982	Ras activation uopn Ca2+ infux through NMDA receptor	0.511192585248604	-0.671008880623761	19	2	0.00275482093663912	726	8202	817,2905	CAMK2D,GRIN2C
R-HSA-3858494	Beta-catenin independent WNT signaling	0.513296179213788	-0.666902253016955	144	13	0.0179063360881543	726	8202	54331,7311,8322,5721,160,5720,23513,7855,4343,1175,2783,8324,5331	GNG2,UBA52,FZD4,PSME2,AP2A1,PSME1,SCRIB,FZD5,MOV10,AP2S1,GNB2,FZD7,PLCB3
R-HSA-428157	Sphingolipid metabolism	0.514580760755862	-0.664402766627292	76	7	0.00964187327823691	726	8202	221,25870,79642,9517,3074,8612,410	ALDH3B1,SUMF2,ARSJ,SPTLC2,HEXB,PLPP2,ARSA
R-HSA-373752	Netrin-1 signaling	0.51680056580291	-0.660098231694471	42	4	0.00550964187327824	726	8202	5588,59277,998,9353	PRKCQ,NTN4,CDC42,SLIT2
R-HSA-73856	RNA Polymerase II Transcription Termination	0.51680056580291	-0.660098231694471	42	4	0.00550964187327824	726	8202	6427,134353,6628,10978	SRSF2,LSM11,SNRPB,CLP1
R-HSA-379724	tRNA Aminoacylation	0.51680056580291	-0.660098231694471	42	4	0.00550964187327824	726	8202	25973,5859,55699,55157	PARS2,QARS,IARS2,DARS2
R-HSA-3769402	Deactivation of the beta-catenin transactivating complex	0.51680056580291	-0.660098231694471	42	4	0.00550964187327824	726	8202	3065,7088,7311,6662	HDAC1,TLE1,UBA52,SOX9
R-HSA-1566948	Elastic fibre formation	0.51680056580291	-0.660098231694471	42	4	0.00550964187327824	726	8202	650,84171,3685,2200	BMP2,LOXL4,ITGAV,FBN1
R-HSA-109688	Cleavage of Growing Transcript in the Termination Region	0.51680056580291	-0.660098231694471	42	4	0.00550964187327824	726	8202	6427,134353,6628,10978	SRSF2,LSM11,SNRPB,CLP1
R-HSA-1253288	Downregulation of ERBB4 signaling	0.523731176021033	-0.646776749162972	8	1	0.00137741046831956	726	8202	7311	UBA52
R-HSA-428643	Organic anion transporters	0.523731176021033	-0.646776749162972	8	1	0.00137741046831956	726	8202	26503	SLC17A5
R-HSA-159763	Transport of gamma-carboxylated protein precursors from the endoplasmic reticulum to the Golgi apparatus	0.523731176021033	-0.646776749162972	8	1	0.00137741046831956	726	8202	5627	PROS1
R-HSA-195399	VEGF binds to VEGFR leading to receptor dimerization	0.523731176021033	-0.646776749162972	8	1	0.00137741046831956	726	8202	5228	PGF
R-HSA-400451	Free fatty acids regulate insulin secretion	0.523731176021033	-0.646776749162972	8	1	0.00137741046831956	726	8202	5331	PLCB3
R-HSA-434316	Fatty Acids bound to GPR40 (FFAR1) regulate insulin secretion	0.523731176021033	-0.646776749162972	8	1	0.00137741046831956	726	8202	5331	PLCB3
R-HSA-389887	Beta-oxidation of pristanoyl-CoA	0.523731176021033	-0.646776749162972	8	1	0.00137741046831956	726	8202	1384	CRAT
R-HSA-5603027	IKBKG deficiency causes anhidrotic ectodermal dysplasia with immunodeficiency (EDA-ID) (via TLR)	0.523731176021033	-0.646776749162972	8	1	0.00137741046831956	726	8202	4792	NFKBIA
R-HSA-194313	VEGF ligand-receptor interactions	0.523731176021033	-0.646776749162972	8	1	0.00137741046831956	726	8202	5228	PGF
R-HSA-192456	Digestion of dietary lipid	0.523731176021033	-0.646776749162972	8	1	0.00137741046831956	726	8202	91289	LMF2
R-HSA-446388	Regulation of cytoskeletal remodeling and cell spreading by IPP complex components	0.523731176021033	-0.646776749162972	8	1	0.00137741046831956	726	8202	87	ACTN1
R-HSA-1483148	Synthesis of PG	0.523731176021033	-0.646776749162972	8	1	0.00137741046831956	726	8202	8760	CDS2
R-HSA-2586552	Signaling by Leptin	0.524105508725659	-0.64606226239991	236	21	0.0289256198347107	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,9021,3667,2261,817,6464,2263,2905,28956,11221,6774,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,SOCS3,IRS1,FGFR3,CAMK2D,SHC1,FGFR2,GRIN2C,LAMTOR2,DUSP10,STAT3,VCL,MAPK1,SPTAN1
R-HSA-5654733	Negative regulation of FGFR4 signaling	0.525759276569257	-0.642911820105618	31	3	0.00413223140495868	726	8202	2254,7311,5594	FGF9,UBA52,MAPK1
R-HSA-167287	HIV elongation arrest and recovery	0.525759276569257	-0.642911820105618	31	3	0.00413223140495868	726	8202	6827,6829,5441	SUPT4H1,SUPT5H,POLR2L
R-HSA-167290	Pausing and recovery of HIV elongation	0.525759276569257	-0.642911820105618	31	3	0.00413223140495868	726	8202	6827,6829,5441	SUPT4H1,SUPT5H,POLR2L
R-HSA-70263	Gluconeogenesis	0.525759276569257	-0.642911820105618	31	3	0.00413223140495868	726	8202	4190,5223,6576	MDH1,PGAM1,SLC25A1
R-HSA-418990	Adherens junctions interactions	0.525759276569257	-0.642911820105618	31	3	0.00413223140495868	726	8202	81607,25945,5818	PVRL4,PVRL3,PVRL1
R-HSA-168274	Export of Viral Ribonucleoproteins from Nucleus	0.525759276569257	-0.642911820105618	31	3	0.00413223140495868	726	8202	55746,3303,3304	NUP133,HSPA1A,HSPA1B
R-HSA-114604	GPVI-mediated activation cascade	0.527115086566631	-0.640336373700501	54	5	0.0068870523415978	726	8202	6464,998,388,5295,5290	SHC1,CDC42,RHOB,PIK3R1,PIK3CA
R-HSA-2022090	Assembly of collagen fibrils and other multimeric structures	0.527115086566631	-0.640336373700501	54	5	0.0068870523415978	726	8202	84171,1292,3909,3691,1291	LOXL4,COL6A2,LAMA3,ITGB4,COL6A1
R-HSA-2871796	FCERI mediated MAPK activation	0.529214412225172	-0.636361613126589	248	22	0.0303030303030303	726	8202	2254,7311,2335,5721,2064,5720,2353,1956,2260,3667,3725,817,2261,6464,2905,2263,28956,11221,7414,5594,6709,4214	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FOS,EGFR,FGFR1,IRS1,JUN,CAMK2D,FGFR3,SHC1,GRIN2C,FGFR2,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1,MAP3K1
R-HSA-5653656	Vesicle-mediated transport	0.533030914081029	-0.629175856346213	294	26	0.0358126721763085	726	8202	10484,10808,5564,8615,7311,1314,5565,7039,11316,3312,5571,2495,23265,162,55330,2799,155382,11196,4905,9632,149371,1174,3998,164,2810,1315	SEC23A,HSPH1,PRKAB1,USO1,UBA52,COPA,PRKAB2,TGFA,COPE,HSPA8,PRKAG1,FTH1,EXOC7,AP1B1,BLOC1S4,GNS,VPS37D,SEC23IP,NSF,SEC24C,EXOC8,AP1S1,LMAN1,AP1G1,SFN,COPB1
R-HSA-2173793	Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	0.535829841964982	-0.623938627332673	43	4	0.00550964187327824	726	8202	3065,1030,7050,7311	HDAC1,CDKN2B,TGIF1,UBA52
R-HSA-432040	Vasopressin regulates renal water homeostasis via Aquaporins	0.535829841964982	-0.623938627332673	43	4	0.00550964187327824	726	8202	54331,112,360,2783	GNG2,ADCY6,AQP3,GNB2
R-HSA-210745	Regulation of gene expression in beta cells	0.539302119831866	-0.61747934593675	20	2	0.00275482093663912	726	8202	389692,2308	MAFA,FOXO1
R-HSA-190241	FGFR2 ligand binding and activation	0.539302119831866	-0.61747934593675	20	2	0.00275482093663912	726	8202	2254,2263	FGF9,FGFR2
R-HSA-2028269	Signaling by Hippo	0.539302119831866	-0.61747934593675	20	2	0.00275482093663912	726	8202	836,154796	CASP3,AMOT
R-HSA-381771	Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1)	0.539302119831866	-0.61747934593675	20	2	0.00275482093663912	726	8202	23478,60559	SEC11A,SPCS3
R-HSA-381340	Transcriptional regulation of white adipocyte differentiation	0.542887705649985	-0.610852784026201	78	7	0.00964187327823691	726	8202	688,54797,85441,7026,5468,51129,8841	KLF5,MED18,HELZ2,NR2F2,PPARG,ANGPTL4,HDAC3
R-HSA-2142753	Arachidonic acid metabolism	0.543867729223426	-0.609049206500566	55	5	0.0068870523415978	726	8202	113612,2053,4048,2876,1545	CYP2U1,EPHX2,LTA4H,GPX1,CYP1B1
R-HSA-451326	Activation of Kainate Receptors upon glutamate binding	0.547744184341364	-0.60194691792237	32	3	0.00413223140495868	726	8202	54331,2783,5331	GNG2,GNB2,PLCB3
R-HSA-186712	Regulation of beta-cell development	0.547744184341364	-0.60194691792237	32	3	0.00413223140495868	726	8202	4851,389692,2308	NOTCH1,MAFA,FOXO1
R-HSA-2173789	TGF-beta receptor signaling activates SMADs	0.547744184341364	-0.60194691792237	32	3	0.00413223140495868	726	8202	7311,5499,25805	UBA52,PPP1CA,BAMBI
R-HSA-196854	Metabolism of vitamins and cofactors	0.549356740670022	-0.599007247645628	90	8	0.0110192837465565	726	8202	55191,113278,6513,55788,9446,8566,93100,4522	NADSYN1,SLC52A3,SLC2A1,LMBRD1,GSTO1,PDXK,NAPRT,MTHFD1
R-HSA-5620912	Anchoring of the basal body to the plasma membrane	0.549356740670022	-0.599007247645628	90	8	0.0110192837465565	726	8202	5108,5116,79867,10383,8655,10121,983,1639	PCM1,PCNT,TCTN2,TUBB4B,DYNLL1,ACTR1A,CDK1,DCTN1
R-HSA-196849	Metabolism of water-soluble vitamins and cofactors	0.549356740670022	-0.599007247645628	90	8	0.0110192837465565	726	8202	55191,113278,6513,55788,9446,8566,93100,4522	NADSYN1,SLC52A3,SLC2A1,LMBRD1,GSTO1,PDXK,NAPRT,MTHFD1
R-HSA-446652	Interleukin-1 signaling	0.554476095336732	-0.58973158342445	44	4	0.00550964187327824	726	8202	246330,7311,1326,3656	PELI3,UBA52,MAP3K8,IRAK2
R-HSA-1362409	Mitochondrial iron-sulfur cluster biogenesis	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	2232	FDXR
R-HSA-391908	Prostanoid ligand receptors	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	5734	PTGER4
R-HSA-196108	Pregnenolone biosynthesis	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	2232	FDXR
R-HSA-2243919	Crosslinking of collagen fibrils	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	84171	LOXL4
R-HSA-389661	Glyoxylate metabolism and glycine degradation	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	1738	DLD
R-HSA-1247673	Erythrocytes take up oxygen and release carbon dioxide	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	760	CA2
R-HSA-425986	Sodium/Proton exchangers	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	10479	SLC9A6
R-HSA-425381	Bicarbonate transporters	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	9497	SLC4A7
R-HSA-428890	Role of Abl in Robo-Slit signaling	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	9353	SLIT2
R-HSA-1480926	O2/CO2 exchange in erythrocytes	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	760	CA2
R-HSA-73614	Pyrimidine salvage reactions	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	1890	TYMP
R-HSA-2179392	EGFR Transactivation by Gastrin	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	1956	EGFR
R-HSA-390696	Adrenoceptors	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	152	ADRA2C
R-HSA-727802	Transport of nucleotide sugars	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	7355	SLC35A2
R-HSA-1237044	Erythrocytes take up carbon dioxide and release oxygen	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	760	CA2
R-HSA-2428933	SHC-related events triggered by IGF1R	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	6464	SHC1
R-HSA-159740	Gamma-carboxylation of protein precursors	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	5627	PROS1
R-HSA-3215018	Processing and activation of SUMO	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	6612	SUMO3
R-HSA-159782	Removal of aminoterminal propeptides from gamma-carboxylated proteins	0.56592926806487	-0.569286176671384	9	1	0.00137741046831956	726	8202	5627	PROS1
R-HSA-381426	Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)	0.566272865504691	-0.568679222417931	21	2	0.00275482093663912	726	8202	3485,3489	IGFBP2,IGFBP6
R-HSA-198753	ERK/MAPK targets	0.566272865504691	-0.568679222417931	21	2	0.00275482093663912	726	8202	1845,5594	DUSP3,MAPK1
R-HSA-5620916	VxPx cargo-targeting to cilium	0.566272865504691	-0.568679222417931	21	2	0.00275482093663912	726	8202	23265,149371	EXOC7,EXOC8
R-HSA-452723	Transcriptional regulation of pluripotent stem cells	0.569119506500539	-0.56366483790962	33	3	0.00413223140495868	726	8202	5087,5441,6774	PBX1,POLR2L,STAT3
R-HSA-3301854	Nuclear Pore Complex (NPC) Disassembly	0.569119506500539	-0.56366483790962	33	3	0.00413223140495868	726	8202	891,55746,983	CCNB1,NUP133,CDK1
R-HSA-163359	Glucagon signaling in metabolic regulation	0.569119506500539	-0.56366483790962	33	3	0.00413223140495868	726	8202	54331,112,2783	GNG2,ADCY6,GNB2
R-HSA-422356	Regulation of insulin secretion	0.570489458560647	-0.561260587395596	80	7	0.00964187327823691	726	8202	54331,152,112,292,2783,6513,5331	GNG2,ADRA2C,ADCY6,SLC25A5,GNB2,SLC2A1,PLCB3
R-HSA-170984	ARMS-mediated activation	0.584627354321665	-0.536780635881266	232	20	0.0275482093663912	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,3667,817,2261,6464,1398,2263,2905,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,CRK,FGFR2,GRIN2C,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-162906	HIV Infection	0.589106034197751	-0.529149087428105	221	19	0.0261707988980716	726	8202	7311,5441,5721,3978,5720,5905,162,6829,292,3105,51616,6827,155382,55746,160,1174,164,60489,1175	UBA52,POLR2L,PSME2,LIG1,PSME1,RANGAP1,AP1B1,SUPT5H,SLC25A5,HLA-A,TAF9B,SUPT4H1,VPS37D,NUP133,AP2A1,AP1S1,AP1G1,APOBEC3G,AP2S1
R-HSA-113418	Formation of the Early Elongation Complex	0.589859998334064	-0.52787006119954	34	3	0.00413223140495868	726	8202	6827,5441,6829	SUPT4H1,POLR2L,SUPT5H
R-HSA-4791275	Signaling by WNT in cancer	0.589859998334064	-0.52787006119954	34	3	0.00413223140495868	726	8202	54894,7855,8322	RNF43,FZD5,FZD4
R-HSA-3928663	EPHA-mediated growth cone collapse	0.589859998334064	-0.52787006119954	34	3	0.00413223140495868	726	8202	4637,4628,9475	MYL6,MYH10,ROCK2
R-HSA-167158	Formation of the HIV-1 Early Elongation Complex	0.589859998334064	-0.52787006119954	34	3	0.00413223140495868	726	8202	6827,6829,5441	SUPT4H1,SUPT5H,POLR2L
R-HSA-5205685	Pink/Parkin Mediated Mitophagy	0.592085955932736	-0.524103458805701	22	2	0.00275482093663912	726	8202	9868,7311	TOMM70A,UBA52
R-HSA-392170	ADP signalling through P2Y purinoceptor 12	0.592085955932736	-0.524103458805701	22	2	0.00275482093663912	726	8202	54331,2783	GNG2,GNB2
R-HSA-2453902	The canonical retinoid cycle in rods (twilight vision)	0.592085955932736	-0.524103458805701	22	2	0.00275482093663912	726	8202	9227,157506	LRAT,RDH10
R-HSA-5205647	Mitophagy	0.592085955932736	-0.524103458805701	22	2	0.00275482093663912	726	8202	9868,7311	TOMM70A,UBA52
R-HSA-2892247	POU5F1 (OCT4), SOX2, NANOG activate genes related to proliferation	0.592085955932736	-0.524103458805701	22	2	0.00275482093663912	726	8202	5441,6774	POLR2L,STAT3
R-HSA-166208	mTORC1-mediated signalling	0.592085955932736	-0.524103458805701	22	2	0.00275482093663912	726	8202	28956,10670	LAMTOR2,RRAGA
R-HSA-112315	Transmission across Chemical Synapses	0.593861308041178	-0.521109475028258	210	18	0.0247933884297521	726	8202	80331,3312,8541,2783,6505,2752,5331,54331,817,7915,4193,2905,4905,160,10550,112,5594,1175	DNAJC5,HSPA8,PPFIA3,GNB2,SLC1A1,GLUL,PLCB3,GNG2,CAMK2D,ALDH5A1,MDM2,GRIN2C,NSF,AP2A1,ARL6IP5,ADCY6,MAPK1,AP2S1
R-HSA-68949	Orc1 removal from chromatin	0.594690519846095	-0.519714143465937	70	6	0.00826446280991736	726	8202	1027,5720,1026,7311,5721,81620	CDKN1B,PSME1,CDKN1A,UBA52,PSME2,CDT1
R-HSA-69052	Switching of origins to a post-replicative state	0.594690519846095	-0.519714143465937	70	6	0.00826446280991736	726	8202	1027,5720,1026,7311,5721,81620	CDKN1B,PSME1,CDKN1A,UBA52,PSME2,CDT1
R-HSA-5663084	Diseases of carbohydrate metabolism	0.604393243579059	-0.503530227370293	10	1	0.00137741046831956	726	8202	7311	UBA52
R-HSA-975144	IRAK1 recruits IKK complex upon TLR7/8 or 9 stimulation	0.604393243579059	-0.503530227370293	10	1	0.00137741046831956	726	8202	246330	PELI3
R-HSA-209968	Thyroxine biosynthesis	0.604393243579059	-0.503530227370293	10	1	0.00137741046831956	726	8202	53905	DUOX1
R-HSA-193692	Regulated proteolysis of p75NTR	0.604393243579059	-0.503530227370293	10	1	0.00137741046831956	726	8202	51107	APH1A
R-HSA-3229121	Glycogen storage diseases	0.604393243579059	-0.503530227370293	10	1	0.00137741046831956	726	8202	7311	UBA52
R-HSA-937039	IRAK1 recruits IKK complex	0.604393243579059	-0.503530227370293	10	1	0.00137741046831956	726	8202	246330	PELI3
R-HSA-430116	GP1b-IX-V activation signalling	0.604393243579059	-0.503530227370293	10	1	0.00137741046831956	726	8202	5295	PIK3R1
R-HSA-3785653	Myoclonic epilepsy of Lafora	0.604393243579059	-0.503530227370293	10	1	0.00137741046831956	726	8202	7311	UBA52
R-HSA-399997	Acetylcholine regulates insulin secretion	0.604393243579059	-0.503530227370293	10	1	0.00137741046831956	726	8202	5331	PLCB3
R-HSA-419812	Calcitonin-like ligand receptors	0.604393243579059	-0.503530227370293	10	1	0.00137741046831956	726	8202	133	ADM
R-HSA-2562578	TRIF-mediated programmed cell death	0.604393243579059	-0.503530227370293	10	1	0.00137741046831956	726	8202	8737	RIPK1
R-HSA-170660	Adenylate cyclase activating pathway	0.604393243579059	-0.503530227370293	10	1	0.00137741046831956	726	8202	112	ADCY6
R-HSA-190377	FGFR2b ligand binding and activation	0.604393243579059	-0.503530227370293	10	1	0.00137741046831956	726	8202	2263	FGFR2
R-HSA-2161522	Abacavir transport and metabolism	0.604393243579059	-0.503530227370293	10	1	0.00137741046831956	726	8202	5243	ABCB1
R-HSA-418889	Ligand-independent caspase activation via DCC	0.604393243579059	-0.503530227370293	10	1	0.00137741046831956	726	8202	836	CASP3
R-HSA-169893	Prolonged ERK activation events	0.608443620630683	-0.496851023878036	235	20	0.0275482093663912	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,3667,817,2261,6464,1398,2263,2905,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,CRK,FGFR2,GRIN2C,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-428930	Thromboxane signalling through TP receptor	0.616734767503021	-0.483316221886555	23	2	0.00275482093663912	726	8202	54331,2783	GNG2,GNB2
R-HSA-5654719	SHC-mediated cascade:FGFR4	0.616734767503021	-0.483316221886555	23	2	0.00275482093663912	726	8202	2254,6464	FGF9,SHC1
R-HSA-211976	Endogenous sterols	0.616734767503021	-0.483316221886555	23	2	0.00275482093663912	726	8202	2232,1545	FDXR,CYP1B1
R-HSA-201451	Signaling by BMP	0.616734767503021	-0.483316221886555	23	2	0.00275482093663912	726	8202	650,9765	BMP2,ZFYVE16
R-HSA-5620922	BBSome-mediated cargo-targeting to cilium	0.616734767503021	-0.483316221886555	23	2	0.00275482093663912	726	8202	123016,55212	TTC8,BBS7
R-HSA-194315	Signaling by Rho GTPases	0.621021708888472	-0.476389239707223	399	34	0.046831955922865	726	8202	389,54821,55143,29127,11004,54509,4628,10788,55845,998,10811,55746,2665,9928,4637,1027,653604,9735,7074,9475,9184,23526,991,6232,5905,26999,995,89941,388,58480,1535,332,5594,2810	RHOC,ERCC6L,CDCA8,RACGAP1,KIF2C,RHOF,MYH10,IQGAP2,BRK1,CDC42,NOXA1,NUP133,GDI2,KIF14,MYL6,CDKN1B,HIST2H3D,KNTC1,TIAM1,ROCK2,BUB3,HMHA1,CDC20,RPS27,RANGAP1,CYFIP2,CDC25C,RHOT2,RHOB,RHOU,CYBA,BIRC5,MAPK1,SFN
R-HSA-69300	Removal of licensing factors from origins	0.622697858037189	-0.473693856908605	72	6	0.00826446280991736	726	8202	1027,5720,1026,7311,5721,81620	CDKN1B,PSME1,CDKN1A,UBA52,PSME2,CDT1
R-HSA-174084	Autodegradation of Cdh1 by Cdh1:APC/C	0.623026538019143	-0.473166163960434	60	5	0.0068870523415978	726	8202	51434,5720,7311,11065,5721	ANAPC7,PSME1,UBA52,UBE2C,PSME2
R-HSA-5419276	Mitochondrial translation termination	0.623210195840289	-0.472871424096834	84	7	0.00964187327823691	726	8202	55173,10573,51021,740,54148,28973,55037	MRPS10,MRPL28,MRPS16,MRPL49,MRPL39,MRPS18B,PTCD3
R-HSA-5389840	Mitochondrial translation elongation	0.623210195840289	-0.472871424096834	84	7	0.00964187327823691	726	8202	55173,10573,51021,740,54148,28973,55037	MRPS10,MRPL28,MRPS16,MRPL49,MRPL39,MRPS18B,PTCD3
R-HSA-5368286	Mitochondrial translation initiation	0.623210195840289	-0.472871424096834	84	7	0.00964187327823691	726	8202	55173,10573,51021,740,54148,28973,55037	MRPS10,MRPL28,MRPS16,MRPL49,MRPL39,MRPS18B,PTCD3
R-HSA-111885	Opioid Signalling	0.623210195840289	-0.472871424096834	84	7	0.00964187327823691	726	8202	54331,112,5499,5594,2783,5142,5331	GNG2,ADCY6,PPP1CA,MAPK1,GNB2,PDE4B,PLCB3
R-HSA-202424	Downstream TCR signaling	0.624242732375349	-0.471215992060071	96	8	0.0110192837465565	726	8202	7311,5721,3635,4792,5295,5290,5720,5588	UBA52,PSME2,INPP5D,NFKBIA,PIK3R1,PIK3CA,PSME1,PRKCQ
R-HSA-73887	Death Receptor Signalling	0.624807263189891	-0.47031205570046	48	4	0.00550964187327824	726	8202	8737,7311,8795,355	RIPK1,UBA52,TNFRSF10B,FAS
R-HSA-3214842	HDMs demethylate histones	0.624807263189891	-0.47031205570046	48	4	0.00550964187327824	726	8202	653604,23210,10765,55818	HIST2H3D,JMJD6,KDM5B,KDM3A
R-HSA-1660661	Sphingolipid de novo biosynthesis	0.629363730237358	-0.463045921945922	36	3	0.00413223140495868	726	8202	221,9517,8612	ALDH3B1,SPTLC2,PLPP2
R-HSA-2029482	Regulation of actin dynamics for phagocytic cup formation	0.637838479464113	-0.449670194673667	61	5	0.0068870523415978	726	8202	26999,55845,1398,998,5594	CYFIP2,BRK1,CRK,CDC42,MAPK1
R-HSA-204998	Cell death signalling via NRAGE, NRIF and NADE	0.637838479464113	-0.449670194673667	61	5	0.0068870523415978	726	8202	572,836,7311,51107,7074	BAD,CASP3,UBA52,APH1A,TIAM1
R-HSA-879518	Transport of organic anions	0.639453119693614	-0.447141968400793	11	1	0.00137741046831956	726	8202	28232	SLCO3A1
R-HSA-2022923	Dermatan sulfate biosynthesis	0.639453119693614	-0.447141968400793	11	1	0.00137741046831956	726	8202	1462	VCAN
R-HSA-73817	Purine ribonucleoside monophosphate biosynthesis	0.639453119693614	-0.447141968400793	11	1	0.00137741046831956	726	8202	3615	IMPDH2
R-HSA-71182	Phenylalanine and tyrosine catabolism	0.639453119693614	-0.447141968400793	11	1	0.00137741046831956	726	8202	2184	FAH
R-HSA-5625970	RHO GTPases activate KTN1	0.639453119693614	-0.447141968400793	11	1	0.00137741046831956	726	8202	998	CDC42
R-HSA-71288	Creatine metabolism	0.639453119693614	-0.447141968400793	11	1	0.00137741046831956	726	8202	548596	CKMT1A
R-HSA-351906	Apoptotic cleavage of cell adhesion  proteins	0.639453119693614	-0.447141968400793	11	1	0.00137741046831956	726	8202	836	CASP3
R-HSA-196757	Metabolism of folate and pterines	0.639453119693614	-0.447141968400793	11	1	0.00137741046831956	726	8202	4522	MTHFD1
R-HSA-1266695	Interleukin-7 signaling	0.639453119693614	-0.447141968400793	11	1	0.00137741046831956	726	8202	5295	PIK3R1
R-HSA-159854	Gamma-carboxylation, transport, and amino-terminal cleavage of proteins	0.639453119693614	-0.447141968400793	11	1	0.00137741046831956	726	8202	5627	PROS1
R-HSA-977606	Regulation of Complement cascade	0.640222904940127	-0.445938874297995	24	2	0.00275482093663912	726	8202	4179,5627	CD46,PROS1
R-HSA-937041	IKK complex recruitment mediated by RIP1	0.640222904940127	-0.445938874297995	24	2	0.00275482093663912	726	8202	8737,7311	RIPK1,UBA52
R-HSA-198725	Nuclear Events (kinase and transcription factor activation)	0.640222904940127	-0.445938874297995	24	2	0.00275482093663912	726	8202	1845,5594	DUSP3,MAPK1
R-HSA-1963640	GRB2 events in ERBB2 signaling	0.644759479348076	-0.438877931966489	228	19	0.0261707988980716	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,3667,817,2261,6464,2263,2905,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,FGFR2,GRIN2C,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-1250347	SHC1 events in ERBB4 signaling	0.644759479348076	-0.438877931966489	228	19	0.0261707988980716	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,3667,817,2261,6464,2263,2905,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,FGFR2,GRIN2C,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-180336	SHC1 events in EGFR signaling	0.644759479348076	-0.438877931966489	228	19	0.0261707988980716	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,3667,817,2261,6464,2263,2905,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,FGFR2,GRIN2C,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-5673001	RAF/MAP kinase cascade	0.644759479348076	-0.438877931966489	228	19	0.0261707988980716	726	8202	2254,7311,2335,5721,2064,5720,1956,2260,3667,817,2261,6464,2905,2263,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,EGFR,FGFR1,IRS1,CAMK2D,FGFR3,SHC1,GRIN2C,FGFR2,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-179812	GRB2 events in EGFR signaling	0.644759479348076	-0.438877931966489	228	19	0.0261707988980716	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,3667,817,2261,6464,2263,2905,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,FGFR2,GRIN2C,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-112412	SOS-mediated signalling	0.644759479348076	-0.438877931966489	228	19	0.0261707988980716	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,3667,817,2261,6464,2263,2905,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,FGFR2,GRIN2C,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-1250196	SHC1 events in ERBB2 signaling	0.644759479348076	-0.438877931966489	228	19	0.0261707988980716	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,3667,817,2261,6464,2263,2905,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,FGFR2,GRIN2C,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-438064	Post NMDA receptor activation events	0.648103191587237	-0.433705349031605	37	3	0.00413223140495868	726	8202	817,5594,2905	CAMK2D,MAPK1,GRIN2C
R-HSA-5685938	HDR through Single Strand Annealing (SSA)	0.648103191587237	-0.433705349031605	37	3	0.00413223140495868	726	8202	6118,672,5982	RPA2,BRCA1,RFC2
R-HSA-419037	NCAM1 interactions	0.648103191587237	-0.433705349031605	37	3	0.00413223140495868	726	8202	1292,375790,1291	COL6A2,AGRN,COL6A1
R-HSA-1251932	PLCG1 events in ERBB2 signaling	0.648103191587237	-0.433705349031605	37	3	0.00413223140495868	726	8202	2064,112,1956	ERBB2,ADCY6,EGFR
R-HSA-2029480	Fcgamma receptor (FCGR) dependent phagocytosis	0.648182340085435	-0.433583233191595	86	7	0.00964187327823691	726	8202	26999,55845,1398,998,5594,5295,5290	CYFIP2,BRK1,CRK,CDC42,MAPK1,PIK3R1,PIK3CA
R-HSA-1474290	Collagen formation	0.648182340085435	-0.433583233191595	86	7	0.00964187327823691	726	8202	1308,84171,64175,1292,3909,3691,1291	COL17A1,LOXL4,P3H1,COL6A2,LAMA3,ITGB4,COL6A1
R-HSA-3108232	SUMO E3 ligases SUMOylate target proteins	0.649566997460654	-0.431449295826959	74	6	0.00826446280991736	726	8202	1912,6612,672,55746,7508,5371	PHC2,SUMO3,BRCA1,NUP133,XPC,PML
R-HSA-3108214	SUMOylation of DNA damage response and repair proteins	0.649566997460654	-0.431449295826959	74	6	0.00826446280991736	726	8202	1912,6612,672,55746,7508,5371	PHC2,SUMO3,BRCA1,NUP133,XPC,PML
R-HSA-5654700	FRS-mediated FGFR2 signaling	0.652402549880974	-0.427093499780356	229	19	0.0261707988980716	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,3667,817,2261,6464,2263,2905,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,FGFR2,GRIN2C,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-5654693	FRS-mediated FGFR1 signaling	0.652402549880974	-0.427093499780356	229	19	0.0261707988980716	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,3667,817,2261,6464,2263,2905,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,FGFR2,GRIN2C,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-5654712	FRS-mediated FGFR4 signaling	0.652402549880974	-0.427093499780356	229	19	0.0261707988980716	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,3667,817,2261,6464,2263,2905,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,FGFR2,GRIN2C,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-5654706	FRS-mediated FGFR3 signaling	0.652402549880974	-0.427093499780356	229	19	0.0261707988980716	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,3667,817,2261,6464,2263,2905,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,FGFR2,GRIN2C,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-168249	Innate Immune System	0.655412668629606	-0.422490213289336	752	64	0.0881542699724518	726	8202	81622,7295,5721,2064,8737,5720,1026,4179,4193,6464,55845,998,7706,2905,28956,5290,1027,11221,5627,7414,7311,5441,5588,837,2260,572,817,1398,1650,6778,27297,22954,4343,5594,23586,2308,2335,9039,1326,1660,3725,2261,10010,112,3107,6709,4214,2254,4303,5295,246330,26999,2353,9636,1956,3667,3106,2263,1845,3656,4792,23220,64135,3659	UNC93B1,TXN,PSME2,ERBB2,RIPK1,PSME1,CDKN1A,CD46,MDM2,SHC1,BRK1,CDC42,TRIM25,GRIN2C,LAMTOR2,PIK3CA,CDKN1B,DUSP10,PROS1,VCL,UBA52,POLR2L,PRKCQ,CASP4,FGFR1,BAD,CAMK2D,CRK,DDOST,STAT6,CRCP,TRIM32,MOV10,MAPK1,DDX58,FOXO1,FN1,UBA3,MAP3K8,DHX9,JUN,FGFR3,TANK,ADCY6,HLA-C,SPTAN1,MAP3K1,FGF9,FOXO4,PIK3R1,PELI3,CYFIP2,FOS,ISG15,EGFR,IRS1,HLA-B,FGFR2,DUSP3,IRAK2,NFKBIA,DTX4,IFIH1,IRF1
R-HSA-69229	Ubiquitin-dependent degradation of Cyclin D1	0.65720950192571	-0.419752434728609	50	4	0.00550964187327824	726	8202	595,5720,7311,5721	CCND1,PSME1,UBA52,PSME2
R-HSA-75815	Ubiquitin-dependent degradation of Cyclin D	0.65720950192571	-0.419752434728609	50	4	0.00550964187327824	726	8202	595,5720,7311,5721	CCND1,PSME1,UBA52,PSME2
R-HSA-429914	Deadenylation-dependent mRNA decay	0.65720950192571	-0.419752434728609	50	4	0.00550964187327824	726	8202	54512,85456,1656,196513	EXOSC4,TNKS1BP1,DDX6,DCP1B
R-HSA-350562	Regulation of ornithine decarboxylase (ODC)	0.65720950192571	-0.419752434728609	50	4	0.00550964187327824	726	8202	51582,5720,1728,5721	AZIN1,PSME1,NQO1,PSME2
R-HSA-373080	Class B/2 (Secretin family receptors)	0.660296197256418	-0.415066760913115	87	7	0.00964187327823691	726	8202	54331,51384,7855,8322,2783,133,8324	GNG2,WNT16,FZD5,FZD4,GNB2,ADM,FZD7
R-HSA-69304	Regulation of DNA replication	0.66255570989187	-0.411650634254337	75	6	0.00826446280991736	726	8202	1027,5720,1026,7311,5721,81620	CDKN1B,PSME1,CDKN1A,UBA52,PSME2,CDT1
R-HSA-997272	Inhibition  of voltage gated Ca2+ channels via Gbeta/gamma subunits	0.662562447070486	-0.411640465834893	25	2	0.00275482093663912	726	8202	54331,2783	GNG2,GNB2
R-HSA-977068	Termination of O-glycan biosynthesis	0.662562447070486	-0.411640465834893	25	2	0.00275482093663912	726	8202	6483,10610	ST3GAL2,ST6GALNAC2
R-HSA-1296059	G protein gated Potassium channels	0.662562447070486	-0.411640465834893	25	2	0.00275482093663912	726	8202	54331,2783	GNG2,GNB2
R-HSA-162588	Budding and maturation of HIV virion	0.662562447070486	-0.411640465834893	25	2	0.00275482093663912	726	8202	155382,7311	VPS37D,UBA52
R-HSA-418592	ADP signalling through P2Y purinoceptor 1	0.662562447070486	-0.411640465834893	25	2	0.00275482093663912	726	8202	54331,2783	GNG2,GNB2
R-HSA-1296041	Activation of G protein gated Potassium channels	0.662562447070486	-0.411640465834893	25	2	0.00275482093663912	726	8202	54331,2783	GNG2,GNB2
R-HSA-375165	NCAM signaling for neurite out-growth	0.664871865840162	-0.408160939839151	266	22	0.0303030303030303	726	8202	2254,1292,7311,2335,375790,5721,2064,5720,2260,1956,3667,2261,817,6464,2263,2905,1291,28956,11221,5594,7414,6709	FGF9,COL6A2,UBA52,FN1,AGRN,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,FGFR3,CAMK2D,SHC1,FGFR2,GRIN2C,COL6A1,LAMTOR2,DUSP10,MAPK1,VCL,SPTAN1
R-HSA-194840	Rho GTPase cycle	0.668544283187837	-0.402652642019519	124	10	0.0137741046831956	726	8202	58480,998,2665,389,23526,29127,54509,89941,7074,388	RHOU,CDC42,GDI2,RHOC,HMHA1,RACGAP1,RHOF,RHOT2,TIAM1,RHOB
R-HSA-1475029	Reversible hydration of carbon dioxide	0.671409783737803	-0.398375622397896	12	1	0.00137741046831956	726	8202	760	CA2
R-HSA-3371511	HSF1 activation	0.671409783737803	-0.398375622397896	12	1	0.00137741046831956	726	8202	6118	RPA2
R-HSA-3656237	Defective EXT2 causes exostoses 2	0.671409783737803	-0.398375622397896	12	1	0.00137741046831956	726	8202	375790	AGRN
R-HSA-2197563	NOTCH2 intracellular domain regulates transcription	0.671409783737803	-0.398375622397896	12	1	0.00137741046831956	726	8202	55534	MAML3
R-HSA-211958	Miscellaneous substrates	0.671409783737803	-0.398375622397896	12	1	0.00137741046831956	726	8202	113612	CYP2U1
R-HSA-3656253	Defective EXT1 causes exostoses 1, TRPS2 and CHDS	0.671409783737803	-0.398375622397896	12	1	0.00137741046831956	726	8202	375790	AGRN
R-HSA-429958	mRNA decay by 3' to 5' exoribonuclease	0.671409783737803	-0.398375622397896	12	1	0.00137741046831956	726	8202	54512	EXOSC4
R-HSA-844456	The NLRP3 inflammasome	0.671409783737803	-0.398375622397896	12	1	0.00137741046831956	726	8202	7295	TXN
R-HSA-211979	Eicosanoids	0.671409783737803	-0.398375622397896	12	1	0.00137741046831956	726	8202	66002	CYP4F12
R-HSA-389359	CD28 dependent Vav1 pathway	0.671409783737803	-0.398375622397896	12	1	0.00137741046831956	726	8202	998	CDC42
R-HSA-432047	Passive transport by Aquaporins	0.671409783737803	-0.398375622397896	12	1	0.00137741046831956	726	8202	360	AQP3
R-HSA-445717	Aquaporin-mediated transport	0.672686205106258	-0.396476320915329	51	4	0.00550964187327824	726	8202	54331,112,360,2783	GNG2,ADCY6,AQP3,GNB2
R-HSA-187706	Signalling to p38 via RIT and RIN	0.674822801046313	-0.393305139541643	232	19	0.0261707988980716	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,3667,817,2261,6464,2263,2905,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,FGFR2,GRIN2C,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-983231	Factors involved in megakaryocyte development and platelet production	0.677908394077604	-0.388743112150122	137	11	0.0151515151515152	726	8202	3833,7465,10112,998,3065,653604,29127,11004,50808,3659,10938	KIFC1,WEE1,KIF20A,CDC42,HDAC1,HIST2H3D,RACGAP1,KIF2C,AK3,IRF1,EHD1
R-HSA-6782135	Dual incision in TC-NER	0.680060731752873	-0.385573173398727	64	5	0.0068870523415978	726	8202	6118,5111,7311,5441,5982	RPA2,PCNA,UBA52,POLR2L,RFC2
R-HSA-170968	Frs2-mediated activation	0.682120436500875	-0.382549043619616	233	19	0.0261707988980716	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,3667,817,2261,6464,2263,2905,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,FGFR2,GRIN2C,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-977444	GABA B receptor activation	0.683530658123185	-0.380483769218093	39	3	0.00413223140495868	726	8202	112,54331,2783	ADCY6,GNG2,GNB2
R-HSA-6788656	Histidine, lysine, phenylalanine, tyrosine, proline and tryptophan catabolism	0.683530658123185	-0.380483769218093	39	3	0.00413223140495868	726	8202	501,1738,2184	ALDH7A1,DLD,FAH
R-HSA-5693616	Presynaptic phase of homologous DNA pairing and strand exchange	0.683530658123185	-0.380483769218093	39	3	0.00413223140495868	726	8202	6118,672,5982	RPA2,BRCA1,RFC2
R-HSA-6782315	tRNA modification in the nucleus and cytosol	0.683530658123185	-0.380483769218093	39	3	0.00413223140495868	726	8202	57570,55621,8270	TRMT5,TRMT1,LAGE3
R-HSA-991365	Activation of GABAB receptors	0.683530658123185	-0.380483769218093	39	3	0.00413223140495868	726	8202	112,54331,2783	ADCY6,GNG2,GNB2
R-HSA-3560782	Diseases associated with glycosaminoglycan metabolism	0.683772422131113	-0.38013013290448	26	2	0.00275482093663912	726	8202	375790,1462	AGRN,VCAN
R-HSA-3781865	Diseases of glycosylation	0.683772422131113	-0.38013013290448	26	2	0.00275482093663912	726	8202	375790,1462	AGRN,VCAN
R-HSA-1971475	A tetrasaccharide linker sequence is required for GAG synthesis	0.683772422131113	-0.38013013290448	26	2	0.00275482093663912	726	8202	375790,1462	AGRN,VCAN
R-HSA-2029485	Role of phospholipids in phagocytosis	0.683772422131113	-0.38013013290448	26	2	0.00275482093663912	726	8202	5295,5290	PIK3R1,PIK3CA
R-HSA-3238698	WNT ligand biogenesis and trafficking	0.683772422131113	-0.38013013290448	26	2	0.00275482093663912	726	8202	51384,79971	WNT16,WLS
R-HSA-76066	RNA Polymerase III Transcription Initiation From Type 2 Promoter	0.683772422131113	-0.38013013290448	26	2	0.00275482093663912	726	8202	27297,5441	CRCP,POLR2L
R-HSA-6781827	Transcription-Coupled Nucleotide Excision Repair (TC-NER)	0.687613089800651	-0.374528968713616	77	6	0.00826446280991736	726	8202	3978,6118,5111,7311,5441,5982	LIG1,RPA2,PCNA,UBA52,POLR2L,RFC2
R-HSA-69541	Stabilization of p53	0.687673624404777	-0.37444093673666	52	4	0.00550964187327824	726	8202	5720,4193,7311,5721	PSME1,MDM2,UBA52,PSME2
R-HSA-187687	Signalling to ERKs	0.690202191435387	-0.370770693250271	246	20	0.0275482093663912	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,3667,817,2261,6464,1398,2263,2905,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,CRK,FGFR2,GRIN2C,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-5368287	Mitochondrial translation	0.695087560914254	-0.363717454426046	90	7	0.00964187327823691	726	8202	55173,10573,51021,740,54148,28973,55037	MRPS10,MRPL28,MRPS16,MRPL49,MRPL39,MRPS18B,PTCD3
R-HSA-5625740	RHO GTPases activate PKNs	0.695087560914254	-0.363717454426046	90	7	0.00964187327823691	726	8202	4637,653604,995,4628,389,2810,388	MYL6,HIST2H3D,CDC25C,MYH10,RHOC,SFN,RHOB
R-HSA-73894	DNA Repair	0.695417005864722	-0.363243604911989	306	25	0.034435261707989	726	8202	1643,7311,5441,63967,7508,5531,3978,6612,672,4350,2189,5982,9636,6118,10973,5111,7158,7706,197342,27343,79913,3838,4798,5429,4595	DDB2,UBA52,POLR2L,CLSPN,XPC,PPP4C,LIG1,SUMO3,BRCA1,MPG,FANCG,RFC2,ISG15,RPA2,ASCC3,PCNA,TP53BP1,TRIM25,EME2,POLL,ACTR5,KPNA2,NFRKB,POLH,MUTYH
R-HSA-418555	G alpha (s) signalling events	0.697732709335902	-0.359919187473392	127	10	0.0137741046831956	726	8202	54331,7433,10846,5142,5734,112,136,2783,133,5139	GNG2,VIPR1,PDE10A,PDE4B,PTGER4,ADCY6,ADORA2B,GNB2,ADM,PDE3A
R-HSA-202403	TCR signaling	0.699664931293398	-0.357153728118448	115	9	0.012396694214876	726	8202	7311,5721,3635,4792,5295,5290,5720,5588,55824	UBA52,PSME2,INPP5D,NFKBIA,PIK3R1,PIK3CA,PSME1,PRKCQ,PAG1
R-HSA-418346	Platelet homeostasis	0.69967353848597	-0.357141426316191	78	6	0.00826446280991736	726	8202	54331,8654,27345,2783,10846,5139	GNG2,PDE5A,KCNMB4,GNB2,PDE10A,PDE3A
R-HSA-749476	RNA Polymerase III Abortive And Retractive Initiation	0.700219249672312	-0.356361779162351	40	3	0.00413223140495868	726	8202	27297,5441,4781	CRCP,POLR2L,NFIB
R-HSA-5675221	Negative regulation of MAPK pathway	0.700219249672312	-0.356361779162351	40	3	0.00413223140495868	726	8202	11221,7311,5594	DUSP10,UBA52,MAPK1
R-HSA-74158	RNA Polymerase III Transcription	0.700219249672312	-0.356361779162351	40	3	0.00413223140495868	726	8202	27297,5441,4781	CRCP,POLR2L,NFIB
R-HSA-1679131	Trafficking and processing of endosomal TLR	0.700537561152087	-0.355907294154255	13	1	0.00137741046831956	726	8202	81622	UNC93B1
R-HSA-211227	Activation of DNA fragmentation factor	0.700537561152087	-0.355907294154255	13	1	0.00137741046831956	726	8202	836	CASP3
R-HSA-5357786	TNFR1-induced proapoptotic signaling	0.700537561152087	-0.355907294154255	13	1	0.00137741046831956	726	8202	8737	RIPK1
R-HSA-3270619	IRF3-mediated induction of type I IFN	0.700537561152087	-0.355907294154255	13	1	0.00137741046831956	726	8202	23220	DTX4
R-HSA-3134963	DEx/H-box helicases activate type I IFN and inflammatory cytokines production	0.700537561152087	-0.355907294154255	13	1	0.00137741046831956	726	8202	1660	DHX9
R-HSA-74217	Purine salvage	0.700537561152087	-0.355907294154255	13	1	0.00137741046831956	726	8202	51292	GMPR2
R-HSA-209543	p75NTR recruits signalling complexes	0.700537561152087	-0.355907294154255	13	1	0.00137741046831956	726	8202	7311	UBA52
R-HSA-140342	Apoptosis induced DNA fragmentation	0.700537561152087	-0.355907294154255	13	1	0.00137741046831956	726	8202	836	CASP3
R-HSA-1660516	Synthesis of PIPs at the early endosome membrane	0.700537561152087	-0.355907294154255	13	1	0.00137741046831956	726	8202	8821	INPP4B
R-HSA-391160	Signal regulatory protein (SIRP) family interactions	0.700537561152087	-0.355907294154255	13	1	0.00137741046831956	726	8202	961	CD47
R-HSA-2564830	Cytosolic iron-sulfur cluster assembly	0.700537561152087	-0.355907294154255	13	1	0.00137741046831956	726	8202	64428	NARFL
R-HSA-1483213	Synthesis of PE	0.700537561152087	-0.355907294154255	13	1	0.00137741046831956	726	8202	1119	CHKA
R-HSA-180585	Vif-mediated degradation of APOBEC3G	0.702169632000807	-0.353580263120026	53	4	0.00550964187327824	726	8202	5720,7311,5721,60489	PSME1,UBA52,PSME2,APOBEC3G
R-HSA-76061	RNA Polymerase III Transcription Initiation From Type 1 Promoter	0.703877486158634	-0.351150963311111	27	2	0.00275482093663912	726	8202	27297,5441	CRCP,POLR2L
R-HSA-180024	DARPP-32 events	0.703877486158634	-0.351150963311111	27	2	0.00275482093663912	726	8202	5499,5142	PPP1CA,PDE4B
R-HSA-114508	Effects of PIP2 hydrolysis	0.703877486158634	-0.351150963311111	27	2	0.00275482093663912	726	8202	5588,1609	PRKCQ,DGKQ
R-HSA-2990846	SUMOylation	0.711417961974338	-0.340495171017427	79	6	0.00826446280991736	726	8202	1912,6612,672,55746,7508,5371	PHC2,SUMO3,BRCA1,NUP133,XPC,PML
R-HSA-174113	SCF-beta-TrCP mediated degradation of Emi1	0.716173995634536	-0.333832130881041	54	4	0.00550964187327824	726	8202	5720,7311,5721,991	PSME1,UBA52,PSME2,CDC20
R-HSA-4641257	Degradation of AXIN	0.716173995634536	-0.333832130881041	54	4	0.00550964187327824	726	8202	5720,7311,5721,8313	PSME1,UBA52,PSME2,AXIN2
R-HSA-442755	Activation of NMDA receptor upon glutamate binding and postsynaptic events	0.71623008713039	-0.333753812902813	41	3	0.00413223140495868	726	8202	817,5594,2905	CAMK2D,MAPK1,GRIN2C
R-HSA-5693567	HDR through Homologous Recombination (HR) or Single Strand Annealing (SSA)	0.71628143157625	-0.333682128388991	129	10	0.0137741046831956	726	8202	6118,5111,7311,63967,7158,197342,5531,672,5982,5429	RPA2,PCNA,UBA52,CLSPN,TP53BP1,EME2,PPP4C,BRCA1,RFC2,POLH
R-HSA-1266738	Developmental Biology	0.722612275533976	-0.324882472405728	710	59	0.081267217630854	726	8202	1948,2335,375790,2308,5721,389,5087,2064,54797,5720,4628,1947,2261,85441,286,6464,998,2905,28956,1291,11221,4637,389692,59277,6386,2051,7414,7074,6774,9353,9475,6709,4851,2254,1292,7311,5441,5468,51107,3312,8841,5588,214,51129,2260,388,1956,3667,817,2263,160,3912,688,3685,7026,5594,10371,1175,1272	EFNB2,FN1,AGRN,FOXO1,PSME2,RHOC,PBX1,ERBB2,MED18,PSME1,MYH10,EFNB1,FGFR3,HELZ2,ANK1,SHC1,CDC42,GRIN2C,LAMTOR2,COL6A1,DUSP10,MYL6,MAFA,NTN4,SDCBP,EPHB6,VCL,TIAM1,STAT3,SLIT2,ROCK2,SPTAN1,NOTCH1,FGF9,COL6A2,UBA52,POLR2L,PPARG,APH1A,HSPA8,HDAC3,PRKCQ,ALCAM,ANGPTL4,FGFR1,RHOB,EGFR,IRS1,CAMK2D,FGFR2,AP2A1,LAMB1,KLF5,ITGAV,NR2F2,MAPK1,SEMA3A,AP2S1,CNTN1
R-HSA-112314	Neurotransmitter Receptor Binding And Downstream Transmission In The  Postsynaptic Cell	0.722878637167824	-0.324513930985617	142	11	0.0151515151515152	726	8202	54331,817,4193,4905,2905,160,112,5594,1175,2783,5331	GNG2,CAMK2D,MDM2,NSF,GRIN2C,AP2A1,ADCY6,MAPK1,AP2S1,GNB2,PLCB3
R-HSA-2022854	Keratan sulfate biosynthesis	0.722906780296089	-0.324474999719707	28	2	0.00275482093663912	726	8202	6483,10678	ST3GAL2,B3GNT2
R-HSA-76071	RNA Polymerase III Transcription Initiation From Type 3 Promoter	0.722906780296089	-0.324474999719707	28	2	0.00275482093663912	726	8202	27297,5441	CRCP,POLR2L
R-HSA-917729	Endosomal Sorting Complex Required For Transport (ESCRT)	0.722906780296089	-0.324474999719707	28	2	0.00275482093663912	726	8202	155382,7311	VPS37D,UBA52
R-HSA-77075	RNA Pol II CTD phosphorylation and interaction with CE	0.722906780296089	-0.324474999719707	28	2	0.00275482093663912	726	8202	5441,6829	POLR2L,SUPT5H
R-HSA-167160	RNA Pol II CTD phosphorylation and interaction with CE	0.722906780296089	-0.324474999719707	28	2	0.00275482093663912	726	8202	6829,5441	SUPT5H,POLR2L
R-HSA-202040	G-protein activation	0.722906780296089	-0.324474999719707	28	2	0.00275482093663912	726	8202	54331,2783	GNG2,GNB2
R-HSA-1483166	Synthesis of PA	0.722906780296089	-0.324474999719707	28	2	0.00275482093663912	726	8202	57678,84803	GPAM,GPAT3
R-HSA-167044	Signalling to RAS	0.723953138571315	-0.323028614421449	239	19	0.0261707988980716	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,3667,817,2261,6464,2263,2905,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,FGFR2,GRIN2C,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-162594	Early Phase of HIV Life Cycle	0.727086557431592	-0.318709747419472	14	1	0.00137741046831956	726	8202	3978	LIG1
R-HSA-68884	Mitotic Telophase/Cytokinesis	0.727086557431592	-0.318709747419472	14	1	0.00137741046831956	726	8202	10112	KIF20A
R-HSA-77595	Processing of Intronless Pre-mRNAs	0.727086557431592	-0.318709747419472	14	1	0.00137741046831956	726	8202	10978	CLP1
R-HSA-428540	Activation of Rac	0.727086557431592	-0.318709747419472	14	1	0.00137741046831956	726	8202	9353	SLIT2
R-HSA-170670	Adenylate cyclase inhibitory pathway	0.727086557431592	-0.318709747419472	14	1	0.00137741046831956	726	8202	112	ADCY6
R-HSA-190322	FGFR4 ligand binding and activation	0.727086557431592	-0.318709747419472	14	1	0.00137741046831956	726	8202	2254	FGF9
R-HSA-399955	SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion	0.727086557431592	-0.318709747419472	14	1	0.00137741046831956	726	8202	10371	SEMA3A
R-HSA-997269	Inhibition of adenylate cyclase pathway	0.727086557431592	-0.318709747419472	14	1	0.00137741046831956	726	8202	112	ADCY6
R-HSA-418885	DCC mediated attractive signaling	0.727086557431592	-0.318709747419472	14	1	0.00137741046831956	726	8202	998	CDC42
R-HSA-5387390	Hh mutants abrogate ligand secretion	0.729688212610771	-0.315137942088095	55	4	0.00550964187327824	726	8202	5720,7311,5721,6400	PSME1,UBA52,PSME2,SEL1L
R-HSA-5362768	Hh mutants that don't undergo autocatalytic processing are degraded by ERAD	0.729688212610771	-0.315137942088095	55	4	0.00550964187327824	726	8202	5720,7311,5721,6400	PSME1,UBA52,PSME2,SEL1L
R-HSA-2151201	Transcriptional activation of mitochondrial biogenesis	0.731570819544604	-0.312561249066513	42	3	0.00413223140495868	726	8202	85441,8841,5442	HELZ2,HDAC3,POLRMT
R-HSA-5693579	Homologous DNA Pairing and Strand Exchange	0.731570819544604	-0.312561249066513	42	3	0.00413223140495868	726	8202	6118,672,5982	RPA2,BRCA1,RFC2
R-HSA-975634	Retinoid metabolism and transport	0.731570819544604	-0.312561249066513	42	3	0.00413223140495868	726	8202	26020,375790,9227	LRP10,AGRN,LRAT
R-HSA-381676	Glucagon-like Peptide-1 (GLP1) regulates insulin secretion	0.731570819544604	-0.312561249066513	42	3	0.00413223140495868	726	8202	54331,112,2783	GNG2,ADCY6,GNB2
R-HSA-5218921	VEGFR2 mediated cell proliferation	0.73712429645586	-0.30499874910539	241	19	0.0261707988980716	726	8202	2254,7311,2335,5721,2064,5720,2260,1956,3667,817,2261,6464,2263,2905,28956,11221,7414,5594,6709	FGF9,UBA52,FN1,PSME2,ERBB2,PSME1,FGFR1,EGFR,IRS1,CAMK2D,FGFR3,SHC1,FGFR2,GRIN2C,LAMTOR2,DUSP10,VCL,MAPK1,SPTAN1
R-HSA-390471	Association of TriC/CCT with target proteins during biosynthesis	0.740892945811064	-0.299899136712877	29	2	0.00275482093663912	726	8202	8237,84261	USP11,FBXW9
R-HSA-445095	Interaction between L1 and Ankyrins	0.740892945811064	-0.299899136712877	29	2	0.00275482093663912	726	8202	286,6709	ANK1,SPTAN1
R-HSA-73854	RNA Polymerase I Promoter Clearance	0.741992272881351	-0.298416449775516	107	8	0.0110192837465565	726	8202	54700,5441,9219,653604,3065,30834,64425,221830	RRN3,POLR2L,MTA2,HIST2H3D,HDAC1,ZNRD1,POLR1E,TWISTNB
R-HSA-73857	RNA Polymerase II Transcription	0.741992272881351	-0.298416449775516	107	8	0.0110192837465565	726	8202	6827,6427,5441,134353,6628,10978,6829,51616	SUPT4H1,SRSF2,POLR2L,LSM11,SNRPB,CLP1,SUPT5H,TAF9B
R-HSA-167246	Tat-mediated elongation of the HIV-1 transcript	0.746251392870742	-0.29269274778361	43	3	0.00413223140495868	726	8202	6827,6829,5441	SUPT4H1,SUPT5H,POLR2L
R-HSA-167200	Formation of HIV-1 elongation complex containing HIV-1 Tat	0.746251392870742	-0.29269274778361	43	3	0.00413223140495868	726	8202	6827,6829,5441	SUPT4H1,SUPT5H,POLR2L
R-HSA-167169	HIV Transcription Elongation	0.746251392870742	-0.29269274778361	43	3	0.00413223140495868	726	8202	6827,6829,5441	SUPT4H1,SUPT5H,POLR2L
R-HSA-72172	mRNA Splicing	0.746498378408886	-0.292361834263944	120	9	0.012396694214876	726	8202	6427,55599,5441,6628,3312,10978,1660,10421,83443	SRSF2,RNPC3,POLR2L,SNRPB,HSPA8,CLP1,DHX9,CD2BP2,SF3B5
R-HSA-504046	RNA Polymerase I, RNA Polymerase III, and Mitochondrial Transcription	0.747831899382902	-0.290577059709322	145	11	0.0151515151515152	726	8202	54700,5441,9219,27297,653604,3065,30834,4781,64425,221830,5442	RRN3,POLR2L,MTA2,CRCP,HIST2H3D,HDAC1,ZNRD1,NFIB,POLR1E,TWISTNB,POLRMT
R-HSA-354194	GRB2:SOS provides linkage to MAPK signaling for Integrins	0.751284793796454	-0.285970479667496	15	1	0.00137741046831956	726	8202	2335	FN1
R-HSA-211935	Fatty acids	0.751284793796454	-0.285970479667496	15	1	0.00137741046831956	726	8202	66002	CYP4F12
R-HSA-391903	Eicosanoid ligand-binding receptors	0.751284793796454	-0.285970479667496	15	1	0.00137741046831956	726	8202	5734	PTGER4
R-HSA-159418	Recycling of bile acids and salts	0.751284793796454	-0.285970479667496	15	1	0.00137741046831956	726	8202	8714	ABCC3
R-HSA-425393	Transport of inorganic cations/anions and amino acids/oligopeptides	0.757434113516503	-0.277818724237595	96	7	0.00964187327823691	726	8202	9497,26503,6560,115111,6505,10479,65010	SLC4A7,SLC17A5,SLC12A4,SLC26A7,SLC1A1,SLC9A6,SLC26A6
R-HSA-111996	Ca-dependent events	0.757871278028078	-0.277241725665369	30	2	0.00275482093663912	726	8202	112,5594	ADCY6,MAPK1
R-HSA-420092	Glucagon-type ligand receptors	0.757871278028078	-0.277241725665369	30	2	0.00275482093663912	726	8202	54331,2783	GNG2,GNB2
R-HSA-68962	Activation of the pre-replicative complex	0.757871278028078	-0.277241725665369	30	2	0.00275482093663912	726	8202	6118,81620	RPA2,CDT1
R-HSA-72086	mRNA Capping	0.757871278028078	-0.277241725665369	30	2	0.00275482093663912	726	8202	5441,6829	POLR2L,SUPT5H
R-HSA-5683826	Surfactant metabolism	0.757871278028078	-0.277241725665369	30	2	0.00275482093663912	726	8202	152,136	ADRA2C,ADORA2B
R-HSA-167152	Formation of HIV elongation complex in the absence of HIV Tat	0.760283731703999	-0.274063584183037	44	3	0.00413223140495868	726	8202	6827,6829,5441	SUPT4H1,SUPT5H,POLR2L
R-HSA-75955	RNA Polymerase II Transcription Elongation	0.760283731703999	-0.274063584183037	44	3	0.00413223140495868	726	8202	6827,5441,6829	SUPT4H1,POLR2L,SUPT5H
R-HSA-112382	Formation of RNA Pol II elongation complex	0.760283731703999	-0.274063584183037	44	3	0.00413223140495868	726	8202	6827,5441,6829	SUPT4H1,POLR2L,SUPT5H
R-HSA-382556	ABC-family proteins mediated transport	0.760283731703999	-0.274063584183037	44	3	0.00413223140495868	726	8202	8714,5825,5243	ABCC3,ABCD3,ABCB1
R-HSA-73864	RNA Polymerase I Transcription	0.760375326951645	-0.273943116353992	109	8	0.0110192837465565	726	8202	54700,5441,9219,653604,3065,30834,64425,221830	RRN3,POLR2L,MTA2,HIST2H3D,HDAC1,ZNRD1,POLR1E,TWISTNB
R-HSA-5693607	Processing of DNA double-strand break ends	0.766874573428524	-0.265432019763539	97	7	0.00964187327823691	726	8202	6118,672,7311,63967,7158,5982,5531	RPA2,BRCA1,UBA52,CLSPN,TP53BP1,RFC2,PPP4C
R-HSA-68827	CDT1 association with the CDC6:ORC:origin complex	0.767327578314518	-0.264841478421064	58	4	0.00550964187327824	726	8202	5720,7311,5721,81620	PSME1,UBA52,PSME2,CDT1
R-HSA-5676590	NIK-->noncanonical NF-kB signaling	0.767327578314518	-0.264841478421064	58	4	0.00550964187327824	726	8202	5720,7311,5721,9039	PSME1,UBA52,PSME2,UBA3
R-HSA-5693538	Homology Directed Repair	0.767412644779283	-0.264730623875687	135	10	0.0137741046831956	726	8202	6118,5111,7311,63967,7158,197342,5531,672,5982,5429	RPA2,PCNA,UBA52,CLSPN,TP53BP1,EME2,PPP4C,BRCA1,RFC2,POLH
R-HSA-2022377	Metabolism of Angiotensinogen to Angiotensins	0.773340154692159	-0.257036282306174	16	1	0.00137741046831956	726	8202	10159	ATP6AP2
R-HSA-937072	TRAF6 mediated induction of TAK1 complex	0.773340154692159	-0.257036282306174	16	1	0.00137741046831956	726	8202	7311	UBA52
R-HSA-399956	CRMPs in Sema3A signaling	0.773340154692159	-0.257036282306174	16	1	0.00137741046831956	726	8202	10371	SEMA3A
R-HSA-450321	JNK (c-Jun kinases) phosphorylation and  activation mediated by activated human TAK1	0.773340154692159	-0.257036282306174	16	1	0.00137741046831956	726	8202	3656	IRAK2
R-HSA-162710	Synthesis of glycosylphosphatidylinositol (GPI)	0.773340154692159	-0.257036282306174	16	1	0.00137741046831956	726	8202	9091	PIGQ
R-HSA-392517	Rap1 signalling	0.773340154692159	-0.257036282306174	16	1	0.00137741046831956	726	8202	6494	SIPA1
R-HSA-418038	Nucleotide-like (purinergic) receptors	0.773340154692159	-0.257036282306174	16	1	0.00137741046831956	726	8202	136	ADORA2B
R-HSA-163615	PKA activation	0.773340154692159	-0.257036282306174	16	1	0.00137741046831956	726	8202	112	ADCY6
R-HSA-399954	Sema3A PAK dependent Axon repulsion	0.773340154692159	-0.257036282306174	16	1	0.00137741046831956	726	8202	10371	SEMA3A
R-HSA-1369062	ABC transporters in lipid homeostasis	0.773340154692159	-0.257036282306174	16	1	0.00137741046831956	726	8202	5825	ABCD3
R-HSA-1296065	Inwardly rectifying K+ channels	0.773879002260951	-0.256339745441107	31	2	0.00275482093663912	726	8202	54331,2783	GNG2,GNB2
R-HSA-2129379	Molecules associated with elastic fibres	0.773879002260951	-0.256339745441107	31	2	0.00275482093663912	726	8202	650,3685	BMP2,ITGAV
R-HSA-168638	NOD1/2 Signaling Pathway	0.773879002260951	-0.256339745441107	31	2	0.00275482093663912	726	8202	837,3656	CASP4,IRAK2
R-HSA-1592389	Activation of Matrix Metalloproteinases	0.773879002260951	-0.256339745441107	31	2	0.00275482093663912	726	8202	7076,4325	TIMP1,MMP16
R-HSA-70171	Glycolysis	0.773879002260951	-0.256339745441107	31	2	0.00275482093663912	726	8202	5211,5223	PFKL,PGAM1
R-HSA-5357905	Regulation of TNFR1 signaling	0.773879002260951	-0.256339745441107	31	2	0.00275482093663912	726	8202	8737,7311	RIPK1,UBA52
R-HSA-68886	M Phase	0.776536289604292	-0.252911902644105	296	23	0.0316804407713499	726	8202	8615,7311,9184,10112,5721,991,54821,55143,5905,5720,6232,11004,891,983,4000,332,55746,653604,51434,9735,5594,11065,7112	USO1,UBA52,BUB3,KIF20A,PSME2,CDC20,ERCC6L,CDCA8,RANGAP1,PSME1,RPS27,KIF2C,CCNB1,CDK1,LMNA,BIRC5,NUP133,HIST2H3D,ANAPC7,KNTC1,MAPK1,UBE2C,TMPO
R-HSA-5607761	Dectin-1 mediated noncanonical NF-kB signaling	0.778925299019142	-0.24984013113803	59	4	0.00550964187327824	726	8202	5720,7311,5721,9039	PSME1,UBA52,PSME2,UBA3
R-HSA-5693532	DNA Double-Strand Break Repair	0.782227800614812	-0.245609275723898	162	12	0.0165289256198347	726	8202	6118,5111,7311,63967,7158,197342,5531,27343,3838,672,5982,5429	RPA2,PCNA,UBA52,CLSPN,TP53BP1,EME2,PPP4C,POLL,KPNA2,BRCA1,RFC2,POLH
R-HSA-112043	PLC beta mediated events	0.786459563680324	-0.240213970799364	46	3	0.00413223140495868	726	8202	112,5594,5331	ADCY6,MAPK1,PLCB3
R-HSA-5654227	Phospholipase C-mediated cascade; FGFR3	0.786459563680324	-0.240213970799364	46	3	0.00413223140495868	726	8202	112,2261,2254	ADCY6,FGFR3,FGF9
R-HSA-165054	Rev-mediated nuclear export of HIV RNA	0.788954656790435	-0.237046429001325	32	2	0.00275482093663912	726	8202	5905,55746	RANGAP1,NUP133
R-HSA-392518	Signal amplification	0.788954656790435	-0.237046429001325	32	2	0.00275482093663912	726	8202	54331,2783	GNG2,GNB2
R-HSA-376176	Signaling by Robo receptor	0.788954656790435	-0.237046429001325	32	2	0.00275482093663912	726	8202	998,9353	CDC42,SLIT2
R-HSA-111931	PKA-mediated phosphorylation of CREB	0.7934421639486	-0.231374628945426	17	1	0.00137741046831956	726	8202	112	ADCY6
R-HSA-450302	activated TAK1 mediates p38 MAPK activation	0.7934421639486	-0.231374628945426	17	1	0.00137741046831956	726	8202	3656	IRAK2
R-HSA-622312	Inflammasomes	0.7934421639486	-0.231374628945426	17	1	0.00137741046831956	726	8202	7295	TXN
R-HSA-450604	KSRP (KHSRP) binds and destabilizes mRNA	0.7934421639486	-0.231374628945426	17	1	0.00137741046831956	726	8202	54512	EXOSC4
R-HSA-164378	PKA activation in glucagon signalling	0.7934421639486	-0.231374628945426	17	1	0.00137741046831956	726	8202	112	ADCY6
R-HSA-1482801	Acyl chain remodelling of PS	0.7934421639486	-0.231374628945426	17	1	0.00137741046831956	726	8202	10162	LPCAT3
R-HSA-264642	Acetylcholine Neurotransmitter Release Cycle	0.7934421639486	-0.231374628945426	17	1	0.00137741046831956	726	8202	8541	PPFIA3
R-HSA-450513	Tristetraprolin (TTP, ZFP36) binds and destabilizes mRNA	0.7934421639486	-0.231374628945426	17	1	0.00137741046831956	726	8202	54512	EXOSC4
R-HSA-72163	mRNA Splicing - Major Pathway	0.79429986218774	-0.23029422884459	113	8	0.0110192837465565	726	8202	6427,5441,6628,3312,10978,1660,10421,83443	SRSF2,POLR2L,SNRPB,HSPA8,CLP1,DHX9,CD2BP2,SF3B5
R-HSA-112040	G-protein mediated events	0.798634282639479	-0.224852156850324	47	3	0.00413223140495868	726	8202	112,5594,5331	ADCY6,MAPK1,PLCB3
R-HSA-168643	Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways	0.798634282639479	-0.224852156850324	47	3	0.00413223140495868	726	8202	7295,837,3656	TXN,CASP4,IRAK2
R-HSA-421270	Cell-cell junction organization	0.800743201680319	-0.222214980469191	61	4	0.00550964187327824	726	8202	81607,50848,25945,5818	PVRL4,F11R,PVRL3,PVRL1
R-HSA-425407	SLC-mediated transmembrane transport	0.800808539183237	-0.222133387722249	264	20	0.0275482093663912	726	8202	30061,64924,29988,7355,6513,65010,9123,26503,6560,28232,6505,27173,126969,1317,115111,55746,10479,7922,9497,204962	SLC40A1,SLC30A5,SLC2A8,SLC35A2,SLC2A1,SLC26A6,SLC16A3,SLC17A5,SLC12A4,SLCO3A1,SLC1A1,SLC39A1,SLC44A3,SLC31A1,SLC26A7,NUP133,SLC9A6,SLC39A7,SLC4A7,SLC44A5
R-HSA-5693568	Resolution of D-loop Structures through Holliday Junction Intermediates	0.803137569707083	-0.219229260023882	33	2	0.00275482093663912	726	8202	672,197342	BRCA1,EME2
R-HSA-72187	mRNA 3'-end processing	0.803137569707083	-0.219229260023882	33	2	0.00275482093663912	726	8202	6427,10978	SRSF2,CLP1
R-HSA-1221632	Meiotic synapsis	0.805522907632255	-0.216263637747448	75	5	0.0068870523415978	726	8202	672,3306,23224,4000,7014	BRCA1,HSPA2,SYNE2,LMNA,TERF2
R-HSA-181430	Norepinephrine Neurotransmitter Release Cycle	0.811763604255912	-0.208546108970029	18	1	0.00137741046831956	726	8202	8541	PPFIA3
R-HSA-209776	Amine-derived hormones	0.811763604255912	-0.208546108970029	18	1	0.00137741046831956	726	8202	53905	DUOX1
R-HSA-181429	Serotonin Neurotransmitter Release Cycle	0.811763604255912	-0.208546108970029	18	1	0.00137741046831956	726	8202	8541	PPFIA3
R-HSA-177243	Interactions of Rev with host cellular proteins	0.816467417929086	-0.202768271924976	34	2	0.00275482093663912	726	8202	5905,55746	RANGAP1,NUP133
R-HSA-5693537	Resolution of D-Loop Structures	0.816467417929086	-0.202768271924976	34	2	0.00275482093663912	726	8202	672,197342	BRCA1,EME2
R-HSA-176033	Interactions of Vpr with host cellular proteins	0.816467417929086	-0.202768271924976	34	2	0.00275482093663912	726	8202	292,55746	SLC25A5,NUP133
R-HSA-211733	Regulation of activated PAK-2p34 by proteasome mediated degradation	0.821242861984474	-0.19693640086861	49	3	0.00413223140495868	726	8202	5720,7311,5721	PSME1,UBA52,PSME2
R-HSA-5654219	Phospholipase C-mediated cascade: FGFR1	0.821242861984474	-0.19693640086861	49	3	0.00413223140495868	726	8202	112,2254,2260	ADCY6,FGF9,FGFR1
R-HSA-2871837	FCERI mediated NF-kB activation	0.823523139067758	-0.194163631316259	77	5	0.0068870523415978	726	8202	5588,5720,7311,5721,4792	PRKCQ,PSME1,UBA52,PSME2,NFKBIA
R-HSA-427413	NoRC negatively regulates rRNA expression	0.82551163298068	-0.191751923679235	104	7	0.00964187327823691	726	8202	3065,653604,5441,30834,64425,221830,64426	HDAC1,HIST2H3D,POLR2L,ZNRD1,POLR1E,TWISTNB,SUDS3
R-HSA-3000480	Scavenging by Class A Receptors	0.828461994196347	-0.188184316195665	19	1	0.00137741046831956	726	8202	2495	FTH1
R-HSA-76046	RNA Polymerase III Transcription Initiation	0.828983857781523	-0.187554595952558	35	2	0.00275482093663912	726	8202	27297,5441	CRCP,POLR2L
R-HSA-5358346	Hedgehog ligand biogenesis	0.830168062394573	-0.186127113876037	64	4	0.00550964187327824	726	8202	5720,7311,5721,6400	PSME1,UBA52,PSME2,SEL1L
R-HSA-913709	O-linked glycosylation of mucins	0.830168062394573	-0.186127113876037	64	4	0.00550964187327824	726	8202	6483,55568,10678,10610	ST3GAL2,GALNT10,B3GNT2,ST6GALNAC2
R-HSA-1650814	Collagen biosynthesis and modifying enzymes	0.830168062394573	-0.186127113876037	64	4	0.00550964187327824	726	8202	1308,64175,1292,1291	COL17A1,P3H1,COL6A2,COL6A1
R-HSA-69017	CDK-mediated phosphorylation and removal of Cdc6	0.831713076472883	-0.18426775764737	50	3	0.00413223140495868	726	8202	5720,7311,5721	PSME1,UBA52,PSME2
R-HSA-169911	Regulation of Apoptosis	0.831713076472883	-0.18426775764737	50	3	0.00413223140495868	726	8202	5720,7311,5721	PSME1,UBA52,PSME2
R-HSA-191859	snRNP Assembly	0.831713076472883	-0.18426775764737	50	3	0.00413223140495868	726	8202	79084,55746,6628	WDR77,NUP133,SNRPB
R-HSA-194441	Metabolism of non-coding RNA	0.831713076472883	-0.18426775764737	50	3	0.00413223140495868	726	8202	79084,55746,6628	WDR77,NUP133,SNRPB
R-HSA-157579	Telomere Maintenance	0.832005988428767	-0.183915640556102	78	5	0.0068870523415978	726	8202	3978,6118,5111,5982,7014	LIG1,RPA2,PCNA,RFC2,TERF2
R-HSA-674695	RNA Polymerase II Pre-transcription Events	0.839137889954907	-0.175380235655555	65	4	0.00550964187327824	726	8202	6827,5441,6829,51616	SUPT4H1,POLR2L,SUPT5H,TAF9B
R-HSA-196071	Metabolism of steroid hormones and vitamin D	0.84072621820718	-0.173489215164229	36	2	0.00275482093663912	726	8202	1591,2232	CYP24A1,FDXR
R-HSA-983695	Antigen activates B Cell Receptor (BCR) leading to generation of second messengers	0.84072621820718	-0.173489215164229	36	2	0.00275482093663912	726	8202	6464,5295	SHC1,PIK3R1
R-HSA-212718	EGFR interacts with phospholipase C-gamma	0.84072621820718	-0.173489215164229	36	2	0.00275482093663912	726	8202	112,1956	ADCY6,EGFR
R-HSA-383280	Nuclear Receptor transcription pathway	0.841652255919667	-0.172388347766968	51	3	0.00413223140495868	726	8202	5468,29959,7025	PPARG,NRBP1,NR2F1
R-HSA-180534	Vpu mediated degradation of CD4	0.841652255919667	-0.172388347766968	51	3	0.00413223140495868	726	8202	5720,7311,5721	PSME1,UBA52,PSME2
R-HSA-349425	Autodegradation of the E3 ubiquitin ligase COP1	0.841652255919667	-0.172388347766968	51	3	0.00413223140495868	726	8202	5720,7311,5721	PSME1,UBA52,PSME2
R-HSA-5654221	Phospholipase C-mediated cascade; FGFR2	0.841652255919667	-0.172388347766968	51	3	0.00413223140495868	726	8202	112,2254,2263	ADCY6,FGF9,FGFR2
R-HSA-163560	Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis	0.843680934955948	-0.169980895012715	20	1	0.00137741046831956	726	8202	5499	PPP1CA
R-HSA-5250941	Negative epigenetic regulation of rRNA expression	0.846815910247716	-0.166271951225617	107	7	0.00964187327823691	726	8202	3065,653604,5441,30834,64425,221830,64426	HDAC1,HIST2H3D,POLR2L,ZNRD1,POLR1E,TWISTNB,SUDS3
R-HSA-1169091	Activation of NF-kappaB in B cells	0.847707333067483	-0.165219828859619	66	4	0.00550964187327824	726	8202	5720,7311,5721,4792	PSME1,UBA52,PSME2,NFKBIA
R-HSA-1268020	Mitochondrial protein import	0.851079519066063	-0.161249712863418	52	3	0.00413223140495868	726	8202	516,9868,25813	ATP5G1,TOMM70A,SAMM50
R-HSA-69613	p53-Independent G1/S DNA damage checkpoint	0.851079519066063	-0.161249712863418	52	3	0.00413223140495868	726	8202	5720,7311,5721	PSME1,UBA52,PSME2
R-HSA-69601	Ubiquitin Mediated Degradation of Phosphorylated Cdc25A	0.851079519066063	-0.161249712863418	52	3	0.00413223140495868	726	8202	5720,7311,5721	PSME1,UBA52,PSME2
R-HSA-69610	p53-Independent DNA Damage Response	0.851079519066063	-0.161249712863418	52	3	0.00413223140495868	726	8202	5720,7311,5721	PSME1,UBA52,PSME2
R-HSA-195253	Degradation of beta-catenin by the destruction complex	0.855475885184347	-0.156097374025732	81	5	0.0068870523415978	726	8202	3065,7088,5720,7311,5721	HDAC1,TLE1,PSME1,UBA52,PSME2
R-HSA-68867	Assembly of the pre-replicative complex	0.855888167982951	-0.155615556254911	67	4	0.00550964187327824	726	8202	5720,7311,5721,81620	PSME1,UBA52,PSME2,CDT1
R-HSA-167172	Transcription of the HIV genome	0.855888167982951	-0.155615556254911	67	4	0.00550964187327824	726	8202	6827,6829,5441,51616	SUPT4H1,SUPT5H,POLR2L,TAF9B
R-HSA-202427	Phosphorylation of CD3 and TCR zeta chains	0.857551338454794	-0.153674231816047	21	1	0.00137741046831956	726	8202	55824	PAG1
R-HSA-2024096	HS-GAG degradation	0.857551338454794	-0.153674231816047	21	1	0.00137741046831956	726	8202	375790	AGRN
R-HSA-156588	Glucuronidation	0.857551338454794	-0.153674231816047	21	1	0.00137741046831956	726	8202	7358	UGDH
R-HSA-196741	Cobalamin (Cbl, vitamin B12) transport and metabolism	0.857551338454794	-0.153674231816047	21	1	0.00137741046831956	726	8202	55788	LMBRD1
R-HSA-425397	Transport of vitamins, nucleosides, and related molecules	0.86204291186862	-0.148450227807375	38	2	0.00275482093663912	726	8202	28232,7355	SLCO3A1,SLC35A2
R-HSA-166658	Complement cascade	0.86204291186862	-0.148450227807375	38	2	0.00275482093663912	726	8202	4179,5627	CD46,PROS1
R-HSA-68874	M/G1 Transition	0.862666420846934	-0.147727196982818	82	5	0.0068870523415978	726	8202	6118,5720,7311,5721,81620	RPA2,PSME1,UBA52,PSME2,CDT1
R-HSA-69002	DNA Replication Pre-Initiation	0.862666420846934	-0.147727196982818	82	5	0.0068870523415978	726	8202	6118,5720,7311,5721,81620	RPA2,PSME1,UBA52,PSME2,CDT1
R-HSA-388841	Costimulation by the CD28 family	0.863692377123331	-0.146538618573295	68	4	0.00550964187327824	726	8202	998,1326,5295,5290	CDC42,MAP3K8,PIK3R1,PIK3CA
R-HSA-212165	Epigenetic regulation of gene expression	0.868965343606765	-0.140452035286728	124	8	0.0110192837465565	726	8202	5441,64426,653604,3065,30834,64425,8726,221830	POLR2L,SUDS3,HIST2H3D,HDAC1,ZNRD1,POLR1E,EED,TWISTNB
R-HSA-140837	Intrinsic Pathway of Fibrin Clot Formation	0.870192547125245	-0.139040773286078	22	1	0.00137741046831956	726	8202	5547	PRCP
R-HSA-975576	N-glycan antennae elongation in the medial/trans-Golgi	0.870192547125245	-0.139040773286078	22	1	0.00137741046831956	726	8202	2517	FUCA1
R-HSA-2187338	Visual phototransduction	0.876237482418752	-0.132118126134802	98	6	0.00826446280991736	726	8202	26020,5588,375790,9249,9227,157506	LRP10,PRKCQ,AGRN,DHRS3,LRAT,RDH10
R-HSA-977443	GABA receptor activation	0.876482242735588	-0.131838834112336	55	3	0.00413223140495868	726	8202	112,54331,2783	ADCY6,GNG2,GNB2
R-HSA-2173782	Binding and Uptake of Ligands by Scavenger Receptors	0.880717116201657	-0.127018798589896	40	2	0.00275482093663912	726	8202	2495,10808	FTH1,HSPH1
R-HSA-72203	Processing of Capped Intron-Containing Pre-mRNA	0.880890532269107	-0.12682191471719	153	10	0.0137741046831956	726	8202	6427,55599,5441,55746,6628,3312,10978,1660,10421,83443	SRSF2,RNPC3,POLR2L,NUP133,SNRPB,HSPA8,CLP1,DHX9,CD2BP2,SF3B5
R-HSA-429947	Deadenylation of mRNA	0.88171335529477	-0.125888269794199	23	1	0.00137741046831956	726	8202	85456	TNKS1BP1
R-HSA-1482839	Acyl chain remodelling of PE	0.88171335529477	-0.125888269794199	23	1	0.00137741046831956	726	8202	10162	LPCAT3
R-HSA-203927	MicroRNA (miRNA) biogenesis	0.88171335529477	-0.125888269794199	23	1	0.00137741046831956	726	8202	5441	POLR2L
R-HSA-212676	Dopamine Neurotransmitter Release Cycle	0.88171335529477	-0.125888269794199	23	1	0.00137741046831956	726	8202	8541	PPFIA3
R-HSA-2142691	Synthesis of Leukotrienes (LT) and Eoxins (EX)	0.88171335529477	-0.125888269794199	23	1	0.00137741046831956	726	8202	4048	LTA4H
R-HSA-2672351	Stimuli-sensing channels	0.882127228703566	-0.125418983147609	99	6	0.00826446280991736	726	8202	6262,6446,6337,7311,26133,6717	RYR2,SGK1,SCNN1A,UBA52,TRPC4AP,SRI
R-HSA-5610787	Hedgehog 'off' state	0.882127228703566	-0.125418983147609	99	6	0.00826446280991736	726	8202	112,5720,79659,7311,51098,5721	ADCY6,PSME1,DYNC2H1,UBA52,IFT52,PSME2
R-HSA-162587	HIV Life Cycle	0.882549837127676	-0.124940019103285	140	9	0.012396694214876	726	8202	155382,6827,7311,5441,55746,3978,5905,6829,51616	VPS37D,SUPT4H1,UBA52,POLR2L,NUP133,LIG1,RANGAP1,SUPT5H,TAF9B
R-HSA-4641258	Degradation of DVL	0.88405395367743	-0.123237184635213	56	3	0.00413223140495868	726	8202	5720,7311,5721	PSME1,UBA52,PSME2
R-HSA-162599	Late Phase of HIV Life Cycle	0.88498616433914	-0.122183267611508	127	8	0.0110192837465565	726	8202	155382,6827,7311,5441,55746,5905,6829,51616	VPS37D,SUPT4H1,UBA52,POLR2L,NUP133,RANGAP1,SUPT5H,TAF9B
R-HSA-168325	Viral Messenger RNA Synthesis	0.889152348452933	-0.117486687562268	41	2	0.00275482093663912	726	8202	5441,55746	POLR2L,NUP133
R-HSA-75893	TNF signaling	0.889152348452933	-0.117486687562268	41	2	0.00275482093663912	726	8202	8737,7311	RIPK1,UBA52
R-HSA-70153	Glucose transport	0.889152348452933	-0.117486687562268	41	2	0.00275482093663912	726	8202	55746,6513	NUP133,SLC2A1
R-HSA-5602358	Diseases associated with the TLR signaling cascade	0.892212940079765	-0.114050452829188	24	1	0.00137741046831956	726	8202	4792	NFKBIA
R-HSA-379716	Cytosolic tRNA aminoacylation	0.892212940079765	-0.114050452829188	24	1	0.00137741046831956	726	8202	5859	QARS
R-HSA-5260271	Diseases of Immune System	0.892212940079765	-0.114050452829188	24	1	0.00137741046831956	726	8202	4792	NFKBIA
R-HSA-1500620	Meiosis	0.893521392353697	-0.112585002471505	115	7	0.00964187327823691	726	8202	6118,653604,672,3306,23224,4000,7014	RPA2,HIST2H3D,BRCA1,HSPA2,SYNE2,LMNA,TERF2
R-HSA-73777	RNA Polymerase I Chain Elongation	0.899760250348385	-0.105626939647341	88	5	0.0068870523415978	726	8202	653604,5441,30834,64425,221830	HIST2H3D,POLR2L,ZNRD1,POLR1E,TWISTNB
R-HSA-1482788	Acyl chain remodelling of PC	0.901781710637177	-0.103382794153158	25	1	0.00137741046831956	726	8202	10162	LPCAT3
R-HSA-380994	ATF4 activates genes	0.901781710637177	-0.103382794153158	25	1	0.00137741046831956	726	8202	54512	EXOSC4
R-HSA-3295583	TRP channels	0.901781710637177	-0.103382794153158	25	1	0.00137741046831956	726	8202	26133	TRPC4AP
R-HSA-112316	Neuronal System	0.903700279132269	-0.101257523197138	289	20	0.0275482093663912	726	8202	80331,3312,8541,2783,6505,2752,5331,54331,817,7915,27345,4193,2905,4905,3783,160,10550,112,5594,1175	DNAJC5,HSPA8,PPFIA3,GNB2,SLC1A1,GLUL,PLCB3,GNG2,CAMK2D,ALDH5A1,KCNMB4,MDM2,GRIN2C,NSF,KCNN4,AP2A1,ARL6IP5,ADCY6,MAPK1,AP2S1
R-HSA-5610785	GLI3 is processed to GLI3R by the proteasome	0.904343557354909	-0.10054594946557	59	3	0.00413223140495868	726	8202	5720,7311,5721	PSME1,UBA52,PSME2
R-HSA-5610780	Degradation of GLI1 by the proteasome	0.904343557354909	-0.10054594946557	59	3	0.00413223140495868	726	8202	5720,7311,5721	PSME1,UBA52,PSME2
R-HSA-5610783	Degradation of GLI2 by the proteasome	0.904343557354909	-0.10054594946557	59	3	0.00413223140495868	726	8202	5720,7311,5721	PSME1,UBA52,PSME2
R-HSA-3214858	RMTs methylate histone arginines	0.908797757078758	-0.0956326990214232	75	4	0.00550964187327824	726	8202	653604,595,79084,6603	HIST2H3D,CCND1,WDR77,SMARCD2
R-HSA-5693606	DNA Double Strand Break Response	0.908797757078758	-0.0956326990214232	75	4	0.00550964187327824	726	8202	3838,672,7311,7158	KPNA2,BRCA1,UBA52,TP53BP1
R-HSA-5693554	Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA)	0.910502082175058	-0.0937590929691392	26	1	0.00137741046831956	726	8202	672	BRCA1
R-HSA-5357956	TNFR1-induced NFkappaB signaling pathway	0.910502082175058	-0.0937590929691392	26	1	0.00137741046831956	726	8202	8737	RIPK1
R-HSA-73886	Chromosome Maintenance	0.912703704111564	-0.0913439810567114	105	6	0.00826446280991736	726	8202	3978,6118,5111,55355,5982,7014	LIG1,RPA2,PCNA,HJURP,RFC2,TERF2
R-HSA-5668914	Diseases of metabolism	0.917647058992828	-0.0859424296162328	45	2	0.00275482093663912	726	8202	7311,2232	UBA52,FDXR
R-HSA-193648	NRAGE signals death through JNK	0.917647058992828	-0.0859424296162328	45	2	0.00275482093663912	726	8202	572,7074	BAD,TIAM1
R-HSA-2559586	DNA Damage/Telomere Stress Induced Senescence	0.918984567061129	-0.0844859499544767	77	4	0.00550964187327824	726	8202	9134,1027,1026,7014	CCNE2,CDKN1B,CDKN1A,TERF2
R-HSA-68875	Mitotic Prophase	0.923576837392598	-0.0795012804297418	136	8	0.0110192837465565	726	8202	8615,55746,653604,891,5594,983,4000,7112	USO1,NUP133,HIST2H3D,CCNB1,MAPK1,CDK1,LMNA,TMPO
R-HSA-73779	RNA Polymerase II Transcription Pre-Initiation And Promoter Opening	0.923610126964834	-0.0794652368966479	46	2	0.00275482093663912	726	8202	5441,51616	POLR2L,TAF9B
R-HSA-73776	RNA Polymerase II Promoter Escape	0.923610126964834	-0.0794652368966479	46	2	0.00275482093663912	726	8202	5441,51616	POLR2L,TAF9B
R-HSA-167161	HIV Transcription Initiation	0.923610126964834	-0.0794652368966479	46	2	0.00275482093663912	726	8202	5441,51616	POLR2L,TAF9B
R-HSA-76042	RNA Polymerase II Transcription Initiation And Promoter Clearance	0.923610126964834	-0.0794652368966479	46	2	0.00275482093663912	726	8202	5441,51616	POLR2L,TAF9B
R-HSA-75953	RNA Polymerase II Transcription Initiation	0.923610126964834	-0.0794652368966479	46	2	0.00275482093663912	726	8202	5441,51616	POLR2L,TAF9B
R-HSA-167162	RNA Polymerase II HIV Promoter Escape	0.923610126964834	-0.0794652368966479	46	2	0.00275482093663912	726	8202	5441,51616	POLR2L,TAF9B
R-HSA-111933	Calmodulin induced events	0.925691493202875	-0.0772142605343488	28	1	0.00137741046831956	726	8202	112	ADCY6
R-HSA-381042	PERK regulates gene expression	0.925691493202875	-0.0772142605343488	28	1	0.00137741046831956	726	8202	54512	EXOSC4
R-HSA-111997	CaM pathway	0.925691493202875	-0.0772142605343488	28	1	0.00137741046831956	726	8202	112	ADCY6
R-HSA-3214815	HDACs deacetylate histones	0.927835749121843	-0.0749005563420805	94	5	0.0068870523415978	726	8202	3065,653604,9219,8841,64426	HDAC1,HIST2H3D,MTA2,HDAC3,SUDS3
R-HSA-189200	Hexose transport	0.92916460893495	-0.0734693664834817	47	2	0.00275482093663912	726	8202	55746,6513	NUP133,SLC2A1
R-HSA-168333	NEP/NS2 Interacts with the Cellular Export Machinery	0.932291441332686	-0.0701098078860743	29	1	0.00137741046831956	726	8202	55746	NUP133
R-HSA-375170	CDO in myogenesis	0.932291441332686	-0.0701098078860743	29	1	0.00137741046831956	726	8202	998	CDC42
R-HSA-170822	Regulation of Glucokinase by Glucokinase Regulatory Protein	0.932291441332686	-0.0701098078860743	29	1	0.00137741046831956	726	8202	55746	NUP133
R-HSA-5601884	PIWI-interacting RNA (piRNA) biogenesis	0.932291441332686	-0.0701098078860743	29	1	0.00137741046831956	726	8202	5441	POLR2L
R-HSA-168271	Transport of Ribonucleoproteins into the Host Nucleus	0.932291441332686	-0.0701098078860743	29	1	0.00137741046831956	726	8202	55746	NUP133
R-HSA-525793	Myogenesis	0.932291441332686	-0.0701098078860743	29	1	0.00137741046831956	726	8202	998	CDC42
R-HSA-195721	Signaling by Wnt	0.932884226782581	-0.06947417288398	326	22	0.0303030303030303	726	8202	7311,55366,8322,5721,79971,6662,23513,54894,5720,2783,8324,5331,54331,160,8313,7088,653604,3065,51384,7855,4343,1175	UBA52,LGR4,FZD4,PSME2,WLS,SOX9,SCRIB,RNF43,PSME1,GNB2,FZD7,PLCB3,GNG2,AP2A1,AXIN2,TLE1,HIST2H3D,HDAC1,WNT16,FZD5,MOV10,AP2S1
R-HSA-5654228	Phospholipase C-mediated cascade; FGFR4	0.934335994074599	-0.0679191687464532	48	2	0.00275482093663912	726	8202	112,2254	ADCY6,FGF9
R-HSA-2871809	FCERI mediated Ca+2 mobilization	0.938305929714484	-0.0636792320700754	30	1	0.00137741046831956	726	8202	6464	SHC1
R-HSA-420029	Tight junction interactions	0.938305929714484	-0.0636792320700754	30	1	0.00137741046831956	726	8202	50848	F11R
R-HSA-1236978	Cross-presentation of soluble exogenous antigens (endosomes)	0.939148467778991	-0.0627816996216792	49	2	0.00275482093663912	726	8202	5720,5721	PSME1,PSME2
R-HSA-159236	Transport of Mature mRNA derived from an Intron-Containing Transcript	0.943624942433905	-0.0580264985276172	50	2	0.00275482093663912	726	8202	6427,55746	SRSF2,NUP133
R-HSA-5658442	Regulation of RAS by GAPs	0.943699013680662	-0.0579480051173519	67	3	0.00413223140495868	726	8202	5720,7311,5721	PSME1,UBA52,PSME2
R-HSA-4641262	Disassembly of the destruction complex and recruitment of AXIN to the membrane	0.94378682729012	-0.0578549568860857	31	1	0.00137741046831956	726	8202	7855	FZD5
R-HSA-2022928	HS-GAG biosynthesis	0.94378682729012	-0.0578549568860857	31	1	0.00137741046831956	726	8202	375790	AGRN
R-HSA-180746	Nuclear import of Rev protein	0.94378682729012	-0.0578549568860857	31	1	0.00137741046831956	726	8202	55746	NUP133
R-HSA-180910	Vpr-mediated nuclear import of PICs	0.94378682729012	-0.0578549568860857	31	1	0.00137741046831956	726	8202	55746	NUP133
R-HSA-5607764	CLEC7A (Dectin-1) signaling	0.94564591866468	-0.0558870731617296	99	5	0.0068870523415978	726	8202	5720,7311,5721,9039,4792	PSME1,UBA52,PSME2,UBA3,NFKBIA
R-HSA-5693571	Nonhomologous End-Joining (NHEJ)	0.947391627664986	-0.0540427257016988	68	3	0.00413223140495868	726	8202	672,7158,27343	BRCA1,TP53BP1,POLL
R-HSA-881907	Gastrin-CREB signalling pathway via PKC and MAPK	0.947744971169795	-0.0536698306722624	424	29	0.0399449035812672	726	8202	2254,7311,2335,5721,1609,5295,2064,5588,5720,5997,2783,2260,1956,5331,301,54331,3667,2261,817,6464,2905,2263,28956,5290,11221,5594,7414,2149,6709	FGF9,UBA52,FN1,PSME2,DGKQ,PIK3R1,ERBB2,PRKCQ,PSME1,RGS2,GNB2,FGFR1,EGFR,PLCB3,ANXA1,GNG2,IRS1,FGFR3,CAMK2D,SHC1,GRIN2C,FGFR2,LAMTOR2,PIK3CA,DUSP10,MAPK1,VCL,F2R,SPTAN1
R-HSA-159227	Transport of the SLBP independent Mature mRNA	0.948781413435343	-0.0525768404801496	32	1	0.00137741046831956	726	8202	55746	NUP133
R-HSA-159230	Transport of the SLBP Dependant Mature mRNA	0.953332783550217	-0.0477912405320917	33	1	0.00137741046831956	726	8202	55746	NUP133
R-HSA-201722	Formation of the beta-catenin:TCF transactivating complex	0.956135404532734	-0.0448557394197266	87	4	0.00550964187327824	726	8202	3065,653604,7088,8313	HDAC1,HIST2H3D,TLE1,AXIN2
R-HSA-2299718	Condensation of Prophase Chromosomes	0.957160895258759	-0.0437837770432396	71	3	0.00413223140495868	726	8202	653604,891,983	HIST2H3D,CCNB1,CDK1
R-HSA-390522	Striated Muscle Contraction	0.957480218882998	-0.0434502172707674	34	1	0.00137741046831956	726	8202	7431	VIM
R-HSA-1489509	DAG and IP3 signaling	0.957480218882998	-0.0434502172707674	34	1	0.00137741046831956	726	8202	112	ADCY6
R-HSA-2514859	Inactivation, recovery and regulation of the phototransduction cascade	0.957480218882998	-0.0434502172707674	34	1	0.00137741046831956	726	8202	5588	PRKCQ
R-HSA-1638091	Heparan sulfate/heparin (HS-GAG) metabolism	0.958586628441415	-0.0422953414031182	54	2	0.00275482093663912	726	8202	375790,1462	AGRN,VCAN
R-HSA-6781823	Formation of TC-NER Pre-Incision Complex	0.958586628441415	-0.0422953414031182	54	2	0.00275482093663912	726	8202	7311,5441	UBA52,POLR2L
R-HSA-72202	Transport of Mature Transcript to Cytoplasm	0.958586628441415	-0.0422953414031182	54	2	0.00275482093663912	726	8202	6427,55746	SRSF2,NUP133
R-HSA-5358351	Signaling by Hedgehog	0.96088860057861	-0.0398967970447451	135	7	0.00964187327823691	726	8202	112,5720,79659,7311,51098,5721,6400	ADCY6,PSME1,DYNC2H1,UBA52,IFT52,PSME2,SEL1L
R-HSA-2514856	The phototransduction cascade	0.961259523624596	-0.0395108506695205	35	1	0.00137741046831956	726	8202	5588	PRKCQ
R-HSA-194068	Bile acid and bile salt metabolism	0.961259523624596	-0.0395108506695205	35	1	0.00137741046831956	726	8202	8714	ABCC3
R-HSA-159231	Transport of Mature mRNA Derived from an Intronless Transcript	0.961259523624596	-0.0395108506695205	35	1	0.00137741046831956	726	8202	55746	NUP133
R-HSA-167021	PLC-gamma1 signalling	0.964703332330665	-0.0359346525453311	36	1	0.00137741046831956	726	8202	112	ADCY6
R-HSA-159234	Transport of Mature mRNAs Derived from Intronless Transcripts	0.964703332330665	-0.0359346525453311	36	1	0.00137741046831956	726	8202	55746	NUP133
R-HSA-5693565	Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks	0.965210869850216	-0.0354086835352286	74	3	0.00413223140495868	726	8202	672,7311,7158	BRCA1,UBA52,TP53BP1
R-HSA-983712	Ion channel transport	0.969316496853036	-0.0311640982814139	198	11	0.0151515151515152	726	8202	6337,7311,10312,523,6717,6262,6446,526,9114,57205,26133	SCNN1A,UBA52,TCIRG1,ATP6V1A,SRI,RYR2,SGK1,ATP6V1B2,ATP6V0D1,ATP10D,TRPC4AP
R-HSA-1442490	Collagen degradation	0.970700808574881	-0.029736985283072	38	1	0.00137741046831956	726	8202	1308	COL17A1
R-HSA-73923	Lipid digestion, mobilization, and transport	0.974119664294732	-0.0262211242672828	60	2	0.00275482093663912	726	8202	91289,5499	LMF2,PPP1CA
R-HSA-5668541	TNFR2 non-canonical NF-kB pathway	0.975412616947403	-0.0248947006376973	96	4	0.00550964187327824	726	8202	5720,7311,5721,9039	PSME1,UBA52,PSME2,UBA3
R-HSA-1251985	Nuclear signaling by ERBB4	0.975680379239466	-0.0246202264898554	40	1	0.00137741046831956	726	8202	51107	APH1A
R-HSA-416476	G alpha (q) signalling events	0.977474557112607	-0.0227830159906663	190	10	0.0137741046831956	726	8202	54331,1609,5295,5290,5588,5997,2149,2783,5331,301	GNG2,DGKQ,PIK3R1,PIK3CA,PRKCQ,RGS2,F2R,GNB2,PLCB3,ANXA1
R-HSA-375280	Amine ligand-binding receptors	0.979814608180853	-0.0203919005390886	42	1	0.00137741046831956	726	8202	152	ADRA2C
R-HSA-1296071	Potassium Channels	0.979826919487557	-0.0203793356831901	99	4	0.00550964187327824	726	8202	54331,27345,3783,2783	GNG2,KCNMB4,KCNN4,GNB2
R-HSA-3214841	PKMTs methylate histone lysines	0.981165397109655	-0.019014233108718	64	2	0.00275482093663912	726	8202	653604,8726	HIST2H3D,EED
R-HSA-382551	Transmembrane transport of small molecules	0.981268194461619	-0.0189094679309309	586	39	0.0537190082644628	726	8202	64924,523,29988,6513,9123,2495,6560,526,28232,6505,2783,27173,1317,6337,5825,55746,7922,6717,6446,112,9114,204962,30061,7311,7355,65010,6262,360,26503,57205,126969,54331,10312,115111,10479,5243,9497,8714,26133	SLC30A5,ATP6V1A,SLC2A8,SLC2A1,SLC16A3,FTH1,SLC12A4,ATP6V1B2,SLCO3A1,SLC1A1,GNB2,SLC39A1,SLC31A1,SCNN1A,ABCD3,NUP133,SLC39A7,SRI,SGK1,ADCY6,ATP6V0D1,SLC44A5,SLC40A1,UBA52,SLC35A2,SLC26A6,RYR2,AQP3,SLC17A5,ATP10D,SLC44A3,GNG2,TCIRG1,SLC26A7,SLC9A6,ABCB1,SLC4A7,ABCC3,TRPC4AP
R-HSA-912446	Meiotic recombination	0.982919393678095	-0.0172281625246537	84	3	0.00413223140495868	726	8202	6118,653604,672	RPA2,HIST2H3D,BRCA1
R-HSA-5632684	Hedgehog 'on' state	0.982919393678095	-0.0172281625246537	84	3	0.00413223140495868	726	8202	5720,7311,5721	PSME1,UBA52,PSME2
R-HSA-5173105	O-linked glycosylation	0.984559381792873	-0.0155610660201861	103	4	0.00550964187327824	726	8202	6483,55568,10678,10610	ST3GAL2,GALNT10,B3GNT2,ST6GALNAC2
R-HSA-201681	TCF dependent signaling in response to WNT	0.986043486260471	-0.0140548216395963	229	12	0.0165289256198347	726	8202	7311,55366,8322,5721,6662,8313,3065,653604,7088,5720,54894,7855	UBA52,LGR4,FZD4,PSME2,SOX9,AXIN2,HDAC1,HIST2H3D,TLE1,PSME1,RNF43,FZD5
R-HSA-977225	Amyloid formation	0.987235471861054	-0.0128466946886051	88	3	0.00413223140495868	726	8202	653604,2934,1471	HIST2H3D,GSN,CST3
R-HSA-5621481	C-type lectin receptors (CLRs)	0.987402242861712	-0.0126777816775642	123	5	0.0068870523415978	726	8202	5720,7311,5721,9039,4792	PSME1,UBA52,PSME2,UBA3,NFKBIA
R-HSA-4839726	Chromatin organization	0.987899553270776	-0.012174253132665	261	14	0.0192837465564738	726	8202	595,10765,9219,8841,64426,54556,3065,653604,23210,117143,79084,6603,55818,8726	CCND1,KDM5B,MTA2,HDAC3,SUDS3,ING3,HDAC1,HIST2H3D,JMJD6,TADA1,WDR77,SMARCD2,KDM3A,EED
R-HSA-3247509	Chromatin modifying enzymes	0.987899553270776	-0.012174253132665	261	14	0.0192837465564738	726	8202	595,10765,9219,8841,64426,54556,3065,653604,23210,117143,79084,6603,55818,8726	CCND1,KDM5B,MTA2,HDAC3,SUDS3,ING3,HDAC1,HIST2H3D,JMJD6,TADA1,WDR77,SMARCD2,KDM3A,EED
R-HSA-212300	PRC2 methylates histones and DNA	0.988373284689569	-0.0116948340780011	70	2	0.00275482093663912	726	8202	653604,8726	HIST2H3D,EED
R-HSA-936837	Ion transport by P-type ATPases	0.989488740504356	-0.0105668929791382	49	1	0.00137741046831956	726	8202	57205	ATP10D
R-HSA-171306	Packaging Of Telomere Ends	0.989488740504356	-0.0105668929791382	49	1	0.00137741046831956	726	8202	7014	TERF2
R-HSA-5578749	Transcriptional regulation by small RNAs	0.995156623600647	-0.00485514355738447	101	3	0.00413223140495868	726	8202	653604,5441,55746	HIST2H3D,POLR2L,NUP133
R-HSA-73728	RNA Polymerase I Promoter Opening	0.99623448909817	-0.00377261828556939	60	1	0.00137741046831956	726	8202	653604	HIST2H3D
R-HSA-5334118	DNA methylation	0.996876108552791	-0.00312878098166777	62	1	0.00137741046831956	726	8202	653604	HIST2H3D
R-HSA-5625886	Activated PKN1 stimulates transcription of AR (androgen receptor) regulated genes KLK2 and KLK3	0.997408524778786	-0.00259483890565192	64	1	0.00137741046831956	726	8202	653604	HIST2H3D
R-HSA-427359	SIRT1 negatively regulates rRNA Expression	0.99763971315987	-0.00236307670790387	65	1	0.00137741046831956	726	8202	653604	HIST2H3D
R-HSA-198933	Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	0.998348357078995	-0.00165300838688973	115	3	0.00413223140495868	726	8202	3106,3107,3105	HLA-B,HLA-C,HLA-A
R-HSA-606279	Deposition of new CENPA-containing nucleosomes at the centromere	0.998520976878886	-0.00148011795546723	70	1	0.00137741046831956	726	8202	55355	HJURP
R-HSA-774815	Nucleosome assembly	0.998520976878886	-0.00148011795546723	70	1	0.00137741046831956	726	8202	55355	HJURP
R-HSA-211000	Gene Silencing by RNA	0.99949383714566	-0.00050629099800036	130	3	0.00413223140495868	726	8202	653604,5441,55746	HIST2H3D,POLR2L,NUP133
R-HSA-3214847	HATs acetylate histones	0.999822120687426	-0.000177895134975021	143	3	0.00413223140495868	726	8202	54556,653604,117143	ING3,HIST2H3D,TADA1
R-HSA-162582	Signal Transduction	0.999886990197613	-0.000113016188476223	2357	167	0.230027548209366	726	8202	836,375790,55366,5565,50865,54894,5720,50848,11004,1026,92737,4628,9765,998,3572,220,5290,11221,5499,7074,1738,7311,51107,79971,23526,5571,983,5162,5228,572,58480,1398,1535,25805,51719,3065,6794,3315,7433,2335,2308,389,1609,6662,29127,3337,5997,9249,57534,3725,650,10811,2665,10846,1291,112,9735,10642,51384,9114,9475,56603,9184,157506,8841,23513,26999,388,1956,355,3667,1845,3091,5986,160,4792,10670,26020,2810,5564,523,5721,79885,2064,8737,526,54509,55824,2783,5139,5331,595,5164,4193,182,6464,55845,55746,2905,9928,28956,1027,4637,2149,7414,55534,152,1292,8322,991,5734,6232,5588,995,8050,133,2260,8324,9021,54331,817,10312,8854,6778,6772,6400,7088,10636,4343,5594,1175,10252,1272,1030,5142,55143,54821,136,1382,10788,2261,8313,653604,79659,6774,154796,6709,4851,2254,7050,51098,4303,8795,5295,5905,3570,54492,89941,9564,9227,301,332,2263,23220,113878,3685,7855	CASP3,AGRN,LGR4,PRKAB2,HEBP1,RNF43,PSME1,F11R,KIF2C,CDKN1A,DNER,MYH10,ZFYVE16,CDC42,IL6ST,ALDH1A3,PIK3CA,DUSP10,PPP1CA,TIAM1,DLD,UBA52,APH1A,WLS,HMHA1,PRKAG1,CDK1,PDHB,PGF,BAD,RHOU,CRK,CYBA,BAMBI,CAB39,HDAC1,STK11,HSPB1,VIPR1,FN1,FOXO1,RHOC,DGKQ,SOX9,RACGAP1,DNAJB1,RGS2,DHRS3,MIB1,JUN,BMP2,NOXA1,GDI2,PDE10A,COL6A1,ADCY6,KNTC1,IGF2BP1,WNT16,ATP6V0D1,ROCK2,CYP26B1,BUB3,RDH10,HDAC3,SCRIB,CYFIP2,RHOB,EGFR,FAS,IRS1,DUSP3,HIF1A,RFNG,AP2A1,NFKBIA,RRAGA,LRP10,SFN,PRKAB1,ATP6V1A,PSME2,HDAC11,ERBB2,RIPK1,ATP6V1B2,RHOF,PAG1,GNB2,PDE3A,PLCB3,CCND1,PDK2,MDM2,JAG1,SHC1,BRK1,NUP133,GRIN2C,KIF14,LAMTOR2,CDKN1B,MYL6,F2R,VCL,MAML3,ADRA2C,COL6A2,FZD4,CDC20,PTGER4,RPS27,PRKCQ,CDC25C,PDHX,ADM,FGFR1,FZD7,SOCS3,GNG2,CAMK2D,TCIRG1,ALDH1A2,STAT6,STAT1,SEL1L,TLE1,RGS14,MOV10,MAPK1,AP2S1,SPRY1,CNTN1,CDKN2B,PDE4B,CDCA8,ERCC6L,ADORA2B,CRABP2,IQGAP2,FGFR3,AXIN2,HIST2H3D,DYNC2H1,STAT3,AMOT,SPTAN1,NOTCH1,FGF9,TGIF1,IFT52,FOXO4,TNFRSF10B,PIK3R1,RANGAP1,IL6R,NEURL1B,RHOT2,BCAR1,LRAT,ANXA1,BIRC5,FGFR2,DTX4,DTX2,ITGAV,FZD5
R-HSA-418594	G alpha (i) signalling events	0.999932701569032	-6.73006956090258e-05	236	7	0.00964187327823691	726	8202	54331,152,112,10636,50865,2783,301	GNG2,ADRA2C,ADCY6,RGS14,HEBP1,GNB2,ANXA1
R-HSA-375276	Peptide ligand-binding receptors	0.999997217316557	-2.78268731482287e-06	193	3	0.00413223140495868	726	8202	2149,50865,301	F2R,HEBP1,ANXA1
R-HSA-500792	GPCR ligand binding	0.999999923807383	-7.61926201174107e-08	444	13	0.0179063360881543	726	8202	54331,152,8322,50865,5734,136,51384,7855,2149,2783,133,8324,301	GNG2,ADRA2C,FZD4,HEBP1,PTGER4,ADORA2B,WNT16,FZD5,F2R,GNB2,ADM,FZD7,ANXA1
R-HSA-373076	Class A/1 (Rhodopsin-like receptors)	0.999999971891993	-2.81080073813363e-08	318	6	0.00826446280991736	726	8202	152,136,2149,50865,5734,301	ADRA2C,ADORA2B,F2R,HEBP1,PTGER4,ANXA1
R-HSA-372790	Signaling by GPCR	0.99999999989492	-1.05079947990319e-10	1230	50	0.068870523415978	726	8202	7433,2335,5721,389,50865,1609,5142,2064,5720,136,5997,2783,5139,5331,2261,6464,998,2905,10846,28956,5290,11221,112,51384,5499,7414,7074,2149,9475,6709,152,2254,7311,8322,5295,5734,5588,133,2260,388,8324,1956,301,54331,3667,817,2263,7855,10636,5594	VIPR1,FN1,PSME2,RHOC,HEBP1,DGKQ,PDE4B,ERBB2,PSME1,ADORA2B,RGS2,GNB2,PDE3A,PLCB3,FGFR3,SHC1,CDC42,GRIN2C,PDE10A,LAMTOR2,PIK3CA,DUSP10,ADCY6,WNT16,PPP1CA,VCL,TIAM1,F2R,ROCK2,SPTAN1,ADRA2C,FGF9,UBA52,FZD4,PIK3R1,PTGER4,PRKCQ,ADM,FGFR1,RHOB,FZD7,EGFR,ANXA1,GNG2,IRS1,CAMK2D,FGFR2,FZD5,RGS14,MAPK1
R-HSA-388396	GPCR downstream signaling	0.999999999915924	-8.40756975914621e-11	928	27	0.0371900826446281	726	8202	7433,152,389,50865,1609,5295,5142,5734,5588,136,5997,2783,133,5139,388,5331,301,54331,6464,998,10846,5290,112,10636,7074,2149,9475	VIPR1,ADRA2C,RHOC,HEBP1,DGKQ,PIK3R1,PDE4B,PTGER4,PRKCQ,ADORA2B,RGS2,GNB2,ADM,PDE3A,RHOB,PLCB3,ANXA1,GNG2,SHC1,CDC42,PDE10A,PIK3CA,ADCY6,RGS14,TIAM1,F2R,ROCK2
R-HSA-381753	Olfactory Signaling Pathway	0.999999999972472	-2.75282085644016e-11	381	0	0	726	8202
R-HSA-5602680	MyD88 deficiency (TLR5)	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-265473	Trafficking of dietary sterols	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-5627083	RHO GTPases regulate CFTR trafficking	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-70350	Fructose catabolism	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-3359463	Defective CUBN causes hereditary megaloblastic anemia 1	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-1483152	Hydrolysis of LPE	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-5624958	ARL13B-mediated ciliary trafficking of INPP5E	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-191650	Regulation of gap junction activity	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-191647	c-src mediated regulation of Cx43 function and closure of gap junctions	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-1299308	Tandem of pore domain in a weak inwardly rectifying K+ channels (TWIK)	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-193681	Ceramide signalling	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-977347	Serine biosynthesis	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-3304347	Loss of Function of SMAD4 in Cancer	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-379401	Dopamine clearance from the synaptic cleft	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-844455	The NLRP1 inflammasome	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-177539	Autointegration results in viral DNA circles	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-5357572	Lysosomal glycogen catabolism	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-190704	Oligomerization of connexins into connexons	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-3359462	Defective AMN causes hereditary megaloblastic anemia 1	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-350864	Regulation of thyroid hormone activity	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-1299503	TWIK related potassium channel (TREK)	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-5339700	TCF7L2 mutants don't bind CTBP	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-1296067	Potassium transport channels	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-2892245	POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-977442	GABA A (rho) receptor activation	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-175567	Integration of viral DNA into host genomic DNA	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-5250958	Toxicity of botulinum toxin type B (BoNT/B)	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-5688031	Defective pro-SFTPB causes pulmonary surfactant metabolism dysfunction 1 (SMDP1) and respiratory distress syndrome (RDS)	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-3296197	Hydroxycarboxylic acid-binding receptors	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-217271	FMO oxidises nucleophiles	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-5602571	TRAF3 deficiency - HSE	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-139910	Activation of BMF and translocation to mitochondria	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-1483248	Synthesis of PIPs at the ER membrane	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-427589	Type II Na+/Pi cotransporters	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-3311021	SMAD4 MH2 Domain Mutants in Cancer	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-5250992	Toxicity of botulinum toxin type E (BoNT/E)	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-444411	Rhesus glycoproteins mediate ammonium transport.	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-190827	Transport of connexins along the secretory pathway	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-5635851	GLI proteins bind promoters of Hh responsive genes to promote transcription	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-844615	The AIM2 inflammasome	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-5250989	Toxicity of botulinum toxin type G (BoNT/G)	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-880009	Interconversion of 2-oxoglutarate and 2-hydroxyglutarate	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-5250971	Toxicity of botulinum toxin type C (BoNT/C)	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-165181	Inhibition of TSC complex formation by PKB	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-1307965	betaKlotho-mediated ligand binding	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-162699	Synthesis of dolichyl-phosphate mannose	0.999999999974913	-2.50872565993668e-11	3	0	0	726	8202
R-HSA-68881	Mitotic Metaphase/Anaphase Transition	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-205017	NFG and proNGF binds to p75NTR	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-168277	Influenza Virus Induced Apoptosis	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-168268	Virus Assembly and Release	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-1483101	Synthesis of PS	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-192905	vRNP Assembly	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-379397	Enzymatic degradation of dopamine by COMT	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-211728	Regulation of PAK-2p34 activity by PS-GAP/RHG10	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-176034	Interactions of Tat with host cellular proteins	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-1299361	TWIK-related alkaline pH activated K+ channel (TALK)	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-177162	Conjugation of phenylacetate with glutamine	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-5652227	Fructose biosynthesis	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-3359469	Defective MTR causes methylmalonic aciduria and homocystinuria type cblG	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-5579031	Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD)	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-3828062	Glycogen storage disease type 0 (muscle GYS1)	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-844623	The IPAF inflammasome	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-5545619	XAV939 inhibits tankyrase, stabilizing AXIN	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-1614603	Cysteine formation from homocysteine	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-380612	Metabolism of serotonin	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-164939	Nef mediated downregulation of CD28 cell surface expression	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-156582	Acetylation	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-1299316	TWIK-releated acid-sensitive K+ channel (TASK)	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-141424	Amplification of signal from the kinetochores	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-3642279	TGFBR2 MSI Frameshift Mutants in Cancer	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-141444	Amplification  of signal from unattached  kinetochores via a MAD2  inhibitory signal	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-888568	GABA synthesis	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-190872	Transport of connexons to the plasma membrane	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-5687868	Defective SFTPA2 causes idiopathic pulmonary fibrosis (IPF)	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-111457	Release of apoptotic factors from the mitochondria	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-168316	Assembly of Viral Components at the Budding Site	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-428559	Proton-coupled neutral amino acid transporters	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-211994	Sterols are 12-hydroxylated by CYP8B1	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-165160	PDE3B signalling	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-5688354	Defective pro-SFTPC causes pulmonary surfactant metabolism dysfunction 2 (SMDP2) and respiratory distress syndrome (RDS)	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-3359467	Defective MTRR causes methylmalonic aciduria and homocystinuria type cblE	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-203754	NOSIP mediated eNOS trafficking	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-380615	Serotonin clearance from the synaptic cleft	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-3359478	Defective MUT causes methylmalonic aciduria mut type	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-5357609	Glycogen storage disease type II (GAA)	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-198765	Signalling to ERK5	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-351143	Agmatine biosynthesis	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-70688	Proline catabolism	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-3359475	Defective MMAA causes methylmalonic aciduria type cblA	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-379398	Enzymatic degradation of Dopamine by monoamine oxidase	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-187042	TRKA activation by NGF	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-75094	Formation of the Editosome	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-166020	Transfer of LPS from LBP carrier to CD14	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-3814836	Glycogen storage disease type XV (GYG1)	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-141333	Biogenic amines are oxidatively deaminated to aldehydes by MAOA and MAOB	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-168315	Inhibition of Host mRNA Processing and RNA Silencing	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-5602566	TICAM1 deficiency - HSE	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-5602636	IKBKB deficiency causes SCID	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-73930	Abasic sugar-phosphate removal via the single-nucleotide replacement pathway	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-3359485	Defective CD320 causes methylmalonic aciduria	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-3359473	Defective MMADHC causes methylmalonic aciduria and homocystinuria type cblD	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-5619107	Defective TRP may confer susceptibility towards thyroid papillary carcinoma (TPC)	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-451307	Activation of Na-permeable Kainate Receptors	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-3858516	Glycogen storage disease type 0 (liver GYS2)	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-432030	Transport of glycerol from adipocytes to the liver by Aquaporins	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-111452	Activation and oligomerization of BAK protein	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-72200	mRNA Editing: C to U Conversion	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-1483226	Synthesis of PI	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-5662702	Melanin biosynthesis	0.99999999997658	-2.34199430682036e-11	2	0	0	726	8202
R-HSA-1222499	Response of Mtb to phagocytosis	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-5340573	WNT ligand secretion is abrogated by the PORCN inhibitor LGK974	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-3359454	Defective TCN2 causes hereditary megaloblastic anemia	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-5602410	TLR3 deficiency - HSE	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-389542	NADPH regeneration	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-190840	Microtubule-dependent trafficking of connexons from Golgi to the plasma membrane	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-112122	ALKBH2 mediated reversal of alkylation damage	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-1299344	TWIK-related spinal cord K+ channel (TRESK)	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-1839128	FGFR4 mutant receptor activation	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-163316	Mitochondrial transcription termination	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-2534343	Interaction With Cumulus Cells	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-3248023	Regulation by TREX1	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-1222352	Latent infection of Homo sapiens with Mycobacterium tuberculosis	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-480985	Synthesis of dolichyl-phosphate-glucose	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-169131	Inhibition of PKR	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-1855231	Synthesis of IPs in the ER lumen	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-5657655	MGMT-mediated DNA damage reversal	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-162589	Reverse Transcription of HIV RNA	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-211957	Aromatic amines can be N-hydroxylated or N-dealkylated by CYP1A2	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-1299287	Tandem pore domain halothane-inhibited K+ channel (THIK)	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-1483076	Synthesis of CL	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-171286	Synthesis and processing of ENV and VPU	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-3359474	Defective MMACHC causes methylmalonic aciduria and homocystinuria type cblC	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-168275	Entry of Influenza Virion into Host Cell via Endocytosis	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-140180	COX reactions	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-5619058	Defective SLCO1B3 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-162585	Uncoating of the HIV Virion	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-164525	Plus-strand DNA synthesis	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-5678895	Defective CFTR causes cystic fibrosis	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-5619110	Defective SLCO1B1 causes hyperbilirubinemia, Rotor type (HBLRR)	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-164516	Minus-strand DNA synthesis	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-5250982	Toxicity of tetanus toxin (TeNT)	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-2466712	Biosynthesis of A2E, implicated in retinal degradation	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-1222449	Mtb iron assimilation by chelation	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-1300645	Acrosome Reaction	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-5467333	APC truncation mutants are not K63 polyubiquitinated	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-3359457	Defective GIF causes intrinsic factor deficiency	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-975574	Reactions specific to the hybrid N-glycan synthesis pathway	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-2978092	Abnormal conversion of 2-oxoglutarate to 2-hydroxyglutarate	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-2142696	Synthesis of Hepoxilins (HX) and Trioxilins (TrX)	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-5619084	ABC transporter disorders	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-1483196	PI and PC transport between ER and Golgi membranes	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-5602415	UNC93B1 deficiency - HSE	0.999999999983391	-1.66092556375119e-11	1	0	0	726	8202
R-HSA-3134973	LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-390648	Muscarinic acetylcholine receptors	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-111932	CaMK IV-mediated phosphorylation of CREB	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-5652084	Fructose metabolism	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-2161541	Abacavir metabolism	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-3000471	Scavenging by Class B Receptors	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-167827	The proton buffering model	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-1300652	Sperm:Oocyte Membrane Binding	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-163358	PKA-mediated phosphorylation of key metabolic factors	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-444209	Free fatty acid receptors	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-5250981	Toxicity of botulinum toxin type F (BoNT/F)	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-210746	Regulation of gene expression in endocrine-committed (NEUROG3+) progenitor cells	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-166187	Mitochondrial Uncoupling Proteins	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-427652	Sodium-coupled phosphate cotransporters	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-114516	Disinhibition of SNARE formation	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-390651	Dopamine receptors	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-71032	Propionyl-CoA catabolism	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-187024	NGF-independant TRKA activation	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-5250955	Toxicity of botulinum toxin type D (BoNT/D)	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-2855086	Ficolins bind to repetitive carbohydrate structures on the target cell surface	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-380095	Tachykinin receptors bind tachykinins	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-112303	Electric Transmission Across Gap Junctions	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-561048	Organic anion transport	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-433137	Sodium-coupled sulphate, di- and tri-carboxylate transporters	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-391906	Leukotriene receptors	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-203641	NOSTRIN mediated eNOS trafficking	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-68911	G2 Phase	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-5368598	Negative regulation of TCF-dependent signaling by DVL-interacting proteins	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-426048	Arachidonate production from DAG	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-1169092	Activation of RAS in B cells	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-112307	Transmission across Electrical Synapses	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-167826	The fatty acid cycling model	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-209931	Serotonin and melatonin biosynthesis	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-5661270	Catabolism of glucuronate to xylulose-5-phosphate	0.999999999986358	-1.36419845036788e-11	5	0	0	726	8202
R-HSA-5250968	Toxicity of botulinum toxin type A (BoNT/A)	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-5221030	TET1,2,3 and TDG demethylate DNA	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-193144	Estrogen biosynthesis	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-3642278	Loss of Function of TGFBR2 in Cancer	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-3645790	TGFBR2 Kinase Domain Mutants in Cancer	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-173736	Alternative complement activation	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-204626	Hypusine synthesis from eIF5A-lysine	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-1296061	HCN channels	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-111448	Activation of NOXA and translocation to mitochondria	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-3656535	TGFBR1 LBD Mutants in Cancer	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-1296053	Classical Kir channels	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-194306	Neurophilin interactions with VEGF and VEGFR	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-2473224	Antagonism of Activin by Follistatin	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-5603037	IRAK4 deficiency (TLR5)	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-888593	Reuptake of GABA	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-427975	Proton/oligopeptide cotransporters	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-1855191	Synthesis of IPs in the nucleus	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-1369007	Mitochondrial ABC transporters	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-75896	Plasmalogen biosynthesis	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-3000497	Scavenging by Class H Receptors	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-399710	Activation of AMPA receptors	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-110381	Resolution of AP sites via the single-nucleotide replacement pathway	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-209905	Catecholamine biosynthesis	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-209563	Axonal growth stimulation	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-3878781	Glycogen storage disease type IV (GBE1)	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-196819	Vitamin B1 (thiamin) metabolism	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-428776	Class II GLUTs	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-5619099	Defective AVP causes neurohypophyseal diabetes insipidus (NDI)	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-165158	Activation of AKT2	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-75108	Activation, myristolyation of BID and translocation to mitochondria	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-173107	Binding and entry of HIV virion	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-442745	Activation of CaMK IV	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-1296025	ATP sensitive Potassium channels	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-390650	Histamine receptors	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-167060	NGF processing	0.999999999986604	-1.33961835900457e-11	4	0	0	726	8202
R-HSA-196780	Biotin transport and metabolism	0.999999999988099	-1.19009146375599e-11	11	0	0	726	8202
R-HSA-2485179	Activation of the phototransduction cascade	0.999999999988099	-1.19009146375599e-11	11	0	0	726	8202
R-HSA-68689	CDC6 association with the ORC:origin complex	0.999999999988099	-1.19009146375599e-11	11	0	0	726	8202
R-HSA-376172	DSCAM interactions	0.999999999988099	-1.19009146375599e-11	11	0	0	726	8202
R-HSA-5602498	MyD88 deficiency (TLR2/4)	0.999999999988099	-1.19009146375599e-11	11	0	0	726	8202
R-HSA-2468052	Establishment of Sister Chromatid Cohesion	0.999999999988099	-1.19009146375599e-11	11	0	0	726	8202
R-HSA-5603041	IRAK4 deficiency (TLR2/4)	0.999999999988099	-1.19009146375599e-11	11	0	0	726	8202
R-HSA-375281	Hormone ligand-binding receptors	0.999999999988099	-1.19009146375599e-11	11	0	0	726	8202
R-HSA-975110	TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling	0.999999999988099	-1.19009146375599e-11	11	0	0	726	8202
R-HSA-3296469	Defects in cobalamin (B12) metabolism	0.999999999988099	-1.19009146375599e-11	11	0	0	726	8202
R-HSA-211999	CYP2E1 reactions	0.999999999988099	-1.19009146375599e-11	11	0	0	726	8202
R-HSA-629594	Highly calcium permeable postsynaptic nicotinic acetylcholine receptors	0.999999999988099	-1.19009146375599e-11	11	0	0	726	8202
R-HSA-193048	Androgen biosynthesis	0.999999999988099	-1.19009146375599e-11	11	0	0	726	8202
R-HSA-71240	Tryptophan catabolism	0.999999999988099	-1.19009146375599e-11	11	0	0	726	8202
R-HSA-5336415	Uptake and function of diphtheria toxin	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-68952	DNA replication initiation	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-70921	Histidine catabolism	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-388479	Vasopressin-like receptors	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-171052	LDL-mediated lipid transport	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-5660668	CLEC7A/inflammasome pathway	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-171319	Telomere Extension By Telomerase	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-2142700	Synthesis of Lipoxins (LX)	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-193993	Mineralocorticoid biosynthesis	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-947581	Molybdenum cofactor biosynthesis	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-5626978	TNFR1-mediated ceramide production	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-173623	Classical antibody-mediated complement activation	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-68616	Assembly of the ORC complex at the origin of replication	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-111957	Cam-PDE 1 activation	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-187015	Activation of TRKA receptors	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-174430	Telomere C-strand synthesis initiation	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-442717	CREB phosphorylation through the activation of CaMKK	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-177135	Conjugation of benzoate with glycine	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-428808	Na+-dependent glucose transporters	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-3304356	SMAD2/3 Phosphorylation Motif Mutants in Cancer	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-166662	Lectin pathway of complement activation	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-5339717	Misspliced LRP5 mutants have enhanced beta-catenin-dependent signaling	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-189483	Heme degradation	0.999999999989391	-1.06088945914584e-11	6	0	0	726	8202
R-HSA-168799	Neurotoxicity of clostridium toxins	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-1660517	Synthesis of PIPs at the late endosome membrane	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-381183	ATF6-alpha activates chaperone genes	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-419771	Opsins	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-418359	Reduction of cytosolic Ca++ levels	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-5685939	HDR through MMEJ (alt-NHEJ)	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-2474795	Diseases associated with visual transduction	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-2470946	Cohesin Loading onto Chromatin	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-418886	Netrin mediated repulsion signals	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-549127	Organic cation transport	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-2453864	Retinoid cycle disease events	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-1300644	Interaction With The Zona Pellucida	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-1433617	Regulation of signaling by NODAL	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-5621480	Dectin-2 family	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-190873	Gap junction degradation	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-418890	Role of second messengers in netrin-1 signaling	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-1855167	Synthesis of pyrophosphates in the cytosol	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-5687613	Diseases associated with surfactant metabolism	0.999999999989789	-1.02111591159372e-11	10	0	0	726	8202
R-HSA-1482922	Acyl chain remodelling of PI	0.999999999990053	-9.94659172449037e-12	16	0	0	726	8202
R-HSA-2559584	Formation of Senescence-Associated Heterochromatin Foci (SAHF)	0.999999999990053	-9.94659172449037e-12	16	0	0	726	8202
R-HSA-1170546	Prolactin receptor signaling	0.999999999990053	-9.94659172449037e-12	16	0	0	726	8202
R-HSA-1433559	Regulation of KIT signaling	0.999999999990053	-9.94659172449037e-12	16	0	0	726	8202
R-HSA-416700	Other semaphorin interactions	0.999999999991834	-8.16577177965609e-12	19	0	0	726	8202
R-HSA-190861	Gap junction assembly	0.999999999991834	-8.16577177965609e-12	19	0	0	726	8202
R-HSA-1181150	Signaling by NODAL	0.999999999991834	-8.16577177965609e-12	19	0	0	726	8202
R-HSA-418360	Platelet calcium homeostasis	0.999999999991834	-8.16577177965609e-12	19	0	0	726	8202
R-HSA-442660	Na+/Cl- dependent neurotransmitter transporters	0.999999999991834	-8.16577177965609e-12	19	0	0	726	8202
R-HSA-193368	Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol	0.999999999992133	-7.86725038694647e-12	24	0	0	726	8202
R-HSA-164944	Nef and signal transduction	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-5619115	Disorders of transmembrane transporters	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-416550	Sema4D mediated inhibition of cell attachment and migration	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-1483115	Hydrolysis of LPC	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-450520	HuR (ELAVL1) binds and stabilizes mRNA	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-5688849	Defective CSF2RB causes pulmonary surfactant metabolism dysfunction 5 (SMDP5)	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-73928	Depyrimidination	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-110329	Cleavage of the damaged pyrimidine	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-804914	Transport of fatty acids	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-5688890	Defective CSF2RA causes pulmonary surfactant metabolism dysfunction 4 (SMDP4)	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-199418	Negative regulation of the PI3K/AKT network	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-112311	Neurotransmitter Clearance In The Synaptic Cleft	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-196783	Coenzyme A biosynthesis	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-444821	Relaxin receptors	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-5358493	Synthesis of diphthamide-EEF2	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-3304351	Signaling by TGF-beta Receptor Complex in Cancer	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-177128	Conjugation of salicylate with glycine	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-389397	Orexin and neuropeptides FF and QRFP bind to their respective receptors	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-5362798	Release of Hh-Np from the secreting cell	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-72731	Recycling of eIF2:GDP	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-5632681	Ligand-receptor interactions	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-210747	Regulation of gene expression in early pancreatic precursor cells	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-163765	ChREBP activates metabolic gene expression	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-193634	Axonal growth inhibition (RHOA activation)	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-110328	Recognition and association of DNA glycosylase with site containing an affected pyrimidine	0.999999999994903	-5.09744461376332e-12	8	0	0	726	8202
R-HSA-194002	Glucocorticoid biosynthesis	0.999999999994922	-5.07800568658224e-12	9	0	0	726	8202
R-HSA-425561	Sodium/Calcium exchangers	0.999999999994922	-5.07800568658224e-12	9	0	0	726	8202
R-HSA-156587	Amino Acid conjugation	0.999999999994922	-5.07800568658224e-12	9	0	0	726	8202
R-HSA-162592	Integration of provirus	0.999999999994922	-5.07800568658224e-12	9	0	0	726	8202
R-HSA-1300642	Sperm Motility And Taxes	0.999999999994922	-5.07800568658224e-12	9	0	0	726	8202
R-HSA-426486	Small interfering RNA (siRNA) biogenesis	0.999999999994922	-5.07800568658224e-12	9	0	0	726	8202
R-HSA-70635	Urea cycle	0.999999999994922	-5.07800568658224e-12	9	0	0	726	8202
R-HSA-189085	Digestion of dietary carbohydrate	0.999999999994922	-5.07800568658224e-12	9	0	0	726	8202
R-HSA-419408	Lysosphingolipid and LPA receptors	0.999999999994922	-5.07800568658224e-12	9	0	0	726	8202
R-HSA-629597	Highly calcium permeable nicotinic acetylcholine receptors	0.999999999994922	-5.07800568658224e-12	9	0	0	726	8202
R-HSA-193697	p75NTR regulates axonogenesis	0.999999999994922	-5.07800568658224e-12	9	0	0	726	8202
R-HSA-159424	Conjugation of carboxylic acids	0.999999999994922	-5.07800568658224e-12	9	0	0	726	8202
R-HSA-196025	Formation of annular gap junctions	0.999999999994922	-5.07800568658224e-12	9	0	0	726	8202
R-HSA-139853	Elevation of cytosolic Ca2+ levels	0.999999999994922	-5.07800568658224e-12	9	0	0	726	8202
R-HSA-201688	WNT mediated activation of DVL	0.999999999994922	-5.07800568658224e-12	9	0	0	726	8202
R-HSA-1462054	Alpha-defensins	0.999999999994922	-5.07800568658224e-12	9	0	0	726	8202
R-HSA-390450	Folding of actin by CCT/TriC	0.999999999994922	-5.07800568658224e-12	9	0	0	726	8202
R-HSA-202430	Translocation of ZAP-70 to Immunological synapse	0.999999999996058	-3.94171551999764e-12	18	0	0	726	8202
R-HSA-5635838	Activation of SMO	0.999999999996058	-3.94171551999764e-12	18	0	0	726	8202
R-HSA-1660514	Synthesis of PIPs at the Golgi membrane	0.999999999996058	-3.94171551999764e-12	18	0	0	726	8202
R-HSA-5223345	Miscellaneous transport and binding events	0.999999999996058	-3.94171551999764e-12	18	0	0	726	8202
R-HSA-3296482	Defects in vitamin and cofactor metabolism	0.999999999996058	-3.94171551999764e-12	18	0	0	726	8202
R-HSA-2162123	Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	0.999999999996549	-3.45086195215553e-12	14	0	0	726	8202
R-HSA-181431	Acetylcholine Binding And Downstream Events	0.999999999996549	-3.45086195215553e-12	14	0	0	726	8202
R-HSA-5467340	AXIN missense mutants destabilize the destruction complex	0.999999999996549	-3.45086195215553e-12	14	0	0	726	8202
R-HSA-629602	Activation of Nicotinic Acetylcholine Receptors	0.999999999996549	-3.45086195215553e-12	14	0	0	726	8202
R-HSA-4839744	truncated APC mutants destabilize the destruction complex	0.999999999996549	-3.45086195215553e-12	14	0	0	726	8202
R-HSA-5467348	Truncations of AMER1 destabilize the destruction complex	0.999999999996549	-3.45086195215553e-12	14	0	0	726	8202
R-HSA-193775	Synthesis of bile acids and bile salts via 24-hydroxycholesterol	0.999999999996549	-3.45086195215553e-12	14	0	0	726	8202
R-HSA-4839735	AXIN mutants destabilize the destruction complex, activating WNT signaling	0.999999999996549	-3.45086195215553e-12	14	0	0	726	8202
R-HSA-622327	Postsynaptic nicotinic acetylcholine receptors	0.999999999996549	-3.45086195215553e-12	14	0	0	726	8202
R-HSA-5467337	APC truncation mutants have impaired AXIN binding	0.999999999996549	-3.45086195215553e-12	14	0	0	726	8202
R-HSA-5682910	LGI-ADAM interactions	0.999999999996549	-3.45086195215553e-12	14	0	0	726	8202
R-HSA-4839748	AMER1 mutants destabilize the destruction complex	0.999999999996549	-3.45086195215553e-12	14	0	0	726	8202
R-HSA-166663	Initial triggering of complement	0.999999999996778	-3.22151426769616e-12	20	0	0	726	8202
R-HSA-209952	Peptide hormone biosynthesis	0.999999999999063	-9.36633407984581e-13	15	0	0	726	8202
R-HSA-5358751	S45 mutants of beta-catenin aren't phosphorylated	0.999999999999063	-9.36633407984581e-13	15	0	0	726	8202
R-HSA-193807	Synthesis of bile acids and bile salts via 27-hydroxycholesterol	0.999999999999063	-9.36633407984581e-13	15	0	0	726	8202
R-HSA-5358747	S33 mutants of beta-catenin aren't phosphorylated	0.999999999999063	-9.36633407984581e-13	15	0	0	726	8202
R-HSA-549132	Organic cation/anion/zwitterion transport	0.999999999999063	-9.36633407984581e-13	15	0	0	726	8202
R-HSA-4839743	phosphorylation site mutants of CTNNB1 are not targeted to the proteasome by the destruction complex	0.999999999999063	-9.36633407984581e-13	15	0	0	726	8202
R-HSA-194223	HDL-mediated lipid transport	0.999999999999063	-9.36633407984581e-13	15	0	0	726	8202
R-HSA-5358752	T41 mutants of beta-catenin aren't phosphorylated	0.999999999999063	-9.36633407984581e-13	15	0	0	726	8202
R-HSA-975577	N-Glycan antennae elongation	0.999999999999063	-9.36633407984581e-13	15	0	0	726	8202
R-HSA-5358749	S37 mutants of beta-catenin aren't phosphorylated	0.999999999999063	-9.36633407984581e-13	15	0	0	726	8202
R-HSA-5339716	Misspliced GSK3beta mutants stabilize beta-catenin	0.999999999999063	-9.36633407984581e-13	15	0	0	726	8202
R-HSA-3772470	Negative regulation of TCF-dependent signaling by WNT ligand antagonists	0.999999999999063	-9.36633407984581e-13	15	0	0	726	8202
R-HSA-192105	Synthesis of bile acids and bile salts	0.999999999999752	-2.48482143630264e-13	27	0	0	726	8202
R-HSA-5423646	Aflatoxin activation and detoxification	1.00000000000115	1.14685258561919e-12	22	0	0	726	8202
R-HSA-203765	eNOS activation and regulation	1.00000000000115	1.14685258561919e-12	22	0	0	726	8202
R-HSA-389513	CTLA4 inhibitory signaling	1.00000000000115	1.14685258561919e-12	22	0	0	726	8202
R-HSA-202131	Metabolism of nitric oxide	1.00000000000115	1.14685258561919e-12	22	0	0	726	8202
R-HSA-442720	CREB phosphorylation through the activation of Adenylate Cyclase	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-174577	Activation of C3 and C5	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-3656534	Loss of Function of TGFBR1 in Cancer	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-3323169	Defects in biotin (Btn) metabolism	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-3304349	Loss of Function of SMAD2/3 in Cancer	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-3656225	Defective CHST6 causes MCDC1	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-199920	CREB phosphorylation	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-83936	Transport of nucleosides and free purine and pyrimidine bases across the plasma membrane	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-629587	Highly sodium permeable acetylcholine nicotinic receptors	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-3315487	SMAD2/3 MH2 Domain Mutants in Cancer	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-166665	Terminal pathway of complement	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-3656244	Defective B4GALT1 causes B4GALT1-CDG (CDG-2d)	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-429593	Inositol transporters	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-3371599	Defective HLCS causes multiple carboxylase deficiency	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-163767	PP2A-mediated dephosphorylation of key metabolic factors	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-5619102	SLC transporter disorders	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-5649702	APEX1-Independent Resolution of AP Sites via the Single Nucleotide Replacement Pathway	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-448706	Interleukin-1 processing	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-3656532	TGFBR1 KD Mutants in Cancer	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-3656243	Defective ST3GAL3 causes MCT12 and EIEE15	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-164843	2-LTR circle formation	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-426496	Post-transcriptional silencing by small RNAs	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-2393930	Phosphate bond hydrolysis by NUDT proteins	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-2142789	Ubiquinol biosynthesis	1.00000000000304	3.04024375278511e-12	7	0	0	726	8202
R-HSA-389948	PD-1 signaling	1.00000000000457	4.5748310548168e-12	23	0	0	726	8202
R-HSA-203615	eNOS activation	1.00000000000568	5.67611789575839e-12	12	0	0	726	8202
R-HSA-451308	Activation of Ca-permeable Kainate Receptor	1.00000000000568	5.67611789575839e-12	12	0	0	726	8202
R-HSA-451306	Ionotropic activity of Kainate Receptors	1.00000000000568	5.67611789575839e-12	12	0	0	726	8202
R-HSA-390666	Serotonin receptors	1.00000000000568	5.67611789575839e-12	12	0	0	726	8202
R-HSA-199220	Vitamin B5 (pantothenate) metabolism	1.00000000000568	5.67611789575839e-12	12	0	0	726	8202
R-HSA-71384	Ethanol oxidation	1.00000000000568	5.67611789575839e-12	12	0	0	726	8202
R-HSA-2168880	Scavenging of heme from plasma	1.00000000000568	5.67611789575839e-12	12	0	0	726	8202
R-HSA-1296346	Tandem pore domain potassium channels	1.00000000000568	5.67611789575839e-12	12	0	0	726	8202
R-HSA-176974	Unwinding of DNA	1.00000000000568	5.67611789575839e-12	12	0	0	726	8202
R-HSA-417957	P2Y receptors	1.00000000000568	5.67611789575839e-12	12	0	0	726	8202
R-HSA-166786	Creation of C4 and C2 activators	1.00000000000568	5.67611789575839e-12	12	0	0	726	8202
R-HSA-622323	Presynaptic nicotinic acetylcholine receptors	1.00000000000568	5.67611789575839e-12	12	0	0	726	8202
R-HSA-113501	Inhibition of replication initiation of damaged DNA by RB1/E2F1	1.00000000000568	5.67611789575839e-12	12	0	0	726	8202
R-HSA-1474151	Tetrahydrobiopterin (BH4) synthesis, recycling, salvage and regulation	1.00000000000568	5.67611789575839e-12	12	0	0	726	8202
R-HSA-381033	ATF6-alpha activates chaperones	1.00000000000568	5.67611789575839e-12	12	0	0	726	8202
R-HSA-352230	Amino acid transport across the plasma membrane	1.00000000000622	6.22216638385717e-12	31	0	0	726	8202
R-HSA-1474165	Reproduction	1.00000000000666	6.65905220424235e-12	26	0	0	726	8202
R-HSA-975298	Ligand-gated ion channel transport	1.00000000000666	6.65905220424235e-12	26	0	0	726	8202
R-HSA-1187000	Fertilization	1.00000000000666	6.65905220424235e-12	26	0	0	726	8202
R-HSA-202433	Generation of second messenger molecules	1.00000000000765	7.65312654716029e-12	32	0	0	726	8202
R-HSA-1502540	Signaling by Activin	1.00000000000863	8.63236755667846e-12	13	0	0	726	8202
R-HSA-2029481	FCGR activation	1.00000000000863	8.63236755667846e-12	13	0	0	726	8202
R-HSA-977441	GABA A receptor activation	1.00000000000863	8.63236755667846e-12	13	0	0	726	8202
R-HSA-5210891	Uptake and function of anthrax toxins	1.00000000000863	8.63236755667846e-12	13	0	0	726	8202
R-HSA-171007	p38MAPK events	1.00000000000863	8.63236755667846e-12	13	0	0	726	8202
R-HSA-112308	Depolarization of the Presynaptic Terminal Triggers the Opening of Calcium Channels	1.00000000000863	8.63236755667846e-12	13	0	0	726	8202
R-HSA-209822	Glycoprotein hormones	1.00000000000863	8.63236755667846e-12	13	0	0	726	8202
R-HSA-75892	Platelet Adhesion to exposed collagen	1.00000000000863	8.63236755667846e-12	13	0	0	726	8202
R-HSA-5607763	CLEC7A (Dectin-1) induces NFAT activation	1.00000000000863	8.63236755667846e-12	13	0	0	726	8202
R-HSA-5673000	RAF activation	1.00000000000894	8.9411949441322e-12	25	0	0	726	8202
R-HSA-5669034	TNFs bind their physiological receptors	1.00000000000894	8.9411949441322e-12	25	0	0	726	8202
R-HSA-196299	Beta-catenin phosphorylation cascade	1.00000000000992	9.91905231067112e-12	17	0	0	726	8202
R-HSA-1482925	Acyl chain remodelling of PG	1.00000000000992	9.91905231067112e-12	17	0	0	726	8202
R-HSA-174800	Chylomicron-mediated lipid transport	1.00000000000992	9.91905231067112e-12	17	0	0	726	8202
R-HSA-5676594	TNF receptor superfamily (TNFSF) members mediating non-canonical NF-kB pathway	1.00000000000992	9.91905231067112e-12	17	0	0	726	8202
R-HSA-432142	Platelet sensitization by LDL	1.00000000000992	9.91905231067112e-12	17	0	0	726	8202
R-HSA-1461957	Beta defensins	1.00000000001014	1.01407541332396e-11	42	0	0	726	8202
R-HSA-5218920	VEGFR2 mediated vascular permeability	1.00000000001302	1.3024968584765e-11	28	0	0	726	8202
R-HSA-190828	Gap junction trafficking	1.00000000001302	1.3024968584765e-11	28	0	0	726	8202
R-HSA-157858	Gap junction trafficking and regulation	1.0000000000133	1.32967927530232e-11	30	0	0	726	8202
R-HSA-174824	Lipoprotein metabolism	1.0000000000133	1.32967927530232e-11	30	0	0	726	8202
R-HSA-1461973	Defensins	1.00000000001542	1.54186783968928e-11	51	0	0	726	8202
R-HSA-1296072	Voltage gated Potassium channels	1.00000000001934	1.93401156436618e-11	43	0	0	726	8202
R-HSA-5339562	Uptake and actions of bacterial toxins	1.00000000002158	2.15769441912261e-11	29	0	0	726	8202
R-HSA-420499	Class C/3 (Metabotropic glutamate/pheromone receptors)	1.00000000002465	2.46509310386596e-11	39	0	0	726	8202
R-HSA-5173214	O-glycosylation of TSR domain-containing proteins	1.00000000002465	2.46509310386596e-11	39	0	0	726	8202
R-HSA-380108	Chemokine receptors bind chemokines	1.0000000000247	2.47024092957219e-11	56	0	0	726	8202
R-HSA-211981	Xenobiotics	1.00000000002499	2.49905686297703e-11	21	0	0	726	8202
R-HSA-5621575	CD209 (DC-SIGN) signaling	1.00000000002499	2.49905686297703e-11	21	0	0	726	8202
